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1 INTRODUCTION 
 
This chapter introduces the family of carbazole alkaloids. Their natural occurrence and 
pharmacological properties are presented. Various strategies for the synthesis of carbazole 
derivatives are compared to the approach of choice, the iron-mediated synthesis.  
 
1.1 Carbazole alkaloids 
 
Over the past five decades a broad range of biologically active carbazole alkaloids were 
isolated. In 1959 Schmutz et al. were the first to describe a naturally occurring carbazole 
alkaloid: olivacine (1, Fig. 1) was isolated from Aspidosperma olivaceum[1]. Six years later 
Chakraborty et al. described the isolation and antibiotic effects of a further carbazole alkaloid 
and named it murrayanine (2)[2]. It derived from the leaves of Murraya koenigii, a small tree 
from India, commonly known as curry-leaf tree. Since the discovery of their antibiotic 
properties there has been an intensive interest in isolation, synthesis and biological activity of 
carbazole alkaloids by both biologists and chemists. The fact that several reviews[3, 4] and 
book chapters[5] have been published in the last years emphasises the increasing interest.  
 
 
 
 
 
 
All carbazole alkaloids consist of a carbazole framework or related structures. Carbazole (3) 
itself was first isolated from coal tar (content 1.5%) in 1872 by Graebe and Glaser[6]. 
Commonly, all atoms are denoted as shown in Fig. 2, with the A ring usually being the higher 
substituted one. Carbazole exists mostly in that tautomeric form, whereas one hydrogen atom 
is located at the nitrogen atom (N-9), named 9H-carbazole (Fig. 2). In 1987, 9H-carbazole 
was isolated from a natural source for the first time. Bhattacharyya et al. isolated the 
heterocycle from the root bark of Glycosmis pentaphylla, an Indian medicinal plant[7]. 
N
H
N
N
H O
CHO
1 2  
Fig. 1: Olivacine (1) and murrayanine (2) 
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1.2 Natural sources  
 
There are diverse biological sources from which carbazole alkaloids can be obtained. Most of 
these natural products have been isolated from higher plants like Murraya, Glycosmis, 
Micromelum and Clausena from the family Rutaceae. However, several alkaloids have been 
found in microorganisms, bacteria, like different Streptomyces, yeasts, and marine sources 
like the blue-green alga Hyella caespitosa.  
 
Some alkylated carbazoles can be detected in soil humus, coal tar or polluted atmosphere such 
as cigarette smoke. A list of all known natural sources of carbazole alkaloids is shown in 
reference [5]. 
 
1.3 Biosynthesis of carbazole alkaloids 
 
In general there are two different biosynthetic pathways discussed for naturally occurring 
carbazole alkaloids. It is considered that they are either synthesised in vivo from shikimic acid 
or L-tryptophan, depending on their origin[5].  
 
3-Methylcarbazole (4) and its oxidised derivatives (3-formylcarbazole and methyl carbazole-
3-carboxylate) are assumed to be intermediates in the biosynthesis of more complex and 
higher oxidised carbazole alkaloids. These compounds could be isolated from all natural 
sources in the family of Rutaceae. This fact indicates that the methyl group in 3-
methylcarbazole (4) can be oxidised in vivo and that 4 is a key biogenetic precursor. The 
simultaneous occurrence of various 1-, 2- and 4-oxygenated 3-methylcarbazoles verifies the 
importance of 3-methylcarbazole (4) in biosynthesis[5]. 
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Fig. 2: 9H-Carbazole (3) 
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The exact pathway for the formation of the carbazole framework in nature has not yet been 
proven. There are considerations that the carbazole nucleus could be derived from shikimic 
acid and either mevalonic or prephenic acid (shikimic acid pathway), or from L-tryptophan 
and mevalonic acid (L-tryptophan pathway). Both considered paths are discussed in the 
following paragraphs[5].  
 
1.3.1 Shikimic acid pathway 
 
In higher plants the shikimic acid pathway is the most accepted biogenetic route to carbazole 
alkaloids, especially for those with a methyl group in 3-position, although it is not fully 
proved by experiments. Until now, different approaches of feeding experiments (with 13C- or 
14C-labelled compounds) followed by measurements of radioactivity or 13C NMR were 
undertaken, which strongly indicate the shikimic acid route[5]. 
 
The biosynthesis of shikimic acid starts with an aldol-type reaction of phosphoenolpyruvate 
and D-erythrose 4-phosphate. It is further generated via 3-dehydroshikimic acid after several 
steps. Anthranilic acid is formed from shikimic acid by reaction with L-glutamine. Shikimic 
acid is a precursor of two possible routes to form 3-methylcarbazole (4). The shikimic acid 
pathway forks in two possible roads, route A and route B in Scheme 1[5].  
 
Route A (Scheme 1) shows the biogenetic pathway via quinolone, which undergoes alkylation 
with prenyl diphosphate at C-3. Prenyl diphosphate derives biogenetically from mevalonic 
acid. Rearrangement of a 3-prenylquinolone to a 2-prenylindole and subsequent cyclisation 
and aromatisation leads to 3-methylcarbazole (4). In this route one of the aromatic rings of the 
carbazole nucleus derives from mevalonic acid[5, 8-11]. 
 
Route B from anthranilic acid to 3-methylcarbazole (4) was first suggested by Chakraborty 
et al.[12]. They proposed the formation of 9H-carbazole (3) as precursor of 3-methylcarbazole 
(4) via N-phenylated anthranilic acid. In this theory, C-methylation of carbazole (3) takes 
place by methionine. N-Phenylated anthranilic acids are not known to occur naturally so far 
which indicates the limit of this hypothesis (Scheme 1)[5].  
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The key intermediate in the biosynthesis of terpenes, mevalonic acid, is a precursor for 
carbazoles in higher plants following route A.  
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Scheme 1: Shikimic acid pathway 
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1.3.2 L-Tryptophan pathway 
 
Until now all reports about the generation of the carbazole framework of alkaloids isolated 
from other sources than higher plants (see 1.2) indicate that the carbazole nucleus derives 
from the amino acid L-tryptophan (5). Nakamura and his coworkers published the 
biosynthesis of carbazomycin B (6). They analysed carbazomycin B (6) after feeding 
experiments with 13C- or 14C-enriched precursors and realised that all carbon atoms of the 
carbazole nucleus (except C-1 and C-2) emerge from L-tryptophan (5). The carbon atom of 
the methoxy group in 3-position of the carbazole nucleus (C-12) derives from methionine and 
C-1 and C-10 arise from acetate in form of sodium pyruvate[13]. Suitable precursors for C-2 
and C-11 were found in 1990[14]. It has been established that C-2 and C-11 are also 
incorporated by sodium pyruvate (Scheme 2).  
 
 
 
 
 
 
 
 
 
In the last years a few studies regarding the biosynthesis of carbazole alkaloids like 
rebeccamycin[15], staurosporinone[16, 17], and other derivatives isolated from lower plants or 
other natural sources than plants were published. The carbazole nuclei of all analysed 
compounds derive from L-tryptophan[5, 18].  
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Scheme 2: L-Tryptophan pathway 
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1.4 Biological and pharmacological activity of carbazole alkaloids 
 
Today, various interesting biological features of carbazole alkaloids are known in the 
literature. The scope of biological properties ranges from activity against tumour cells or 
antibiotic and anti-viral qualities to anti-inflammatory effects and action against malaria and 
tuberculosis[5].  
 
Attention should be paid to the anti-tumour activity of carbazole alkaloid ellipticine and its 
derivative elliptinium, respectively. In 1977 elliptinium (celiptium®) was established in cancer 
chemotherapy. Since then, several elliptinium analogues were introduced that show even 
better in vivo activity. It is very likely that these compounds react in vivo by more than one 
mechanism on the inhibition of tumour growth. However, these mechanisms are not fully 
understood yet. One effect is that elliptinium and some derivatives act as intercalator into 
DNA and bind to RNA with covalent bonds, causing an irreversible damage on RNA and 
therefore to the affected cells. Yet, toxic side effects have been observed, which exclude some 
carbazole alkaloids and their derivatives from pharmacological application, despite of their 
potency[5, 19-21].  
 
R. Koch discovered Mycobacterium tuberculosis as the pathogenic agent of tuberculosis (TB) 
in 1890. Thirty years later, a vaccine against TB was applied for the first time on human 
beings, but because of its enormous side reactions this serum was withdrawn a few years 
later. Until now tuberculosis is a great challenge for human kind. The World Health 
Organisation numbers about 30% of the world population (2 billions) infected, whereas 10% 
of the infected humans suffer from a disease outbreak. Still 2 million people have to die from 
tuberculosis every year. Especially, in southern Africa the mortality rate is very high. Three 
different types of tuberculosis are defined depending on their drug resistance. Besides the 
uncomplicated TB, there is the so-called MDR-TB (multiple drug resistance TB), which is 
caused by bacteria that are resistant against the antibiotics isoniazid and rifampicin. Even 
more dangerous is XDR-TB (extremely drug resistant TB), which is resistant against 
isoniazid and rifampicin, all fluorochinolones and at least against one of the antibiotics 
capreomycin, kanamycin or amikacin[5, 22, 23].  
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Because of the high number of infections with MDR-TB or even XDR-TB the research for 
new lead structures for the development of new antibiotics against TB has become very active 
in the last years[24, 25]. The carbazole alkaloids clausine K (clausozoline J), a natural product 
isolated from different sources, and micromeline isolated from the stem bark of Micromelum 
hirsutum, were found to exhibit anti-TB activity. Based on that finding the research groups of 
Prof. Knölker and Prof. Franzblau screened a series of carbazole alkaloids and their 
derivatives for anti-TB activity in vitro. Clausine O (7, Fig. 3), methyl 6-methoxycarbazol-3-
yl-carboxylate (8) and 3-methoxy-2-methyl-1,4-carbazolequinone (9) were found to be active 
against tuberculosis on a similar level as commercial antibiotics (ethambutol, isoniazid, 
rifampicin)[5, 22, 23, 26, 27].  
 
 
 
 
 
 
 
 
All compounds were characterised by measuring their MIC90, IC50 and SI values. The MIC90 
values give the minimal concentration [µM] for inhibition against the virulent strain H37Rv, 
whereupon 90% of the Mycobacterium tuberculosis are inhibited in their growth. The IC50 
shows the toxicity against mammalian cells and the selectivity index SI is defined as 
IC50/MIC90. As the value for the toxicity (IC50) should be high (less toxic), the selectivity 
index should be as high as possible to establish a broad therapeutic index. The selectivity 
indices for aforementioned carbazoles have lower values than the antibiotic rifampicin, but 
they show strong anti-TB activity (e.g. 9: MIC90 = 8 µM). Thus, 3-methoxy-2-methyl-1,4-
carbazolequinone (9) represents a potential lead structure for the development of new 
antibiotics against tuberculosis[22].  
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Fig. 3: Anti-TB active carbazole alkaloids and derivatives 
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1.5 Syntheses in carbazole chemistry  
 
Mainly, there are two different principles for the synthesis of carbazole derivatives. Either a 
benzoid ring system gets annelated to an indole derivative in 2,3-position, or the central 
pyrrole system is formed by an intramolecular reaction of an appropriate precursor. In several 
reviews both strategies are highlighted[3-5], as shown in the following sections with the main 
focus on pericyclic, classical and transition metal-mediated and -catalysed reactions.  
1.5.1 Pericyclic reactions  
 
Vinylindoles are promising precursors for the synthesis of carbazole alkaloids. 3-Vinylindoles 
10 a can be transferred to substituted carbazoles 11 a via a tetrahydrocarbazole or a 
dihydrocarbazole, respectively, by Diels-Alder reaction with an electron withdrawing 
substituted alkene or alkyne 12 followed by dehydrogenation (e.g. with palladium on 
charcoal). By using a diversity of alkenes and alkynes, highly substituted carbazoles can be 
generated. Usually, this reaction is catalysed by trifluoroacetic acid. This method is limited by 
the substitution pattern of the product (electron-withdrawing functional groups in 1-and 2-
position). Later, Pindur et al. established a synthesis of 2-vinylindoles 10 b, which can easily 
react to carbazole 11 b. The mechanism of this [4+2]-cycloaddition of 2-vinylindole with 
acethylene derivatives has been analysed by Ertl and Pindur. Depending on the desired 
substitution pattern of the carbazole 2- or 3-vinylindoles are used (Scheme 3)[28-31].  
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Scheme 3: Diels-Alder reaction of 2- and 3-vinylindoles with alkenes and alkynes 
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1.5.2 Classical syntheses 
 
Classical methods for the synthesis of carbazole alkaloids like the Cadogan synthesis[32], 
whereas a nitrobiphenyl reacts via a deoxygenative cyclisation using triethylphosphite at 
reflux to carbazole derivatives, should also be mentioned. Waterman and Vivian[33] first 
reported deoxygenation of o-nitrobiphenyl with iron oxalate at high temperatures (200 °C). 
The method of thermal or photolytic decomposition of o-azidobiphenyls is often used, 
whereas the photolytic transformation is more applicable for thermally labile functional 
groups[5].  
 
Important approaches for carbazoles like the Fischer-Borsche[34, 35] synthesis or the Japp-
Klingemann[36] reaction start with phenylhydrazone as precursor. In the first approach 
cyclohexanone reacts with a substituted phenylhydrazine to form a phenylhydrazone, which 
undergoes conversion to a tetrahydrocarbazole via a [3,3]-sigmatropic rearrangement 
followed by elimination of ammonia. Dehydrogenation of the tetrahydrocarbazole affords a 
A-ring substituted carbazole. The formation of the hyradzone was improved by Japp and 
Klingemann. They established a synthesis starting from formylcyclohexanone and a 
diazotated aromatic amine. The Graebe-Ullmann[37] carbazole synthesis involves the thermal 
treatment of 1-arylbenzotriazole. This method provides excellent yields for unsubstituted        
1-arylbenzotriazoles, but is limited by substitution on the benzotriazole[5].  
 
1.5.3 Transition metal-catalysed and -mediated syntheses 
 
Transition metal-catalysed and -mediated reactions are widespread in the synthesis of 
carbazole derivatives. Aside from molybdenum and rhodium, especially palladium and iron 
are the transition metals of choice and their applications are therefore presented in detail.  
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1.5.3.1 Palladium-catalysed syntheses 
 
Diarylamines 13 can be transferred by palladium-catalysed reactions to highly substituted 
carbazoles 14 via an intramolecular cyclisation. This procedure was performed under thermal 
or photochemical conditions or in the presence of elemental iodine or metals at high 
temperatures, until Åkermark et al. established a palladium(II)-mediated synthesis under less 
harsh conditions[38]. Their intramolecular oxidative process can tolerate various functional 
groups. Knölker et al. showed that the reaction becomes catalytic if palladium(0) is reoxidised 
to palladium(II) by appropriate reagents. Mostly, cupric acetate is used as reoxidant and acetic 
acid or pivalic acid as solvent[39-43]. Several palladium-catalysed cyclisations have been 
published[44-46]. Recently, Knölker et al. described a palladium(II) and even copper(II) 
catalysed C-C bond formation in the synthesis of the alkaloid clausine L[47]. This 
methodology has been widely used for the total synthesis of a broad range of carbazole 
alkaloids (Scheme 4)[5]. 
 
 
 
 
 
 
 
Buchwald et al. only lately developed a palladium- and copper-catalysed reaction of 2-
acetamidobiphenyl to N-acetylcarbazole. In the presence of oxygen, catalytic amounts of 
palladium acetate and copper acetate are sufficient. Due to its tolerance of both electron-
withdrawing and electron-donating substituents this procedure was applied for the synthesis 
of various carbazole alkaloids[48, 49]. 
 
1.5.3.2 Iron-mediated syntheses 
 
The tricarbonyliron-coordinated cyclohexadienylium ions (15) represent useful electrophiles 
for the electrophilic aromatic substitution of highly substituted electron-rich arylamines (16) 
R1
R2
R3
N
H
R4
R5
R6
cat. Pd(OAc)2
Cu(OAc)2
HOAc, !
R1
R2
R3
N
H
R4
R5
R6
13 14  
Scheme 4: Palladium-catalysed synthesis of substituted carbazoles  
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to give arylamine-substituted tricarbonyl(η4-cyclohexadiene)iron complexes (17). The 
reaction of tricarbonyl(cyclohexadienyl)iron cations with nucleophiles was initiated by Birch 
in 1979[50]. Combination of the electrophilic aromatic substitution to 17 with an oxidative 
cyclisation of the complexes 17 leads to a highly convergent synthesis of carbazoles, which 
was already applied in the total synthesis of various carbazole alkaloids. Knölker et al. 
developed three different procedures for the iron-mediated synthesis, which consist of iron-
induced C-C and C-N bond formations followed by aromatisation and loss of the iron 
fragment to form the carbazole nucleus. The three different iron-mediated procedures are the 
arylamine cyclisation, the quinone imine cyclisation and the oxidative cyclisation by air[3, 5, 39, 
51-54]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The iron-mediated arylamine cyclisation is shown in Scheme 5. The arylamine-substituted 
tricarbonyl(η4-cyclohexadiene)iron complex 17 is generated by a electrophilic aromatic 
substitution of an iron complex and an arylamine. The following one-pot transformation of 
the arylamine-substituted tricarbonyl(η4-cyclohexadiene)iron complex 17 to 9H-carbazole 
derivatives 18 proceeds via cyclisation, aromatisation, and subsequent demetalation. First, a 
tricarbonyliron-complexed 4a,9a-dihydro-9H-carbazole 19 is formed by a single electron 
transfer (SET, Scheme 6). The mechanism was discovered by studies with deuterium labelled 
compounds[51]. After the initial single electron transfer to a 17-electron radical cation 20, an 
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Scheme 5: Iron-mediated arylamine cyclisation 
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intramolecular, syn-stereospecific hydrogen transfer provides compound 21. Dehydrogenation 
via compound 22 forms a tricarbonyliron-complexed dihydrocarbazole 19, which represents a 
stable 18-electron complex. Further dehydrogenation affords 20-electron complex 23, which 
demetalates spontaneously to carbazole 18[3].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The iron-mediated quinone imine cyclisation starts with a chemoselective oxidation of the 
aromatic part of a 3-alkoxyarylamine-substituted tricarbonyl(η4-cyclohexadiene)iron complex 
24 to afford the acyclic quinone imine 25. Oxidative cyclisation of 25 affords 
stereoselectively the cyclised tricarbonyliron-complexed quinone imine 26. Demetalation of 
the quinone imine 26 gives 3-hydroxycarbazole 27 (Scheme 7)[3]. 
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Scheme 6: SET mechanism 
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The third procedure, the one-pot iron-mediated oxidative cyclisation by air, starts from 
tricarbonyliron-coordinated cyclohexadienylium ion 15 and arylamine 16, and produces 
tricarbonyliron-complexed 4a,9a-dihydro-9H-carbazole 28, which can easily be transformed 
to a 9H-carbazole 29 by demetalation and aromatisation via a 20-electron complex 30 
(Scheme 8)[3]. 
 
 
 
 
 
 
 
 
 
 
 
 
The iron-mediated synthesis is a versatile approach to gain carbazole derivatives with 
substitutents in 1-, 2-, 3-, 4-, and 5- or 6-position. Various carbazole alkaloids were 
synthesised applying this method[3, 55, 56].  
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Scheme 7: Quinone-imine cyclisation 
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Scheme 8: Oxidative cyclisation by air 
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2 MOTIVATION AND OBJECTIVE: ANTIOSTATINS A1 TO A4 AND 
B2 TO B5 
2.1 Isolation, structure and properties 
 
Antioxidative substances are considered to be potential agents against various diseases. In 
1990, Seto and his coworkers isolated antioxidative carbazole alkaloids from Streptomyces 
cyaneus 2007-SV1 and named them antiostatins A1 to A4 and B2 to B5 (31 a-d and 32 a-d). 
These unique alkaloids are the first natural carbazole derivatives, which bear an acetamide 
group or a substituted biuret chain, respectively. Seto et al. divided this 3-oxygenated 
carbazole alkaloids into two series (A1 to A4 and B2 to B5) based on their substitution pattern. 
The alkaloids belonging to group A exhibit the acetamide group on C-4 while the four 
compounds of group B bear an iso-butylbiuret side chain on C-4 (Fig. 4)[57]. 
 
 
 
 
 
 
 
 
 
 
 
Antiostatins A1-4 and B2-5 (31 a-d and 32 a-d) offer a strong inhibitory against lipid 
peroxidation, which is induced by free radicals, in rat liver microsome preparations[57].  
 
The method of isolation and separation of antiostatins A1-4 and B2-5 (31 a-d and 32 a-d) was 
described by Seto et al.[57]. After fermentation of the seed culture the entire broth was filtered 
and the mycerial cake was extracted with acetone and ethyl acetate. After crude purification 
over different columns antiostatins A1-4 and B2-5 (31 a-d and 32 a-d) were finally isolated by 
reversed phase HPLC (Senshu Pak C-18) eluted with MeOH-water (81:19).  
 
N
H
OH
Me
R
HN
N
H
OH
Me
R
NH
31 a antiostatin A1 R= (CH2)4Me
31 b antiostatin A2 R= (CH2)2CH(CH3)CH2Me
31 c antiostatin A3 R= (CH2)4CH(Me)2 
31 d antiostatin A4 R= (CH2)6Me
N
H
N
H
OO
32 a antiostatin B2 R= (CH2)5Me
32 b antiostatin B3 R= (CH2)4CH(Me)2
32 c antiostatin B4 R= (CH2)6Me
32 d antiostatin B5 R= (CH2)5CH(Me)2
O
 
Fig. 4: Antiostatins A1-4 and B2-5 
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All antiostatins feature an alkyl chain either linear or branched between five and eight C-
atoms in 1-position, antiostatin A2 (31 b) also bears a stereogenic centre. The structure of all 
antiostatins could be assigned using HMBC-NMR. The absolute configuration of antiostatin 
A2 (31 b) could not be determined.  
 
2.2 Objective: synthesis of antiostatins A1 to A4 and B2 to B5 
 
Topic of this work is the synthesis of the carbazole alkaloids antiostatin A1 to A4 and B2 to B5 
(31 a-d and 32 a-d) from readily commercially available compounds. No total synthesis was 
reported so far for antiostatins A1-4 and B2-5 (31 a-d and 32 a-d). The concept of the 
convergent iron-mediated synthesis of highly substituted carbazoles (described in 1.5.3.2) 
should be applied for their first total synthesis. 
 
Antiostatins A1-4 and B2-5 (31 a-d and 32 a-d) are the first natural carbazole derivatives with 
acetamide or a substituted biuret as functional group. The main focus of this work was to find 
a strategy to introduce the acetamide or the substituted biuret group selectively in 4-position 
at a late stage of the total synthesis. 
 
Arylamine-substituted tricarbonyl(η4-cyclohexadiene)iron complexes have to be generated by 
an electrophilic aromatic substitution of tricarbonyl(η5-cyclohexadienylium)iron and 
appropiate arylamines. The following one-pot transformation to the corresponding carbazole 
derivatives should proceed via cyclisation, aromatisation, and subsequent demetalation in an 
iron-mediated arylamine cyclisation. The corresponding arylamines with defined substitution 
pattern have to be prepared in an effective, scalable route with good yields, as these aromatic 
compounds are key intermediates and are to be used in high quantities. The arylamines should 
bear all substitutents except of the acetamide or the biuret in 4-position (respective sites of the 
carbazole nucleus) because of its possible incompatibility with the iron-mediated arylamine 
cyclisation. 
 
Chiral antiostatin A2 (31 b) should be synthesised in S-configuration in high enantiomeric 
purity. We predicted a S-configuration of the chiral centre of the alkyl side chain by 
comparison to other carbazole alkaloids like carbazomadurin B[58]. Unfortunately, Seto could 
not give any information about the absolute configuration of the side chain or at least an 
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[α]D20 due to shortage of the sample of antiostatin A2 (31 b, 0.8 mg). The correct 
stereochemistry of natural antiostatin A2 (31 b) should be discovered by comparison of 
circular dichroism spectra of the synthetic and the natural antiostatin A2 (31 b). 
 
3 FIRST TOTAL SYNTHESIS OF THE ANTIOSTATINS A1 TO A4 AND 
B2 TO B5 
3.1 State of research 
 
Previous unpublished results of our group in the synthesis of precursors for the natural 
products antiostatin A1 to A4 and B2 to B5 (31 a-d and 32 a-d) by W. Fröhner and M. Dössel 
showed that the substituents in 4-position should be introduced in a late stage to the carbazole 
nucleus and not prior to the iron-mediated steps. The electrophilic aromatic substitution at an 
acetamide-substituted arylamine 33 with the iron salt 34 did not result in the desired product 
35 (Scheme 9)[59].  
 
 
 
 
 
 
 
 
Former studies also dealed with the concept of a late intermediate in the synthesis of 31 a-d 
and 32 a-d. Carbazole 36 was meant to be such a central intermediate which should be easily 
transferred to antiostatins A1-4 and B2-5 (31 a-d and 32 a-d) and precursors of further 
carbazole alkaloids by transition metal-catalysed cross-coupling reactions. However, 
compound 36 could not be generated starting from 1-iso-propoxy-3-methoxy-2-methyl-
carbazole (37) by ether cleavage and reaction with trifluoromethanesulphonic anhydride 
because of the instability of the 1-hydroxycarbazole (Scheme 10)[60].  
Fe+(CO)3
BF4
-
OR2
R1
H2N
+
NHAc
R1
H2N
OR2
(OC)3Fe
NHAc
34 33 35
R1 = OMe, OiPr or C7H15
R2 = Me or H  
Scheme 9: Previous results  
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Until now, there is no total synthesis of carbazoles 31 a-d and 32 a-d known in the literature. 
In 1996, Hibino et al. published a synthesis of new tetracyclic oxazolo[5,4-c]carbazoles that 
were designed as precursors in the synthesis of 31 a-d and 32 a-d[61], but no successful 
synthesis of the final stages was published yet.  
 
3.2 Retrosynthesis and strategic considerations 
 
According to the total synthesis of carazostatin (38)[62] and other carbazole alkaloids the iron-
mediated oxidative cyclisation to carbazoles should be the key step in the generation of the 
carbazole nucleus of antiostatins A1-4 and B2-5 (31 a-d and 32 a-d). Carazostatin (38) has a 
substitution pattern similar to antiostatins A4 (31 d) and B4 (32 c), except of the acetamido-, 
respectively substituted biuret-group, in 4-position. The retrosynthetic analysis of antiostatins 
A1-4 and B2-5 (31 a-d and 32 a-d) is shown in Scheme 11. 
 
The intention was to derive the arylamine-substituted tricarbonyl(η4-cyclohexadiene)iron 
complexes 39 a-f by an electrophilic aromatic substitution of arylamines 40 a-f with 
appropriate substitution pattern with tricarbonyl(η5-cyclohexadienylium)iron tetrafluoroborate 
(34). The following transformation of 39 a-f to the corresponding carbazole derivatives 41 a-f 
and introduction of the substituents in 4-position would complete the sequence to the natural 
compounds. Arylamines 40 a-f should be synthesised applying an improved procedure of the 
route followed in the preparation of carazostatin (38)[62]. The iron complex salt tricarbonyl(η5-
cyclohexadienylium)iron tetrafluoroborate (34) can be generated by azadiene-catalysed 
complexation of cyclohexa-1,3-diene with pentacarbonyliron followed by hydride abstraction 
(Scheme 12).  
 
N
H
O
OTf
N
H
O
O
37 36  
Scheme 10: Central intermediate 36 
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Considering the requirements of aforementioned reactions, the key step in the synthesis of 
antiostatins A1-4 and B2-5 (31 a-d and 32 a-d) is the iron-mediated formation of the carbazole 
nuclei from iron salt 34 and arylamines 40 a-f via iron complexes 39 a-f. If this succeeded, an 
appropriate functional group, which can be easily converted to an acetamide or biuret group, 
has to be established in 4-position (42 to 43). Ether cleavage should finalise the synthesis of 
31 a-d and 32 a-d. 
 
 
 
 
 
 
 
 
 
 
 
 
 
OMe
R1
H2N
N
H R1
HN
OH
R2
N
H R1
OMe
R1
H2N
OMe
(OC)3Fe
Fe+(CO)3
BF4
-
+
34 40 a-f 39 a-f
41 a-f31 a-d or 32 a-d
R1 = alkyl chain
R2 = acyl or -CONHCONHiBu  
Scheme 11: Retrosynthesis of antiostatin A1-4 and B2-5  
(OC)3
+Fe BF4
-
+
H2N
OMe
R1
(OC)3FeOMe
R1
H2N
N
H R1
HN
OMe
R2
N
H R1
OMe
N
H R1
HN
OH
R2
N
H R1
X
OMe
34 40 a-f 39 a-f
41 a-f 42
43 31 a-d or 32 a-d
R1 = alkyl chain
R2 = acyl or -CONHCONHiBu  
Scheme 12: Strategy for the synthesis of antiostatins A1-4 and B2-5  
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3.3 Syntheses of some precursors 
 
In this chapter the syntheses of iron salt 34, alkynes 49 a-f, arylamines 40 a-f and 1,2,3-
substituted carbazoles 41 a-f are described.  
 
3.3.1 Synthesis of iron salt 34 
 
In 1958, tricarbonyl(η4-cyclohexa-1,3-diene)iron 45 was prepared by Pauson via 
complexation of cyclohexa-1,3-diene with pentacarbonyliron under thermal[63] and in 1968 by 
Birch under photolytic conditions[64]. Knölker et al. established a scalable catalytic approach 
for the complexation under less harsh conditions (101 °C vs. 140 °C/autoclave). They 
investigated various 1-azabuta-1,3-dienes as catalysts and appropriate conditions for the 
catalytic complexation[65].  
 
Fischer et al. described hydride abstraction of iron diene complexes using triphenylmethyl 
tetrafluoroborate in 1960[66]. Resulting iron salts (like 34) can be utilised for interesting bond 
formations with a broad range of nucleophiles[39, 54, 67].  
 
Tricarbonyl(η5-cyclohexadienylium)iron tetrafluoroborate (34) was synthesised according to 
literature procedures[65, 68] from cyclohexa-1,3-diene (44) and pentacarbonyliron by 1-(4-
methoxyphenyl)-4-phenyl-1-azabuta-1,3-diene catalysed complexation, followed by hydride 
abstraction of 45 with triphenylmethyl tetrafluoroborate (Scheme 13).  
 
 
 
 
 
 
 
 
 
 
(OC)3
+Fe BF4
-
1.2 eq. Ph3CBF4
DCM, r.t.,
100 min
(OC)3Fe
dioxane, 
reflux,  3 d
1.5
(Lit. 99%) (Lit. 98%)
Fe(CO)5
N
Ph
OMe
25 mol%
3444 45
 
Scheme 13: Complexation of cyclohexa-1,3-diene (44) and hydride abstraction to 34 
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3.3.2 Synthesis of the arylamines 40 a-f 
 
In the following section the preparation of arylamines 40 a-f is described in detail. Compared 
to the route in the synthesis of carazostatin (38), in which 40 d was prepared by Diels-Alder-
cycloaddition of 1-methoxycyclohexa-1,3-diene with an appropriate alkyne, 40 a-f were 
established in a different, improved way. The strategy chosen here is similar to the arylamine 
generation in the synthesis of 6-chlorohyellazole starting from 2,6-dimethoxytoluene (46)[69].  
 
The reaction procedure is shown in Scheme 14. According to a literature procedure[69], 
selective nitration of 2,6-dimethoxytoluene (46) with the mild nitration reagent claycop[70-72] 
and subsequent cleavage of the methyl ether ortho to the nitro group, followed by 
esterification of the free hydroxy group with trifluoromethanesulphonic anhydride provides 
triflate 47 in 88% over three steps.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nitrobenzenes 48 a-f were prepared via a palladium(0)-catalysed Sonogashira-Hagihara 
cross-coupling reaction with the corresponding alkynes 49 a-f, whereas 49 a,c-e are 
commercially available. However, 49 b and 49 f have to be prepared; their synthesis is 
described in detail in section 3.3.3.  
 
 
 
OMe
OTf
O2N
OMe
O2N
R
OMe
OMe
88%  over
three steps
85 – 100% 84 – 100%
i - iii
OMe
R'
H2N
iv
48 a R = (CH2)2Me
48 b R = (S)-CH(CH3)CH2Me
48 c R = (CH2)2CH(Me)2 
48 d R = (CH2)4Me
48 e R = (CH2)3Me
48 f  R = (CH2)3CH(Me)2
40 a R' = (CH2)4Me
40 b R' = (S)-(CH2)2CH(CH3)CH2Me
40 c R' = (CH2)4CH(Me)2 
40 d R' = (CH2)6Me
40 e R' = (CH2)5Me
40 f  R' = (CH2)5CH(Me)2
46 47
v
 
Scheme 14: Synthesis of arylamines 40 a-f. Reagents and conditions: (i) claycop, 10 eq. Ac2O, 
Et2O, r.t., 3 h; (ii) 1.5 eq. AlCl3, DCM, r.t., 24 h; (iii) 1.05 eq. Tf2O, 2 eq. Et3N, DCM, –20 °C to r.t.; (iv) 10 
mol% PdCl2(PPh3)2, 20 mol% CuI, 1.2 – 3 eq. 49 a-f, 1 – 3 eq. (n-Bu)4NI, MeCN/Et3N = 5/1, reflux, 3 –
 5 h; (v) 1 – 5 bar H2, 10 wt% Pd/C, MeOH, DCM or EtOAc, r.t., 3 – 5 d. 
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The yields of the Sonogashira reaction towards 48 d could be improved from 69%[60] up to 
100% by modifying the reaction conditions and by exchanging the catalyst from Pd(PPh3)4 to 
PdCl2(PPh3)2 and by using very dry triethylamine (dried over calcium hydride instead of 
potassium hydroxide). This reaction works in excellent yields for nitrobenzenes 48 a and 
48 c-f. As described in section 3.3.3, 48 b was synthesised in a sequence of Corey-Fuchs 
rearrangement and Sonogashira cross-coupling in 45% yield. Catalytic hydrogenation of     
48 a-f led to the arylamines 40 a-f in very good yields (Table 1). 
 
  Yield [%] 
  a b c d e f 
48 .. 100 45* 98 100 82 85 
40 .. 100 88 95 100 96 84 
Table 1: Yields of cross-coupling reaction to 48 a-f and catalytic hydogenation to 40 a-f.  
(*) yield over two steps from alkene 64 (see 3.3.3) 
 
This improved route gives access to arylamines 40 a and 40 c-f in five steps in excellent 
yields between 72% and 90% (previous route to 40 d: six steps, 26%[62]). However, arylamine 
40 b could only be synthesised in 40% from dibromoalkene 64 in three steps because of the 
low yield in the sequence Corey-Fuchs homologisation and Sonogashira cross-coupling (see 
3.3.3).  
3.3.3 Preparation of alkynes 49 b and 49 f 
 
With exception of 49 b and 49 f, all alkynes (49 a and 49 c-d, Fig. 5) are commercially 
available and can be used without further purification. In consequence, quick and elegant 
methods had to be found for the preparation of 49 b and 49 f. 
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Alkyne 49 f was produced by a protocol from Carballeira et al. using 1-bromo-4-
methylpentane (50). Deprotonation of trimethylsilylacetylene with n-butyllithium and 
subsequent nucleophilic substitution on bromoalkane 50 provides alkyne 51, which was 
treated with sodium hydroxide to give the desired terminal alkyne 49 f (Scheme 15). The 
yields are within the same range as published by Carballeira[73].  
 
 
 
 
 
 
 
 
Syntheses for alkyne 49 b are known in literature: starting from racemic hydrogen phthalate 
52 of α-hydroxyalkyne 52 a, alkyne 49 b can be obtained in five steps. Chiral resolution of 
the racemic hydrogen phthalate 52 and hydrolysis gives (S)-52 a. It is transferred to the 
corresponding methanesulphonate (S)-53, which gives bromoallene (Ra)-54 upon treatment 
with LiCu2Br3. After hydrolysis, reduction with lithium aluminium hydride provides 49 b 
(Scheme 16, A)[74].  
 
Alternatively, starting from commercial (S)-1-chloro-2-methylbutane (55) alkyne 49 b is 
synthesised in six steps following procedure B in Scheme 16. The Gringard reagent 55 a 
obtained from 55 was transferred to (S)-dimethyl-(3-methylpentyl)amine (56) using 
dimethyl(methylene)iminium chloride (Eschenmoser’s salt). Applying hydrogen peroxide in a 
Br
Me3Si H
TMS
n-BuLi
NaOH/MeOH
–78 °C to r.t.,
1 d, 54 %
r.t., 2 d, 94 %
50 51 49 f  
Scheme 15: Synthesis of 49 f 
49 a 49 b 49 c
49 d 49 e 49 f  
Fig. 5: Alkynes 49 a-f 
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Cope elimination affords alkene 57, from which 49 b is obtained using a bromination-
dehydrobromination protocol[75].  
 
 
 
 
 
 
 
 
 
 
 
Following a third route, we found commercial (S)-2-methyl-1-butanol (58) to be an 
appropriate starting material for chiral alkyne 49 b. After oxidation to (S)-2-methyl-1-butanal 
(59) it should be transferred to a terminal alkyne 49 b by homologisation (Scheme 17).  
 
 
 
 
 
Oxidation of 58 to 59 is already known in literature using Swern conditions (82% yield)[76-79] 
and TEMPO (82 – 84% yield)[80] as oxidising reagent. Using the Swern protocol or TEMPO 
were not reproducible. Pyridinium dichromate[81] and tetrapropylammonium perruthenate 
(TPAP/NMO)[82] also did not give any reliable amounts of 59 or even isolable product, 
respectively. However, using Dess-Martin periodinane[83, 84] as oxidising reagent provided 59 
in good yields (83%). The specific rotation of 59 is in good agreement with the literature 
value ([α]20D = +29.3, lit. +33.1[80], acetone, c = 2.5).  
 
Aldehyde 59 should be transferred to 49 b via a rearrangement reaction with chain extension 
by one C-atom. Colvin and his coworkers established a one-step conversion to acetylenes 
from aldehydes using a base induced reaction with (trimethylsilyl)diazomethane[85-87]. Under 
the formal loss of trimethylsilylhydroxide and nitrogen, rearrangement to a terminal alkyne 
OOH
58 59 49 b  
Scheme 17: Strategy for the synthesis of 49 b 
Me
Et
OH Me
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OSO2Me
C
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Me
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NMe2Cl
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O
OH
(S)-52 a (S)-53 (Ra)-54
55 56 57 49 b
52
55 a  
Scheme 16: Syntheses of alkyne 49 b in the literature 
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takes place. Using the Colvin procedure for the transformation of aldehyde 59 did not result in 
any desired product. GC-MS analysis showed only products from aldol-type reactions.  
 
The Gilbert-Seyferth homologisation uses dimethyl (diazomethyl)phosphonate (60) in the 
presence of tBuOK in the synthesis of alkynes from aldehydes or ketones[88-90]. As compound 
60 is quite instable and has to be prepared freshly, Ohira and Bestmann[91, 92] developed 
independently a new reagent (61) for the one-carbon homologisation analogue to the Gilbert-
Seyferth reaction (Fig. 6). 61 can be obtained from commercial dimethyl-2-
oxopropylphosphonate (62) by diazo transfer from p-tosyl azide (63) in a single step[93, 94].  
 
 
 
 
 
 
Under typical reaction conditions (61, potassium carbonate, dry methanol) deprotonated 
Gilbert-Seyferth reagent 61 a is formed in situ, which attacks as a nucleophile on the carbonyl 
C-atom of an aldehyde 61 b or ketone to form a four-membered ring 61 c in a Wittig-like 
process. Under loss of (MeO)2PO2K and elution of nitrogen alkylidene carbene 61 d is 
formed which rearranges to alkyne 61 e (Scheme 18)[91, 92]. 
 
Aldehyde 59 was transferred to alkyne 49 b via the Ohira-Bestmann protocol (see above), but 
could never be isolated in a pure fraction. After aqueous work-up and extraction with either 
diethyl ether or dichloromethane, only a mixture of 49 b, the solvent of work-up, and 
methanol could be isolated by distillation. 49 b has a boiling point of 56 – 58 °C, which is 
fairly close to the boiling point of methanol (bp. 65 °C). Using ethanol (bp. 78 °C) and 
propanol (bp. 97 °C) instead, mixtures were isolated, too. Direct distillation of the reaction 
mixture with propanol as the solvent also results in a mixture due to the high amount of 
solvent compared to the amount of desired product. Additionally, the mixtures of methanol, 
ethanol, propanol and traces of water cause transesterification of 3-methoxy-2-methyl-6-nitro-
phenyl trifluoromethanesulphonate (47). High amounts of 3-methoxy-2-methyl-6-nitro-
phenol are formed due to decomposition of the aromatic starting material 47.   
 
 
P
O
MeO
MeO
H
N2
60  61
P
O
MeO
MeO
N2
O
 
Fig. 6: Gilbert-Seyferth (60) and Ohira-Bestmann reagent (61) 
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Corey and Fuchs established a two-step homologisation of aldehydes to terminal alkynes in 
1972[95]. The first step involves a chain extension of the aldehyde by one carbon using carbon 
tetrabromide, zinc dust and triphenylphosphine to generate an α,α-dibromoalkene. In the 
process, carbon tetrabromide and triphenylphosphine are in situ converted to an ylide, which 
in reaction with an aldehyde affords an α,α-dibromoalkene[96]. The formation of 
dibromoalkene 64 is already known and proceeds in good yields (77%, lit. 79%[97]). The 
specific rotation of 64 is in exellent agreement with the literature value ([α]20D = +14.6, lit. 
+14.3[97], n-heptane, c = 2.0).  
 
In the second step of the Corey-Fuchs protocol, two equivalents of n-butyllithium transfer 64 
to alkyne 49 b via bromo-lithium exchange to a α-lithiated 1-bromoalkyne 65 a, which 
undergoes α-elimination of LiBr to carbene 65 b, followed by a hydrogen transfer to the 
terminal alkyne 49 b (Scheme 19). After aqueous work-up, crude alkyne 49 b is obtained. 
However, applying Corey-Fuchs reaction only gave alkyne 49 b after distillation in a mixture 
with n-heptane, which was used for work-up. Also in this case the following Sonogashira 
reaction bears the problem of saponification with traces of water and only very low yields of 
48 b could be obtained[96].  
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Scheme 18: Mechanism of the Ohira-Bestmann reaction 
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The decision to introduce crude alkyne 49 b (after work-up in heptane), either derived from 
Ohira-Bestmann protocol or from Corey-Fuchs reaction, brought the break-through. Using the 
Ohira-Bestmann rearrangement only gave 3% over two steps, but Corey-Fuchs reaction gave 
at least 45% of 48 b. It is important to mention that the yield of 48 b enormously decreases if 
49 b is given to the reaction mixture in one portion. It is more efficient to add it dropwise 
over 3 h (Scheme 20).  
 
A solution was found for the establishment of 48 b by Sonogashira reaction of 47 with alkyne 
49 b. Starting from commerical (S)-2-methyl-1-butanol (58) chiral nitrobenzene 48 b can be 
obtained in four steps and 29% overall yield (Scheme 20). 
 
 
 
 
 
 
 
 
 
 
 
3.3.4 Synthesis of compounds 41 a-f 
 
Carbazoles 41 a-f were prepared via iron-mediated arylamine cyclisation described in   
section 1.5.3.2. Tricarbonyl[η4-5-(2-amino-3-alkyl-5-methoxy-4-methyl-phenyl)cyclohexa-
1,3-diene]iron complexes 39 a-f were synthesised by electrophilic aromatic substitution of 
arylamine 40 a-f with the iron complex salt 34 in excellent yields of 89 – 100%. The reaction 
i ii
O
Br
Br
OMe
O2Niii
64 49 b 48 b59  
Scheme 20: Corey-Fuchs-Sonogashira sequence. Reagents and conditions: (i) 2 eq. CBr4, 2 eq. 
Zn, 2 eq. PPh3, DCM, r.t., 14 h, 77%; (ii) 3.3 eq. n-BuLi, THF, –78 °C, 1 h and r.t., 1 h; (iii) 1 eq. 47, 10 
mol% PdCl2(PPh3)2, 20 mol% CuI, 1.2 eq. 49 b, 1 eq. (n-Bu)4NI, MeCN/Et3N = 5/1, reflux, 4.5 h, 45% 
over two steps from 64. 
 
 
Br
Br
Li
Br
H
65 a 65 b 49 b64  
Scheme 19: Mechanism of the second step of the Corey-Fuchs homologisation 
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runs in acetonitrile at reflux and affords the iron complexes 39 a-f quantitatively. The 
electrophilic aromatic substitution is presumed to proceed via an N-alkylated arylamine as 
kinetic product of the reaction. Knölker et al. showed that at reflux temperatures these 
intermediates rearrange intermolecularly in the presence of excess arylamine to form the 
thermodynamic C-C-linked products 39 a-f. Trapping tetrafluoroboric acid, which derives 
from the nucleophilic attack on the cyclohexadienyl cation, affords an additional equivalent of 
the arylamine. Using e.g. triethylamine as auxiliary the intermolecular rearrangement from N-
alkylated to C-alkylated product cannot take place. In total, 2.2 equivalents of the arylamine 
are needed because of the slight excess required for the intermolecular rearrangement[53].  
 
Davies, Green and Mingos established rules for the attack of nucleophiles on organotransition 
metal cations containing unsaturated hydrocarbon ligands. They classified the alkene ligands 
in even or odd, depending on how many C-atoms are coordinated to the metal, and open or 
closed (e.g. cyclopentadienyl vs. pentadienyl) ligands. η5-Cyclohexadienyl belongs to the 
odd/open ligands, which are regioselectively attacked by nucleophiles on their terminus, if the 
metal fragment coordinated is electron-withdrawing[98]. As indicated in Scheme 21 the 
electrophilic aromatic substitution is stereospecific: the attack of the arylamine is conducted 
by the tricarbonyliron fragment to the opposite site of the cyclohexadiene.  
 
 
 
 
 
 
 
 
 
 
 
 
 
In case of nucleophilic addition of 40 b on 34 two diastereoisomers of 39 b are formed due to 
the stereospecific anti-addition. The stereocenter in the alkyl chain is not meant to have any 
R
H2N
OMe
(OC)3Fe
Fe+(CO)3
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+ 2.2
OMe
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H2N
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H
O
R
39, 40, 41:
a  R = (CH2)4Me
b  R = (S)-(CH2)2CH(CH3)CH2Me
c  R = (CH2)4CH(Me)2 
d  R = (CH2)6Me
e  R = (CH2)5Me
f   R = (CH2)5CH(Me)2
40  a-f 39 a-f
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a, 100%
b, 95%
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e, 96%
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conditions and yields
 see Table 2
 
Scheme 21: Iron-mediated synthesis of carbazoles 41 a-f  
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influence on the stereoselectivity, so none of the diastereoisomers should be preferred. The 
two diastereomers are isochronous in NMR (see 5.2).  
 
The cyclisation to carbazoles 41 a-f is performed via an iron-mediated arylamine cyclisation 
with ferrocenium hexafluorophosphate as single electron acceptor (mechanism see 1.5.3.2). 
O-Methylcarazostatin (41 d) was previously synthesised by Hopfmann from 39 d in 53% via 
a cyclisation step with ferrocenium hexafluorophosphate and subsequent aromatisation and 
demetalation of an inseparable intermediate with trimethylamine-N-oxide. Tricarbonyl[(5-8-
η)-4b,8a-dihydro-1-heptyl-2-methyl-3H-carbazol-3-one]iron was formed via an iron-
mediated quinone-imine cyclisation. Hence, carazostatin (38) was formed in 33% yield[42]. To 
avoid the undesired formation of carazostatin (38) and in order to achieve higher yields of 
41 d more equivalents of ferrocenium hexafluorophosphate and sodium carbonate were 
added. For the same reason, the reaction mixture was stirred at room temperature for three 
days under water-free conditions. Water can act as a nucleophile in the cleavage of the methyl 
ether. Therefore, trimethylamine-N-oxide does not have to be used under improved 
conditions. The yield for 41 d was increased to 96% (entry 6) in comparison to 53%[62]. The 
best reproduced yields of the oxidative cyclisations to 41 a-f are in the range between 63 and 
96% (Table 2). 
      
Entry 39 Eq. FeCp2PF6 Eq. Na2CO3 Conditions Yield [%] of 41 a-f 
1 7 10 DCM, r.t., 5 d 57 
2 6 10 DCM, r.t., 4 d 28 (41 a)/67 (66) 
3 
a 
11 16 DCM, r.t., 5 d 63 
4 b 11 16 DCM, r.t., 3 d 93 
5 c 11 16 DCM, r.t., 4 d 93 
6 7 10 DCM, r.t., 3.5 d 96 
7 
d 
11 16 DCM, r.t., 5 d 84 
8 e 11 16 DCM, r.t., 3 d 81 
9 f 11 16 DCM, r.t., 4 d 91 
Table 2: Oxidative cyclisation of 39 a-f to 41 a-f 
In case of 41 a only 63% yield could be achieved, even if eleven equivalents of ferrocenium 
hexafluorophosphate and 16 equivalents of sodium carbonate were used, instead of seven and 
ten, like in the synthesis of O-methylcarazostatin (41 d, Table 2, entries 1 and 3). Because 
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there was no starting material left in either case, six equivalents of the oxidising agent and ten 
equivalents of sodium carbonate were added to the reaction. This condition provided only 
28% of 41 a along with 67% of tricarbonyl[(5-8-η)-3-methoxy-2-methyl-1-pentyl-4b,8a-
dihydro-9H-carbazole]iron (66, Table 2, entry 2), which is an intermediate of the reaction (see 
1.5.3.2). 41 b-c and 41 e-f were produced in high yields with eleven equivalents of 
ferrocenium hexafluorophosphate and 16 equivalents of sodium carbonate (Table 2, entries 4, 
5, 7 and 8).  
 
However, in this oxidative reaction step excellent yields can be achieved only using very pure 
reagents and especially freshly synthesised iron complexes 39 a-f. 
 
3.4 Attempts towards the synthesis of antiostatin A4 (31 d) 
 
Antiostatin A4 (31 d) was chosen as first target of the antiostatin group. Therewith the scope 
of reaction should be emblazed and transmitted to the total synthesis of all antiostatins A1 to 
A4 (31 a-d).  
 
3.4.1 Halogenation of diverse carbazoles on C-4 and C-6 
 
After the successful synthesis of carbazole 41 d a method had to be found in order to 
introduce the acetamide group in 4-position. The idea was to establish a leaving group like 
chloride or bromide at C-4 by direct chlorination or bromination at the carbazole nucleus. 
Buchwald-Hartwig cross-coupling reaction of 67 with an appropriate reagent (at best 
acetamide) should then provide acetamidocarbazole 68 (Scheme 22).  
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Scheme 22: Halogenation and cross-coupling reaction 
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The introduction of chloride or bromide to 41 d was investigated. Chlorination of 41 d on C-4 
with N-chlorosuccinimide (NCS) in the presence of hydrochloric acid (cat.) was already 
established during the precedent diploma thesis[60]. It resulted in a mixture of mono-
chlorinated and dichlorinated products (relation 2:1), even using only one equivalent of NCS. 
However, using lower temperatures could solve this problem: at –20 °C, chlorination 
proceeds quantitatively to the desired product 4-chloro-1-heptyl-3-methoxy-2-methyl-
carbazole (69). Usually, the 3- and 6-positions of carbazoles are electronically favoured for 
electrophilic aromatic substitutions. In case of 41 d chlorination proceeds at the more 
electron-rich ring, although C-4 is more sterically hindered then C-6 (Scheme 23). 
 
In case of bromination of 41 d facts are different, as it takes selectively place on C-6 to afford 
compound 70 in high yield (86%) under equivalent conditions compared to chlorination. 
Electronically there is almost no difference, but bromide has a larger Van der Waals radius 
than chloride and therefore prefers the less hindered C-6 position over C-4. In order to 
deactivate the 6-position, Moody et al. introduced the electron-withdrawing tert-
butyloxycarbonyl (Boc) group as protecting group to the carbazole nitrogen[99, 100]. The 
electronic situation of the molecule is changed thereby, so that electrophilic substitution can 
take place at C-4 instead of C-6, in spite of sterical effects. 41 d was converted quantitatively 
to 71 d under the presence of di-tert-butyl oxydiformate and 4-(dimethylamino)pyridine. 
Bromination of N-tert-butyloxycarbonylcarbazole 71 d occured at designated 4-position and 
gave 4-bromocarbazole 72 in excellent yields (96%). Bromination of 41 d with 2.1 
equivalents of N-bromosuccinimide in the presence of hydrobromic acid (cat.) afforded 4,6-
dibrominated product 73 in 91% (Scheme 23).  
 
Previous results from our group in the synthesis of 6-chlorohyellazole confirm the same 
difference in regiochemistry of bromination and chlorination of electron-rich 1,2,3-substituted 
carbazoles. Chlorination proceeds on C-4 (A-ring) and bromination on C-6 (B-ring)[69]. 
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In the synthesis of 6-chlorohyellazole cuprous chloride was successfully applied in a halogen 
exchange: 6-bromohyellazole was transferred to 6-chlorohyellazole[69]. Using cuprous 
bromide under the same conditions in order to exchange chloride to bromide, meaning 69 to 
76, did only result in decomposition (Scheme 24). 
 
 
 
 
 
 
In order to introduce the acetamido substituent in 4-position, 4-chloro and 4-bromo 
derivatives should be subjected to a cross-coupling reaction with acetamide or an ammonia 
equivalent, respectively.  
 
During the past years great progress was achieved[101] in copper-catalysed or -mediated 
coupling reactions, which was originally introduced by Ullmann in 1901[102]. Originally, the 
copper-mediated Ullmann reaction was used for the formation of a C-C bond between two 
aryl units, which derive from two aryl halides. It was soon developed to a Ullmann 
condensation reaction to form aryl ethers, diarylamines and diaryl thioethers. Goldberg 
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Scheme 23: Chlorination of 41 d and bromination of 41 d and 71 d 
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Scheme 24: Halogen exchange from 69 to 76 
 RESULTS AND DISCUSSION 
 - 34 -  
modified the Ullmann reaction to a copper-mediated coupling of an aryl halide with an amide 
in 1906[103].  
 
Buchwald and his coworkers established a simple catalyst system for the amidation of aryl 
halides using copper(I) iodide as catalyst, a bidentate chelating 1,2-diamine ligand and 
K2CO3, K3PO4 or Cs2CO3 as base[104, 105]. They reported excellent yields by coupling 
substituted amides like acetamide (74) with various aryl halides, even for less reactive aryl 
chlorides. Unfortunately, adopting that system to compound 69 did not result in any desired 
product. We tried two dissimilar 1,2-diamine ligands (75 a and 75 b, ligands see Fig. 7) under 
various conditions, but could only reisolate starting material with no trace of any product 
(Table 3, entries 1-3). Even under microwave irradiation no conversion took place (Table 3, 
entry 4). Ligand 75 c, which was developed for the amidation of aryl halides[106], gave 75% 
starting material and traces of hydrodechlorinated product 41 d under microwave conditions 
(Table 3, entry 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Shakespeare published the first palladium-catalysed intermolecular arylation of an amide[107]. 
He analysed the coupling of lactams with aryl bromides employing a dppf/Pd system as 
catalyst. Especially for electron-poor aryl bromides he achieved very good yields. Yin and 
Buchwald reported bis(dibenzylideneacetone)palladium together with Xantphos (75 d) as 
competent catalyst system for the arylation of amides. Trans-chelating bis(phosphine) ligand 
75 d can be generally used both for electron-poor and electron-rich aryl halides. Many 
functional groups like ester-, cyano-, nitro- or methoxy-substituents are compatible under 
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Fig. 7: Ligands for transition metal-catalysed amidation  
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optimised reaction conditions with dioxane as solvent and cesium carbonate as base[108, 109]. 
Verkade developed a catalyst system of tris(dibenzylideneacetone)dipalladium and a 
triaminophosphine ligand (75 e) for amination of aryl halides. It works particularly well for 
either electron-rich or electron-poor aryl chlorides[110-112]. 75 f and XPhos (75 h) are also 
frequently used in palladium-catalysed C-N bond formation processes[113-115].  
 
N-Heterocyclic carbene (NHC) palladium complexes with bulky substituents have been 
developed because of their stability and advancement of the reductive elimination. In 
comparison to phosphine ligands, NHCs are very tightly bound to Pd(0) because of their σ-
donating power and thus stabilise the catalyst and increase turnover numbers. PEPPSI™ (75 g, 
Pyridine-Enhanced Precatalyst Preparation Stabilization and Initiation) was established 
because of aforementioned benefits and was already used for a broad range of aminations[116]. 
Several general reviews of Pd-catalysed reactions are given in the literature[117, 118]. 
 
Entry Conditions Result 
1 1 eq. 69, 2 eq. 74, 10 mol% CuI, 11 mol% 75 a, K3PO4, xylole, reflux, 2 d n. c. 
2 1 eq. 69, 10 eq. 74, 50 mol% CuI, 50 mol% 75 a, 2 eq. K2CO3, solvent free, 130 °C, 3 d 
n. c. 
3 1 eq. 69, 1.5 eq. 74, 5 mol% CuI, 5 mol% 75 b, 2 eq. K2CO3, dioxane, reflux, 1 d 
n. c. 
4 1 eq. 69, 1.5 eq. 74, 10 mol% CuI, 22 mol% 75 b, 2 eq. K2CO3, DMF, 155 °C, 2 h, MW 
n. c. 
5 1 eq. 69, 1.5 eq. 74, 10 mol% CuI, 20 mol% 75 c, 2 eq. K2CO3, DMF, 155 °C, 2 h, MW 
75% 69, traces 
of 41 d 
Table 3: Attempts in Cu-catalysed cross-coupling reactions of 69 
 
In our case, coupling of 69 with acetamide (74) applying Xantphos/Pd2(dba)3 did not result in 
any product. In all cases starting material could be reisolated quantitatively, even under 
microwave irradiation, which should at best shorten the reaction time enormously (Table 4, 
entries 1 – 3). Using the catalyst system established by Verkade[110-112] could not improve 
conversion of 69. Traces of hydrodechlorinated product 41 d were isolated besides 69 if 
toluene was employed as solvent instead of DMF (entries 5 and 6). 41 d was also obtained 
using PdCl2(PPh3)2/Et3N (entry 8) and PEPPSI™ (75 g, entry 9). In the presence of 
P(tBu)3/Pd2(dba)3 reduced carbazole 41 d was quantitatively formed (entry 10).  
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Buchwald and Huang established mild ammonia equivalents for the amination of aryl halides. 
For hindered aryl halides like our 4-chlorocarbazole (69) with a methoxy group in ortho-
position they used triphenylsilylamide. However, in our case no conversion took place (Table 
3, entry 4)[119].  
 
Nickel-catalysed C-N bond formation processes could neither be transferred to our 
system[120]. No product was detected, but hydrodebromination to 41 d occurred (Table 3, 
entry 11).   
 
All attempts in C-N bond formation of 4-chloro-1-heptyl-3-methoxy-2-methylcarbazole (69) 
with acetamide did not show any conversion to the desired product. Aryl chlorides in general 
are of relatively low reactivity in terms of oxidative addition to Pd(0) species because of the 
large dissociation energy of the C-Cl bond compared to th energy of the C-Br bond (97 
kcal/mol vs. 84 kcal/mol at 298 K[121]).  
 
Thus 72 should be exposed palladium-catalysed protocols for coupling of aryl halides with 
amides. Using various catalyst systems did not result in any product. Either starting material 
was reisolated, or the Boc group was removed to form 4-bromo-1-heptyl-3-methoxy-2-
methyl-carbazole (76). Reduction to the hydrodebrominated product (41 d) took place, too 
(Table 5, entries 1 – 5).  
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Entry Conditions Result 
1 1 eq. 69, 2.5 eq. 74, 2 mol% Pd2(dba)3, 3.6 mol% 75 d, 1.4 eq. NaOtBu, dioxane, 105 °C, 2 h, MW n. c. 
2 1 eq. 69, 2.5 eq. 74, 2.3 mol% Pd2(dba)3, 3.6 mol% 75 d, 2.5 eq. NaOtBu, DMF, 155 °C, 2 h, MW n. c. 
3 1 eq. 69, 1.2 eq. 74, 10 mol% Pd(OAc)2, 15 mol% 75 d, 2 eq. Cs2CO3, dioxane, reflux, 2 d 
n. c. 
4 1 eq. 69, 1.2 eq. Ph3SiNH2, 2 mol% Pd2(dba)3, 2.4 mol% 75 d, 1.3 eq. LHDMS, toluene, reflux, 3 d n. c. 
5 1 eq. 69, 1.4 eq. 74, 2 mol% Pd2(dba)3, 8 mol% 75 e, 1.5 eq. NaOtBu, toluene, reflux, 4 d 
95 – 99% 69, 
trace 41 d 
6 1 eq. 69, 1.4 eq. 74, 2.5 mol% Pd2(dba)3, 10 mol% 75 e, 3 eq. NaOtBu, DMF, 155 °C, 2 h, MW n. c 
7 1 eq. 69, 3 eq. 74, 10 mol% Pd(OAc)2, 10 mol% 75 f, 3 eq. NaOtBu, DMF, 155 °C, 2 h, MW 55% 69 
8 1 eq. 69, 3 eq. 74, 10 mol% PdCl2(PPh3)2, CH3CN/Et3N = 5/1, 85 °C, 2 h, MW 
90% 69, 3% 
41 d 
9 1 eq. 69, 1.5 eq. 74, 5 mol% PEPPSI (75 g), 1.5 eq. KOtBu, DMF, reflux, 2 d 
74% 69, 14% 
41 d  
10 1 eq. 69, 3 eq. 74, 10 mol% Pd2(dba)3, 30 mol% P(tBu)3, 3 eq. NaOtBu, DMF, 155 °C, 2 h, MW 
100% 41 d 
11 1 eq. 69, 3 eq. 74, 10 mol% Ni(COD)2, 20 mol% dppf, toluene, reflux, 9 h 
mix. of  
69 and 41 d 
Table 4: Attempts in Pd-catalysed cross-coupling reactions of 69  
 
Aryl bromide 72 is less electron-rich than 69 due to the electron-withdrawing Boc group, 
which should be favourable for the reductive elimination. Also aryl bromides are more 
reactive in oxidative additions than aryl chlorides; but no conversion to the desired product 
could be achieved. Hydrodebromination proceeds faster than the formation of the desired 
product.  
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Entry Conditions Result 
1 1 eq. 72, 3 eq. 74, 10 mol% PdCl2(PPh3)2, CH3CN/Et3N = 5/1, 85 °C, 2 h, MW 
66% 72 
2 1 eq. 72, 3 eq. 74, 10 mol% Pd(OAc)2, 20 mol% 75 h, 3 eq. NaOtBu, dioxane, 120 °C, 2 h, MW 
82% 72, 15% 
76 
3 1 eq. 72, 3 eq. 74, 10 mol% Pd(OAc)2, 20 mol% 75 h, 3 eq. NaOtBu, DMAA, 160 °C, 2 h, MW 63% 41 d 
4 1 eq. 72, 1.5 eq. 74, 10 mol% Pd2(dba)3, 10 mol% 75 d, 2 eq. Cs2CO3, dioxane, reflux, 3 h 
decomp.  
5 1 eq. 72, 1.2 eq. 74, 10 mol% Pd(OAc)2, 10 mol% rac-BINAP, 1.2 eq. Cs2CO3, toluene, reflux, 18 h 
decomp. 
Table 5: Attempts in Pd-catalysed Buchwald-Hartwig reaction of 72 
 
A hydride source has to be available for the formation of the hydrodechlorinated or 
hydrodebrominated product 41 d. It is not clear yet, where it derives from. One suggestion is 
that it gains from DMF, which is not applicable using DMAA or toluene as solvents (Table 4, 
entries 5, 8 – 11 and Table 5, entry 3).  
 
Driver and Hartwig investigated the key step in C-N bond formation, the reductive 
elimination of amidoarylpalladium complexes in cross-coupling of aryl halides with amines. 
In general, this involves ligand dissociation, dimerisation, ligand association, or direct 
reaction, depending on the catalyst system and concentration of the ligands. They noticed a 
correlation between the nucleophilicity of the amine and the rate for the reductive elimination 
to the C-N coupled product[122, 123]. Transferred to our system, in which acetamide (74) should 
form an amidopalladium complex, this would mean low rates for the key step due to less 
reactivity of acetamide (74). This explanation agrees with our results.  
 
Hartwig and his coworker also observed that electron-withdrawing substituents on the aryl 
halide could accelerate the reductive elimination, especially due to resonance effects[122, 123]. 
But in our case the application of 72 did not lead to any product formation. The hindrance of 
the 4-position by H-5 is a further reason for the unsatisfying results of the Buchwald-Hartwig 
amidation. This applies to 4-chlorocarbazole 69 and 4-bromocarbazole 72.  
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3.4.2 Nitration of diverse carbazoles on C-4 
 
Another theoretical route to antiostatin A4 (31 d) is the selective nitration on C-4 (77 c), 
followed by a catalytic hydrogenation of the nitro group to an amine (78 c). Acylation to 79 d 
and methyl ether cleavage should provide 31 d (Scheme 25).   
 
 
 
 
 
 
 
 
 
 
 
Various nitrating reagents like claycop, nitronium tetrafluoroborate, nitric acid and metal 
nitrates were tried to achieve selective nitration of 41 d to 4-nitrocarbazole 77 c. Mild 
nitrating reagent claycop[70-72] was already used for the mononitration of 2,6-
dimethoxytoluene (46) in high yields. In case of 41 d only traces of the desired product 77 c 
could be isolated and residual educt was decomposed (Table 6, entry 4). Applying silver or 
zirconyl nitrate[124, 125] to 41 d only resulted in reisolation of the starting material and 
decompostion at longer reaction times (entries 1 and 3). Direct nitration with nitric acid of 
9H-carbazole derivatives with free carbazole-NH are known, but only applied for electron-
poor carbazoles[126, 127]. Nitric acid (40%) gave no product at all, but 60% of starting material 
were reisolated (entry 2), whereas higher concentrated nitric acid (60%) gave total 
decomposition.  
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Scheme 25: Strategy for the synthesis of 31 d via a 4-nitrocarbazole 
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Nitronium tetrafluoroborate[71, 128] was the only applicable nitrating agent for 41 d and gave 
35% of 77 c using DME as solvent and even 64% using THF (Scheme 26). But due to 
greasiness of nitronium tetrafluoroborate its weighted sample fluctuates and therefore the 
yields of nitration vary (Table 6, entries 5 and 6). Using commercial nitronium 
tetrafluoroborate dissolved in sulfolane to overcome this problem proceeded in decomposition 
(entry 7).  
 
Entry Conditions Result 
1 1 eq. AgNO3, 1 eq. BF3 · CH3CN, CH3CN, 0 °C to r.t., 3.5 h 83% 41 d 
2 3 eq. HNO3 (40%), CH3CN, 0 °C to r.t., 3.5 h 60% 41 d 
3 1 eq. ZrO(NO3)2 · H2O, acetone, r.t., 30 h decomp. 
4 claycop, 10 eq. Ac2O, Et2O, 0 °C to r.t., 20 h 
traces of 77 c, 
rest decomp. 
5 1.2 eq. NO2BF4, DME, –50 °C to –20 °C, 50 min 35% 77 c 
6 2.1 eq. NO2BF4, THF, –50 °C to –25 °C, 17 h 64% 77 c 
7 1.2 eq. NO2BF4 in sulfolane, DME, –50 °C to –20 °C, 7 h decomp. 
Table 6: Attempts in the nitration of 41 d 
Bismuth nitrate[129] and zirconyl nitrate[125] were efficiently used in nitration reactions of 
phenolic compounds. Therefore, the methyl ether of 41 d was cleaved using boron tribromide 
to afford carazostatin (38) in 99% yield. 38 was previously prepared in our group by ether 
cleavage from 41 d (100%)[130] or along with O-methylcarazostatin (41 d) in an oxidative 
cyclisation of iron complex 39 d (33%)[62]. Thus, the overall yield for the iron-mediated 
synthesis of carazostatin (38) over three steps from iron salt 34 was increased to 96% 
(previous 83%)[130].  
 
 
 
 
 
 
Nitration of carazostatin (38) with metal nitrates caused decomposition (Table 7, entries 2 and 
3), even using nitronium tetrafluoroborate (entry 1, Scheme 27).  
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Scheme 27: Nitration of carazostatin (38) 
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It seems that compound 41 d and especially 38 are too labile for the nitration process with 
well-established mild nitration reagents. The problem derives from the free NH-group, which 
is very susceptible to oxidative processes.  
 
Entry Conditions Result 
1 1.2 eq. NO2BF4, DME, –50 °C to –30 °C, 1.5 h decomp. 
2 1 eq. Bi(NO3)3 · 5 H2O, acetone, r.t., 7 min  decomp. 
3 1 eq. ZrO(NO3)2 · H2O, acetone, r.t., 6 h  decomp. 
Table 7: Nitration of carazostatin (38) 
 
Carbazole 77 c can be hydrogenated to 4-aminocarbazole 78 c under hydrogen atmosphere in 
a heterogenic catalysed reaction with palladium on activated charcoal in excellent yields. 
From 4-amino-1-heptyl-3-methoxy-2-methyl-9H-carbazole (78 c) an X-ray structure was 
obtained from its colourless single crystals (Fig. 8).  
 
 
 
 
 
 
 
 
Applying various acetylation protocols to 78 c did afford 4-acetamidocarbazole 79 d only in 
traces (Scheme 28). Acetic anhydride/DMAP, peptide coupling reagents like MSNT (2,4,6-
mesitylene-sulphonyl-3-nitro-1,2,4-triazolide)[131] and acetic acid with 
trifluoromethanesulphonic anhydride[132] did not give any satisfying result.  
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Scheme 28: Hydrogenation and acylation 
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In the synthesis of polyazapentalenes Albini et al. applied an in situ acylshift via 
hydrogenation of a nitro group to an amine in the presence of an ortho acetoxy group, which 
provided an acetamidohydroxyaryl compound[133]. Carbazole 77 c was then transferred to the 
hydroxycarbazole 80 by methyl ether cleavage using boron tribromide[130]. Acylation of the 
free hydroxy group with acetic anhydride and DMAP established compound 81 in 35% yield. 
However, carbazole 81 did not undergo hydrogenation with in situ acyl shift with palladium 
on charcoal under hydrogen atmospere to compound 31 d (Scheme 29).  
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Scheme 29: Attempts towards an acyl shift  
 
Fig. 8: Molecular structure of 78 c in the crystal 
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3.5 First total synthesis of antiostatin A4 (31 d) 
 
Antiostatin A4 (31 d) was finally synthesised by nitration of butyloxycarbonyl protected 71 d, 
followed by catalytic hydrogenation to an aminocarbazole, acylation of the amino group, 
removal of the Boc group and methyl ether cleavage.  
 
Introduction of the electron-withdrawing butyloxycarbonyl group as protecting group in 9-
position was already applied in the synthesis of Boc protected 4-bromocarbazole 72 and 
allows selective nitration of the 4-position, too. Using nitronium tetrafluoroborate gave 80% 
yield of 82 d, whereas claycop gave 91% of 82 d. Because reactions with claycop instead of 
nitronium tetrafluoroborate are more reproducible and gave higher yields, only claycop was 
used in the syntheses of further antiostatins A1-3 and B2-5 (31 a-c and 32 a-d). Traces of 4,6-
dinitro products, which can be separated by chromatography, were detected as well.   
 
Heterogenic catalytic hydrogenation with palladium on activated charcoal (30 wt%) under 
hydrogen atmosphere gave 4-aminocarbazole 83 d in 92%. Acylation with acetyl chloride and 
triethylamine was found to be the best procedure for acylation of 83 d. It provided 4-
acetamidocarbazole 84 d in 84% yield.  
 
Removal of the Boc group was realised under thermal conditions. Heating neat compound 
84 d to 180 °C for 45 min gave quantitatively O-methylantiostatin-A4 (79 d). Moody et al. 
already used this procedure for the removal of Boc protecting groups on carbazoles[99, 100].  
 
There are various methods known for ether dealkylation[134]. Typical demethylation reagents 
for arylmethyl ethers are lewis acids, but also reductive and oxidative procedures are used. 
Applying the standard reagent for ether cleavage of carbazoles, boron tribromide, methyl 
ether removal in 3-position of 79 d provided antiostatin A4 (31 d) in excellent yield of 94% 
(Scheme 30).  
 
The first total synthesis of antiostatin A4 (31 d) was achieved using a iron-mediated synthesis 
for highly substituted carbazoles, which proceeded in excellent yields. The implementation of 
a protecting group on N-9 is needed for reproducible high yields in the nitration step and 
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especially for the acylation step, which did not work with unprotected aminocarbazole 78 d. 
Both the introduction and the removal of the protecting group proceeds quantitatively, so the 
overall scheme can easily cope with this two additional steps. Antiostatin A4 (31 d) was 
synthesised from iron salt 34 in eight steps in excellent 63% yield.  
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Scheme 30: First total synthesis of antiostatin A4 (31 d) 
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3.6 First total synthesis of antiostatins A1 and A3 (31 a and 31 c) 
 
The synthetic route, which was applied in the preparation of antiostatin A4 (31 d), could 
easily be transferred to the syntheses of antiostatins A1 and A3 (31 a and 31 c). The reaction 
path starting with carbazole 41 a and 41 c is shown in Scheme 31. Introduction of the Boc 
protecting group proceeds almost quantitatively to compounds 71 a and c. Selective nitration 
on C-4 of 71 a and c yields 82 a and c. 82 a is formed in 81% together with 13% of 4,6-
dinitrocarbazole 82 g. Catalytic hydrogenation gives quantitatively 83 a and c. Acylation with 
acetyl chloride to 84 a (81%) and 84 c (91%) and quantitative removal of the protecting group 
gave 79 a and c. Ether cleavage with boron tribromide provided antiostatins A1 and A3 (31 a 
and 31 c) in 80% and 65%, respectively.  
 
The total yield for antiostatin A1 (31 a) over eight steps starting from iron salt 34 amounts to 
31%, for antiostatin A3 (31 c) it sums up to 39%. The total yield over eight steps for 
antiostatins A1 and A3 is lower than for A4 due to lower yields in the oxidative cyclisation step 
(see 3.3.4) in the A1-series (63%) and in the methyl ether cleavage in the A3-series (65%), 
respectively. Likewise for A4 (31 d), the above mentioned reaction pathways are the first total 
syntheses for antiostatins A1 and A3 (31 a and 31 c).  
 
In summary, the reaction route established for the synthesis of antiostatin A4 (31 d) was 
brought forward to the syntheses of antiostatins A1 and A3 (31 a and 31 c). 
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As mentioned before, nitration with claycop proceeds at the 4-position in high yields, but 
about 10% of 4,6-dinitrocarbazoles are produced as well. tert-Butyl 3-methoxy-2-methyl-4,6-
dinitro-1-pentyl-9H-carbazole-9-carboxylate (82 g) was isolated and an X-ray analysis could 
be obtained of the yellow single crystals (Fig. 9). 
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Scheme 31: First total synthesis of antiostatins A1 (31 a) and A3 (31 c) 
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3.7 First total synthesis of antiostatin A2 (31 b) 
 
As mentioned earlier, the decision to synthesise antiostatin A2 (31 b) with S-configuration 
stems from the assumption that the stereogenic centre could have the same configuration as 
carbazomadurin B or other related alkaloids, which were found in microorganisms. 
Carbazomadurin B was isolated from Actinomadura madurae 2808-SV1 in 1997[135]. 
Therefore, it is likely, that both alkoloids have the same biogenetic pathway and terpene 
precursors. Carbazoquinocins A and D – exponents of the carbazolequinone alkaloids – were 
isolated from microorganisms[136] and are substituted by (S)-configured chiral alkyl chains in 
1-position. Carbazoquinocin A even bears exactly the same alkyl chain as antiostatin A2 (31 
b), a 3-methyl-pentyl side chain[137].  
 
The synthesis of (S)-antiostatin A2 (31 b) was put into practice applying the same route as for 
antiostatins A1, A3 and A4 (31 a, c and d) starting from iron salt 34. The chiral information 
was established by alkyne 49 b, which was prepared from (S)-2-methyl-1-butanol (58). 
Alkyne 49 b was subjected to a Sonogashira reaction with 47, which was transferred after 
hydrogenation to carbazole 41 b by C-C and C-N bond formation with iron salt 34 (see 3.3). 
Free NH of 41 b was protected with butyloxycarbonyl (71 b), followed by selective nitration 
with claycop (82 b). Hydrogenation to 83 b, acylation to 84 b, quantitative removal of the 
Boc group to 79 b and ether cleavage finally provided (S)-antiostatin A2 (31 b). The overall 
yield over eight steps sums up to 62% from iron salt 34. 
 
Fig. 9: Molecular structure of 82 g in the crystal 
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The limiting step of the first total synthesis of (S)-antiostatin A2 (31 b) is the sequence of the 
Corey-Fuchs and Sonogashira reaction (see 3.3.3). The further synthetic proceedings adopted 
from antiostatin A4 (31 d) succeeded in high yields (Scheme 32).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Due to limited amounts of natural antiostatin A2 (31 b), Seto et al. could not give its specific 
rotation. The [α]20D of the synthesised (S)-antiostatin A2 ((S)-31 b) is +5.0 (CHCl3, c = 1.0). 
In Table 8 the [α]20D values of all precursors are summerised. As synthesised (S)-antiostatin 
A2 ((S)-31 b) and some (S)-precursors did not show any circular dichroism effect, no 
comparison to the natural product, by courtesy of Prof. Seto, could be drawn. 1H NMR data of 
synthesised (S)-antiostatin A2 ((S)-31 b) are in good agreement with natural antiostatin A2 (31 
b) provided by Prof. Seto. The 1H NMR data of both are compared in Table 9. Due to 
concentration effects the signal of the OH-group of synthetic A2 ((S)-31 b) was not detected.  
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Scheme 32: First total synthesis of antiostatin A2 (31 b) 
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Compound [a]20D  [a]20D  Lit. values c in g/100mL Solvent 
59 + 29.3 + 33.1 2.5 acetone 
64 + 14.6 + 14.3 2.0 n-heptane 
49 b* – – – – 
48 b + 27.8 – 1.0 CHCl3 
40 b + 7.2 – 0.5 CHCl3 
39 b + 2.8 – 1.0 CHCl3 
41 b + 6.4 – 1.0 CHCl3 
71 b + 7.2 – 1.0 CHCl3 
82 b + 4.5 – 1.0 CHCl3 
83 b + 9.3 – 1.0 CHCl3 
84 b + 8.5 – 1.0 CHCl3 
79 b + 5.2 – 1.0 CHCl3 
(S)-31 b + 5.0  – 1.0 CHCl3 
Table 8: Specific rotation ([a]20D). (*) [a]20D was not measured due lack of purification; compounds listed 
analogue their occurrence in the reaction sequence. 
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C-atom nr.,  
number of protons 
1H NMR of natural 
A2 in acetone-d6 
1H NMR of 
synthesised A2 in 
acetone-d6 
1a, 2 H 2.95 – 3.08 (m) 2.93 – 3.08 (m) 
1c, 1 H 1.19 – 1.30 (m) 1.23 – 1.39 (m) 
1b, 2 H; 1d, 2 H 1.44 –1.58 (m); 1.64 – 1.71 (m) 
1.44 – 1.61 (m); 
1.65 – 1.71 (m) 
1e, 3 H 0.93 – 0.96 (m) 0.93 – 0.96 (m) 
1f, 3 H 1.05 (d) 1.06 (d) 
2a, 3 H 2.42 (s) 2.42 (s) 
3, OH 8.07 (br s) - 
4, NH 9.78 (br s) 9.78 (br s) 
4b, 3 H 2.50 (s) 2.51 (s) 
5, 1 H 8.16 (d) 8.17 (d) 
6, 1 H; 7, 1 H 7.12 (dt);  7.33 (dt) 
7.12 (dt);  
7.33 (dt) 
8, 1 H 7.47 (d) 7.47 (d) 
NH 10.23 (br s) 10.20 (br s) 
Table 9: Comparison of 1H NMR data of synthesised and natural antiostatin A2 (31 b) 
 
3.8 Attempts towards the synthesis of antiostatin B4 (32 c) 
  
The scheme of the synthesis of antiostatin B4 (32 c) starts with 4-aminocarbazoles 78 c or 
83 d, which were already prepared for synthetic approaches towards antiostatin A4 (31 d). At 
best the iso-butylbiuret group should be introduced in one step to form 85 c or 86. Removal of 
the Boc protecting group (if necessary) and subsequent cleavage of the methyl ether should 
then give antiostatin B4 (32 c) in two or three steps (Scheme 33).  
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Abdel-Razik established N-chlorocarbonyl isocyanate (87) for the synthesis of an N-
substituted aminocarbonyl isocyanate with diamino compounds in the presence of 
triethylamine and dichloromethane[138]. According to him the addition-elimination process 
takes place on the carbonyl chloride in preference over addition to the competing isocyanate, 
which was indicated by characteristic vibrations in the IR spectra of the product. Adopting 
this reaction to our system would mean a conversion of iso-butylamine (88) with 
chlorocarbonyl isocyanate (87) to iso-butylaminocarbonyl isocyanate (89). The isolation of 89 
failed and only mixtures could be isolated. The idea was to generate 89 in situ to introduce the 
substituted biuret group in one step to carbazole 83 d to give 86. Reaction conditions were 
varied using different reaction times and amounts of 87 and 88 between 1.2 and seven 
equivalents, but carbazole 86 could not be isolated. Instead, a carbazole derivative 90 was 
formed, which is substituted with iso-butylurea instead of a biuret group in 4-position. 90 is 
generated under formal loss of “HNCO” (Scheme 34).   
 
Isocyanates are important intermediates in the synthesis of biologically active compounds due 
to their high reactivity. In 1995, Knölker et al. established a mild, phosgene-free synthesis for 
isocyanates of alkyl- and arylamines with di-tert-butyl dicarbonate and DMAP as 
nucleophilic nitrogen base. The conversion proceeds at room temperature in about 10 min, in 
most cases quantitatively[139].  
 
The idea to generate an isocyanate of an arylamine as intermediate for the synthesis of 1-aryl-
5-alkylbiurets was already established in the literature. The arylisocyanate is then converted 
to a substituted biuret by addition of an alkylurea[140, 141].  
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Scheme 33: Approach for the synthesis of B4 (32 c) 
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Adopted to our case, 4-aminocarbazoles 78 c or 83 d should be converted to isocyanates 91 
and 92, respectively, which should undergo nucleophilic addition with 1-iso-butylurea (93) to 
form compounds 85 c and 86 (Scheme 35). 
 
 
 
 
 
 
 
 
 
Therefore, 1-iso-butylurea (93) was prepared in 89% using potassium cyanate (94) and iso-
butylamine (88) in sulphuric acid in a Wöhler-type reaction (Scheme 36)[142, 143]. Alkylation 
of urea with iso-butyl iodide did not result in any product[144]. 
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Scheme 34: Reactions of N-chlorocarbonyl isocyanate 87 
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Scheme 35: Approach via isocyanates 91 and 92 
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Compounds 91 and 92 were generated using a slight excess of di-tert-butyl dicarbonate and 
stoichiometric amounts of DMAP in acetonitrile. Arylisocyanates 91 and 92 could not be 
isolated because they decomposed during purification on silica gel. But the IR spectra of the 
crude products show strong vibrations of the NCO-group, which strongly indicates the 
formation of 91 and 92. Conversion to 91 and 92 could be monitored by TLC and needed 
longer reaction times for 91 (60 min) than for 92 (20 min). In situ created compounds 91 and 
92 were subjected a nucleophilic addition by adding two equivalents of 93 to the solution. 
However, carbazoles 85 c and 86 did not arise, instead urea-substituted carbazoles 90 and 95 
were formed in 88% and 80% yield (Scheme 37).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The reason for the formation of urea-substituted carbazoles 90 and 95 by the formal loss of 
“HNCO” could be the nucleophilic attack of N-1 instead of N-3 of 1-iso-butylurea (93), 
although it seems to be the less favoured version because of sterical hindrance. The resulting 
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Scheme 36: Synthesis of isobutylurea 93 
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Scheme 37: Conversion of aminocarbazoles 78 c and 83 d 
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product 96 could then undergo loss of HNCO (97) in a hypothetic six-membered cyclic 
transition state. 98 would isomerise subsequently to urea 99 (Scheme 38).  
 
Therefore, we planned to synthesise iso-butylurea protected with benzyloxycarbonyl (Cbz) on 
N-1 to prevent attack of N-1 instead of N-3 on isocyanates 91 and 92. However, protection 
with CbzCl takes place on N-3 to iso-butylaminocarbonylcarbamic acid benzyl ester 100 
(Scheme 39).   
 
In case of the reaction of carbazole 83 d with N-chlorocarbonyl isocyanate (87) this 
hypothesis fails. What could happen is that 87 reacts with aminocarbazoles 78 d or 83 d in 
that way that an allophanic acid chloride 101 is formed by attack of the amine on the 
isocyanate group instead of the acid chloride. Hagemann describes in his article “N-
Chlorcarbonyl-isocyanat – Synthese und Reaktionen” that amines in reaction with 87 form 
products respective to 101[156]. By reaction with another amine, 1,5-disubstituted biurets are 
generated. Thermolysis of 1,1-dialkylallophanic acid chlorides (like 101) provides 
dialkylcarbamide acid chlorides (like 102) under loss of HNCO (97). 102 and amine 88 then 
react to urea 99 (Scheme 38).  
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Scheme 38: Hypothetical mechanism for the loss of HNCO 
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N-Substituted 1H-imidazole-1-carboxamides can be used in a similar manner than isocyanates 
in reaction with nucleophiles to form substituted urea derivatives. The conversion of 4-
aminocarbazole 83 d with carbonyl diimidazole (CDI) did not give any N-carbazoyl-1H-
imidazole-1-carboxamide 103. Starting material was reisolated (80%) and slight 
decomposition took place (Scheme 40).  
 
Curd et al. describe the conversion of aromatic allophanic acid ethyl esters with amines to 
1,5-substituted biurets[145]. However, the reaction of the isocyanate of 83 d with ethyl 
carbamate did not give any N-carbazoyl-allophanic acid ethyl ester 104. Isocyanate 92 was 
formed (TLC control), but it was not converted to 104. After aqueous work-up 20% educt was 
reisolated, the rest decomposed (Scheme 40). 103 and 104 should then undergo reaction with 
iso-butylurea (93) and iso-butylamine (88), respectively. 
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Scheme 39: Reaction of iso-butylurea with CbzCl 
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Scheme 40: Reactions of 83 d  
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3.9 First total synthesis of antiostatin B4 (32 c) 
3.9.1 Reactions with 1-nitrobiuret and its derivatives 
  
1-Nitrobiuret (105) has been known since 1898, when Thiele and Uhlfelder reported its 
preparation from biuret (106) with concentrated sulphuric and nitric acid[146]. 105 is a versatile 
reagent in the synthesis of substituted biuret derivatives from 1-nitrobiuret (105). In 1929, 
Davis and Blanchard synthesised various 1-alkyl and 1-arylsubstituted biurets[147]. Seven 
years later, Davis and Constan reported a synthesis of 1,1-dimethyl-5-nitrobiuret and its 
conversion to 1,1-dimethyl-5-phenylbiuret without giving any yield for the second step[148]. In 
1951 Detweiler et al. established a conversion of 1-nitrobiuret with heteroarylamines to get 1-
heteroarylbiuret in at most 34% yield[149]. Two years later, Dunnigan prepared 1-alkylbiurets 
from 1-nitrobiuret using equimolar amounts of an alkylamine in water at reflux and reached 
yields between 30 and 90%. 1-iso-Butylbiuret (107) was produced in that manner and 
characterised by its melting point (108 – 109 °C)[150]. In his thesis, Börner improved the 
reaction conditions, by using ethanol instead of water as solvent[151]. Plater et al. enhanced the 
conversion of arylamines with 1-nitrobiuret and synthesised 1-(2-chloro-4-iodophenyl)biuret 
from 1-amino-2-chloro-4-iodobenzene and 1-nitrobiuret (105) in 77%[152]. At reflux, 1-
nitrobiuret (105) decomposes in water[147]. 
 
5-iso-Butyl-1-nitrobiuret (108) was synthesised from biuret (106) by nitration to 1-nitrobiuret 
(105), followed by alkylation to 1-iso-butylbiuret (107), which was again nitrated to generate 
108. Reaction conditions for the nitration of biuret (106) were taken from Thiele et al. and 
afforded the product in 51% yield after purification (lit. 90%[146], Scheme 41).  
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Scheme 41 Synthesis of 5-iso-butyl-1-nitrobiuret (108) 
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The alkylation of 105 with an excess of iso-butylamine (88) was realised in ethanol at room 
temperature. Börner described the formation of a salt (like 109) from alkylamines and            
1-nitrobiuret (105) as an intermediate of the reaction, which decomposes to iso-butylbiuret 
(107) by heating until the colourless solid melts (ca. 150 °C) under loss of water and laughing 
gas[147]. Adopting the melting procedure to our system, the conversion of iso-butylamine (88) 
with 1-nitrobiuret (105) gave 99% of 1-iso-butylbiuret (107, Scheme 41 and Scheme 42).  
 
 
 
 
 
 
Nitration of iso-butylbiuret (107) under the same conditions as for 1-nitrobiuret (105) gave 5-
iso-butyl-1-nitrobiuret (108). Only the temperature for the reaction had to be decreased from 
room temperature to 0 °C, otherwise decomposition and formation of nitrous gases takes 
place. The crude product has to be recrystallised from ethanol to generate 24% of 108. 5-iso-
Butyl-1-nitrobiuret (108) was fully characterised by NMR, IR, MS and HRMS. Moreover, an 
X-ray analysis could be obtained of its colourless single crystals (Fig. 10). It is proved that the 
nitro group is located at the remote end of the molecule compared to the alkyl chain.  
 
 
 
 
 
 
 
 
 
With 108, a potent reagent was found for the synthesis of disubstituted biuret derivatives like  
4-(5-iso-butyl-biuret-1-yl)carbazoles 85 c and 86. Preliminary tests using o-anisidine (110), 1-
nitrobiuret (105) and 5-iso-butyl-1-nitrobiuret (108) showed very promising results. 110 was 
converted to 1-(2-methoxybenzene)biuret (111) in a very short reaction time (15 min) in 
water in 94% yield. As alkylation of 111 with iso-butyl iodide and sodium tert-butylate as 
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Scheme 42: Mechanism for the formation of 107 
 
 
Fig. 10: Molecular structure of 108 in the crystal 
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base did not proceed in any conversion, o-anisidine (110) was transferred quantitatively to 5-
iso-butyl-1-(2-methoxybenzene)biuret (112) by the use of 5-iso-butyl-1-nitrobiuret (108, 
Scheme 43).  
 
 
 
 
 
 
 
 
 
 
 
Applying the above mentioned system (2 eq. 108, water, reflux) to carbazoles 78 c or 83 d did 
only result in reisolation of the starting material, probably due to poor solubility of 78 c or 
83 d in water. Even under microwave irradiation (150 °C) no product was formed. Using 
DMSO at reflux induced partly decomposition of 78 c or 83 d, especially 83 d was 
decomposed to 78 c, which indicates the lability of the Boc group under high temperatures. 
This results lead to the idea to use 78 c (with free NH) for the reaction with 1-iso-butyl-5-
nitrobiuret (108). Since we presumed that compound 108 is instable at high temperatures in 
water and other solvents like 1-nitrobiuret, 108 was added to the reaction mixture dropwise 
(in solution) over three hours. Using improved conditions in acetonitrile finally gave an 
excellent yield (91%) of 4-(5-iso-butyl-biuret-1-yl)carbazole 85 c in excellent yields 
(Scheme 44).  
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Scheme 43: Reactions of 105 and 108 with o-anisidine (110) 
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Scheme 44: Conversion of 78 c to 85 c with biuret 108 
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An X-ray analysis of a single crystal of 4-(5-iso-butyl-biuret-1-yl)-1-heptyl-3-methoxy-2-
methyl-9H-carbazole (85 c) could be obtained (Fig. 11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From all reactions known for the synthesis of 5-alkyl-1-arylbiurets, i.e. reactions of amines 
with allophanyl esters or chlorocarbonyl isocyanate and arylamines or conversion of 
substituted urea derivatives with isocyanates derived from arylamines, the reaction with 
nitrobiurets works best. All other attempts did not lead to the desired product. 
 
Two different kind of aromatic compounds (110 and 85 c) demonstrate the generation of 5-
alkyl-1-arylbiurets by reaction of an arylamine and an 5-alkyl-1-nitrobiuret like 108 in 
excellent yields. 
 
3.9.2 Alternative route to 78 c and ether cleavage to B4 (32 c) 
 
Using a NH-protection strategy, 4-aminocarbazole 78 c can be easily prepared in four steps in 
91% overall yield (Scheme 45) instead of two steps in 64% yield (see 3.4.2). Nitration, 
removal of the Boc group and hydrogenation complete the reaction sequence.  
 
Fig. 11: Molecular structure of 85 c in the crystal 
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Nitrocarbazole 82 d can also be transferred to 78 c by hydrogenation followed by cleavage of 
the Boc group, but due to the lability of the amino group lower yields are obtained (92% for 
hydrogenation and 91% for Boc cleavage). The mentioned reaction sequence above is more 
favourable.  
 
Finally, cleavage of the methyl ether with 3.3 equivalents of boron tribromide led to 
antiostatin B4 (32 c) in very good yields (Scheme 46).  
 
 
 
 
 
 
 
 
 
Scheme 47 shows the overall synthesis of antiostatin B4 (32 c) from iron salt 34. It was 
synthesised in eight steps in excellent 56% overall yield. Note the introduction of the iso-
butyl substituted biuret group in 4-position, which proceeds in high yields.  
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Scheme 45: Alternative route to 4-aminocarbazole 78 c 
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Scheme 46: Methyl ether cleavage towards antiostatin B4 (32 c) 
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Scheme 47: First total synthesis of antiostatin B4 (32 c) from iron salt 34 
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3.10 First total synthesis of antiostatins B2 (32 a), B3 (32 b) and B5 (32 d) 
 
The synthetic route, which was applied in the preparation of antiostatin B4 (32 c), could be 
easily transferred to the synthesis of antiostatins B2 (32 a), B3 (32 b) and B5 (32 d), 
respectively. The reaction path starting with carbazoles 41 e, 41 c and 41 f is shown in 
Scheme 48. Introduction of the Boc protecting group led quantitatively to compounds 71 e, 
71 c and 71 f. Selective nitration on C-4 afforded 82 e, 82 c and 82 f using claycop in 81% to 
91%. 77 a, 77 b and 77 d were obtained quantitatively after removal of the Boc group under 
thermal conditions (Scheme 48).  
 
After hydrogenation to 78 a, 78 b and 78 d the iso-butylbiuret group in 4-position was 
introduced using 5-iso-butyl-1-nitrobiuret (108) in excellent yields (83% to 87%). Boron 
tribromide assisted methyl ether furnished antiostatins B2 (32 a), B3 (32 b) and B5 (32 d) in 
79% to 94% (Scheme 48).  
 
The total yield for antiostatin B2 (32 a) over eight steps starting from iron salt 34 amounts to 
40%, for antiostatin B3 (32 b) to 50% and for antiostatin B5 (32 d) it sums up to 49%. Again 
the key step of the synthesis is the introduction of the iso-butylbiuret functional group in 4-
position in high yields.  
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Scheme 48: First total synthesis of antiostatins B2, B3 and B5 (32 a, b and d) from 
carbazoles 41 e, 41 c and 41 f 
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3.11 Overview over all total syntheses 
 
All yields of the total syntheses for the A-series and B-series of the carbazole alkaloids 
antiostatin established within this thesis are summarised in Table 10. For most reactions, the 
resulting yields are similar for compounds with different alkyl groups. In case they differ a 
lot, an explanation is given in the corresponding paragraphs.  
 
Yields [%] a b c d e f 
47 88 over three steps from 46 
48 .. 100 45* 98 100 82 85 
40 .. 100 88 95 100 96 84 
39 .. 100 95 89 100 96 100 
41 .. 63 93 93 96 81 91 
71 .. 93 100 98 100 100 100 
precursor 
82 .. 81 81 83 91 90 81 
83 .. 100 100 99 92 - - 
84 .. 81 97 91 84 - - 
79 .. 100 100 100 100 - - 
A-series 
31 .. 80 89 65 94 - - 
77 .. 100 100 100 100 - - 
78 .. 82 96 100 100 - - 
85 .. 87 83 91 84 - - 
B-series 
32 .. 79 94 74 79 - - 
overall 
yield over 
eight steps 
from 34 
31 .. 31 62 39 63 - - 
overall 
yield over 
eight steps 
from 34 
32 .. 40 50 56 49 - - 
Table 10: Summary of all yields of the total syntheses of the antiostatins from 46 
(*) yield over two steps from alkene 64 (see 3.3.3). 
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3.12 Hindered rotation of the N-CO-bond of 79 a-d and 84 a-d 
 
4-Acetamido carbazoles 79 a-d and 84 a-d bear an interesting behaviour: they give a double 
set of signals in 1H and 13C NMR, which indicates the occurrence of two conformers. The      
C-N bond between the carbonyl and the amide group has a strong double bond character due 
to mesomeric effects (Scheme 49). There are two different rotameres possible, namely cis-113 
and trans-113, in which the methyl group and the N-hydrogen of the acetamide functional 
group are in cis and trans position to each other, respectively.  
 
 
 
 
 
 
 
 
 
 
 
By using dynamic 1H NMR spectroscopy, the coalescence temperature, the rate k of rotation 
of cis-113 to trans-113, and the free energy ΔG# for the hindered rotation of 79 a-d and 84 a-
d can be determined[153]. At temperatures below the coalescence temperature the rotation of 
the N-CO-bond is adequately slow on the NMR time scale to give two separated signals of all 
H- and C-atoms (see NMR data of 79 a-d and 84 a-d).  
 
Two-dimensional exchange spectroscopy[154] (2D-EXSY NMR) is a promising alternative for 
the calculation of the activation energy instead of using the coalescence temperature. 
Therefore, cross peaks, which derive from non-coherent magnetisation transfer between sites 
with different resonance frequencies, are interpreted. Dr. Gruner from the NMR department 
of our institute calculated the activation energies and rate constants using EXSY.  
 
 
N
R
OMe
R'
N
H
H
Me
-O
N
R
OMe
R'
N
H
H
-O
Me
cis-113
+
+
R = H or Boc
R' = alkyl
79 a-d or
84 a-d
trans-113
N
R
O
CH3
R'
HN
CH3
O
H
CH3
1/1*
2/2*
3/3*
4/4*
 
Scheme 49: Conformers of 79 a-d and 84 a-d 
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Change of 
conformeres 
cis/trans 
Calcd by coalescence temperature 
Calcd by 2D-
EXSY NMR at 
295 K   
 ΔG
#
cis→trans 
[kcal/mol] 
ΔG#trans→cis 
[kcal/mol] Tc [K] ΔG# [kcal/mol] 
1/1* 16.8 16.3 350 16.0 
2/2* 16.8 16.3 340 - 
79 d in 
TCl-d2 
3/3* 16.8 16.4 345 15.8 
1/1* 17.2 16.7 358  15.8 
2/2* 17.5 17.0 353 16.1 84 d in TCl-d2 
3/3* 17.0 16.5 350 15.6 
1/1* - - - 16.3 
2/2* - - - 16.2 
79 a in 
CDCl3 
3/3* - - - 15.8 
1/1* - - - 16.1 
2/2* - - - 16.5 
79 d in 
CDCl3 
3/3* - - - 15.6 
1/1* - - - 16.3 84 d in 
CDCl3 2/2* - - - 15.8 
Table 11: Free energy (ΔG#) of 79 a, 79 d and 84 d 
 
Compounds 79 a, 79 d and 84 d were chosen as examples for the calculation of the ΔG# 
values. Due to high coalescence temperatures Tc of various H/H* systems TCl-d2 was used as 
solvent instead of CDCl3 for coalescence measurements. In CDCl3 both rotamers exchange in 
the same rate, in TCl-d2 the rate differs due to solvent effects (cis/trans 1:1 to 2:1). This 
means that in TCl-d2 the energy barrier, which has to be overcome in order to generate trans 
from cis must be higher than to form cis from trans. The average value for ΔG#cis→trans is in 
case of 79 d 16.8 kcal/mol, in case of 84 d 17.2 kcal/mol, ΔG#trans→cis is 16.3 kcal/mol and 
16.4 kcal, respectively. The difference between ΔG#cis→trans and ΔG#trans→cis is in the range of 
0.5 kcal/mol for both compounds (Table 11). The limit of error of coalescence calculation lies 
within 0.3 kcal/mol.  
 
EXSY calculations gave an average value for forward and back reaction in TCl-d2 of about 
15.9 kcal/mol for 79 d and 15.8 kcal/mol for 84 d. In CDCl3 16.1 kcal/mol for 79 a, 16.4 
kcal/mol for 79 d and 16.1 kcal/mol for 84 d were calculated. Substituents in 1- and 9-
position (alkyl and Boc group, respectively) do not have any influence on the rotation of the 
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N-CO-bond, as exspected due to their distance (Table 11). Differences of the ΔG#  values are 
in the limit of error.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12 demonstrates the coalescence of the singlets at 1.82 ppm (trans-113) and 2.32 ppm 
(cis-113) of the 1/1* system at 358 K of 4-acetamidocarbazole 84 d.  
 
3.13 Biological activity against tuberculosis 
 
In order to establish the ability of inhibition of the tubercolosis agent, the MIC values of 
various precursors and antiostatins against the virulent strain H37Rv were determined in 
cooperation with the group of Prof. Franzblau using a microplate alamar blue assay. None of 
the compounds did show any significant inhibition.  
 
 
 
Fig. 12: 1H NMR of 84 d in TCl-d2, coalescence of 1/1*  
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4 CONCLUSION AND OUTLOOK 
 
Within this thesis the first total syntheses of eight biologically active natural products from 
the family of carbazole alkaloids, antiostatins A1 to A4 and B2 to B5 (31 a-d and 32 a-d), were 
established. Spectroscopic data of the synthesised natural products are in good agreement 
with the isolated antiostatins from Streptomyces cyaneus 2007-SV1, which confirms the 
molecular structures assigned to the natural products by Prof. Seto. 
 
The total synthesis of the antiostatins A1 to A4 and B2 to B5 (31 a-d and 32 a-d) were achieved 
employing the iron-mediated synthesis to form the carbazole nucleus, which was established 
in our group and already used in the synthesis of various carbazole alkaloids. This transition 
metal-mediated approach could be applied to all antiostatins in excellent yields. 
 
All precursors for the iron-mediated approach could be prepared in high yields and quantities. 
Therefore, six different arylamines 40 a-f were synthesised as starting materials in five steps 
starting from commercial 2,6-dimethoxytoluene (46) using a sequence of electrophilic 
aromatic substitution with claycop, establishing a leaving group, a palladium-catalysed cross-
coupling reaction and hydrogenation. Non-commerical alkynes 49 b and 49 f, which are 
applied in the Sonogashira reaction, were prepared.  
 
Antiostatins A1-4 and B2-5 (31 a-d and 32 a-d) represent the first carbazole alkaloids with an 
acetamide (A-group) or substituted biuret (B-group) chain. Approaches could be found to 
introduce these sophisticated substituents selectively on C-4 in high yields.  
 
The nitrogen substituent in 4-position was established by selective nitration of Boc-protected 
carbazoles (71 a-f). Hydrogenation, acylation and removal of the Boc group and methyl ether 
cleavage provides antiostatins A1 to A4 (31 a-d) in high yields.  
 
A method for the synthesis of 5-alkyl-1-aryl-substituted biurets was found. Therefore 1-iso-
butyl-5-nitrobiuret (108) was synthesised in three steps from biuret (106). The reaction of the 
arylamines 78 a-d with 108 gives 5-alkyl-1-arylbiurets 85 a-d in high yields. Ether cleavage 
completes the synthesis of antiostatins B2 to B5 (32 a-d).  
 RESULTS AND DISCUSSION 
 - 69 -  
 
The overall yields of antiostatins A1 to A4 and B2 to B5 (31 a-d and 32 a-d) over eight steps 
from iron salt 34 are in the range of 31 – 63%. 
 
As side benefit the overall yield over three steps from iron salt 34 in the synthesis of 
carazostatin (38), a 3-oxygenated carbazole alkaloid, was increased to 96% (previous 83%).  
 
The absolute stereochemistry of the natural carbazole derivative antiostatin A2 (31 b), isolated 
by Seto in 1990, could not be assigned due to lack of substance. Synthetic antiostatin A2 (31 
b) has a [a]20D value of +5.0.  
 
Perspective projects would be synthesising the racemic or the (R)-configurated antiostatin A2. 
A comparison of the enantiomers via chiral HPLC should give information about the 
configuration of the natural product. Detecting retention times of the synthesised (R)- and (S)-
antiostatin A2 and natural A2 inoculated with racemtic antiostatin A2 (31 b) gives certain 
information about the actual stereochemistry. 
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5 EXPERIMENTAL 
5.1 General  
5.1.1  Reaction conditions and reagents  
 
All reactions that are sensitive to air or moisture were carried out under inert gas atmosphere 
(argon or nitrogen) and in dry solvents. Tetrahydrofuran, diethyl ether, ethyl acetate, and 
dichloromethane were dried using a solvent purification system (MBRAUN-SPS). Acetonitrile 
was dried by filtration over an Alox B (Super I) column and stored over 3 Å molecular sieves 
and argon atmosphere. Triethylamine was distilled from calcium hydride and stored over 4 Å 
molecular sieves. Dry methanol was purchased from VWR PROLABO (water content less than 
20 ppm). All other chemicals were used as received from commercial sources (ACROS, 
ALDRICH, FLUKA, LANCASTER, MERCK, STREM). Weight percentages are given for all 
aqueous solutions used for work up in the corresponding procedures. 
Elemental analysis:  
Elemental analyses were measured on an EUROVECTOR EuroEA3000. From all compounds 
the content of carbon, hydrogen and nitrogen was recorded.  
Claycop: 
Claycop was made from 13 g Cu(NO3)2 · 3 H2O and 15 g montmorillonite K10. The 
suspension was stirred for one hour in acetone (200 mL). Evaporation of the solvent and 
drying in vacuo provides the turquoise reagent (28 g).  
Chromatography:  
MERCK silica gel (0.040 – 0.063 mm) was used for flash chromatography. Methanol and 
petrolium aether were employed without further purification; ethyl acetate, diethyl ether and 
dichloromethane were distilled before use. Thin layer chromatography was perfomed with 
TLC plates from MERCK (60 F254). 
Melting points:  
Melting points were measured on an ELECTROTHERMAL IA9100 and are uncorrected. 
Mass spectra: 
Mass spectra and high resolution mass spectra were recorded on a FINNIGAN MAT-95 
(electron impact, 70 eV) or by GC/MS-coupling using an AGILENT TECHNOLOGIES 6890N GC 
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System equipped with a 5973 Mass Selective Detector (electron impact EI, 70 eV). ESI-MS 
spectra were recorded on an Esquire LC with an ion trap detector from BRUKER. Positive 
and negative ions were detected.  
Microwave:  
Microwave irradiation was excited using a DISCOVER microwave from CEM.  
NMR spectra:  
NMR spectra were generated using BRUKER DRX 500 and AC-300. The chemical shift δ is 
denoted in ppm referring to the signal of tetramethylsilane or of an internal standard (solvent). 
Abbreviations of signal multiplicities: s = singlet, d = doublet, t = triplet, dd = doublet of a 
doublet, ddd = doublet of a doublet of a doublet, dt = doublet of a triplet, m = multiplet, br = 
broad signal. Further particulars: coupling constants J denoted in Hz, number of protons per 
signal (integration). Double set of signals of two conformers are indicated by the sum (∑) of 
number of protons or C-atoms. Substitution patters of carbon atoms (C, CH, CH2, CH3, C=O) 
were determined by DEPT-measurements. Complete assignment of 1H NMR and 13C NMR 
was achieved by measuring the following 2D NMR spectra: EXSY, COSY, HMBC, HSQC, 
NOESY and ROESY.  
IR spectra:  
Infrared spectra were recorded using a THERMO NICOLET AVATAR 360 FT-IR.  
UV spectra: 
UV spectra were received using a UV-VIS spectrometer from PERKIN ELMER (Lambda 25). 
Maxima and turning points (indicated with sh) of the absorption curve are given.  
X-ray:  
X-ray spectroscopy was carried out on a BRUKER Nonius Kappa CCD with an Oxford 
Cryosystem for cooling. Software SCHAKAL99 was used for the developement of the figures 
of the molecular structures in the crystal. 
Specific optical rotation:  
[α]20D values were recorded on a polarimeter from PERKIN ELMER (Model 341) at 20 °C and a 
wavelength of 589 nm. Both concentration in g/100 mL and the solvent used are given.  
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5.2 Synthesis of the precursors 
 
4-Methoxy-3-methyl-1-nitro-2-(pent-1-ynyl)benzene 48 a 
 
Acetonitrile (75 mL) was added to a mixture of 3-methoxy-2-methyl-6-
nitrophenyl trifluoromethanesulphonate (47, 500.0 mg, 1.586 mmol), 
bis(triphenylphosphine)palladium(II) dichloride (111.3 mg, 0.159 mmol), 
tetra(n-butyl)ammonium iodide (1.758 g, 4.758 mmol) and copper(I) 
iodide (60.5 mg, 0.317 mmol). Triethylamine (15 mL) and 1-pentyne 
(49 a, 324.1 mg, 470 µL, 4.758 mmol) were added to the brownish solution, which was then 
stirred at reflux for 2.5 h. The mixture was cooled to room temperature and quenched with 
ammonium chloride (15%, 20 mL), extracted with DCM (3 x 20 mL) and the combined 
organic layers were dried with magnesium sulphate. Evaporation of the solvent and 
purification of the residue by flash chromatography on silica gel (PE/Et2O = 15/1) provided 
48 a as a yellow oil.  
Yield: 364.0 mg, 1.562 mmol, 99%. 
IR (ATR): ν = 3090, 2964, 2936, 2873, 2836, 2229, 1604, 1570, 1513, 1463, 1435, 1339, 
1312, 1278, 1237, 1167, 1120, 1045, 818, 803, 760, 717, 669, 640 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 1.07 (t, J = 7.4 Hz, 3 H), 1.55 – 1.68 (m, 2 H), 2.36 (s, 
3 H), 2.50 (t, J = 7.0 Hz, 2 H), 3.90 (s, 3 H), 6.78 (d, J = 9.1 Hz, 1 H), 7.89 (d, J = 9.1 Hz, 1 
H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.58 (CH3), 14.56 (CH3), 21.94 (2 CH2), 
55.98 (CH3), 74.92 (C), 103.49 (C), 108.15 (CH), 120.37 (C), 123.96 (CH), 131.32 (C), 
143.80 (C), 160.96 (C) ppm. 
MS (100 °C): m/z (%) = 233 (M+, 3), 218 (12), 216 (28), 204 (40), 190 (35), 188 (30), 174 
(45), 160 (23), 159 (23), 148 (55), 146 (35), 144 (21), 134 (41), 131 (21), 120 (100), 115 (41), 
103 (21), 91 (45), 77 (63), 65 (24), 63 (26), 51 (24), 43 (67).  
HRMS: m/z [M+] calcd for C13H15NO3: 233.1052; found: 233.1055. 
Anal. calcd for C13H15NO3: C 66.94, H 6.48, N 6.00; found C 67.20,  H 6.66, N 5.94%. 
OMe
O2N
C3H7
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4-Methoxy-3-methyl-2-pentylaniline 40 a  
 
Palladium on activated charcoal (10 wt%, 91.9 mg) in DCM (5 mL) was 
added to a solution of 48 a (40 mg, 0.171 mmol) in MeOH (20 mL). The 
reaction mixture was stirred under hydrogen atmosphere (1013 mbar) at 
room temperature for 24 h. Filtration over celite® with Et2O (500 mL) and evaporation of the 
solvent provided 40 a as yellow oil.  
Yield: 35.5 mg, 0.171 mmol, 100%. 
IR (ATR): ν = 3447, 3365, 2953, 2926, 2857, 2831, 1619, 1480, 1466, 1254, 1115, 798, 723, 
693, 615 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.90 (t, J = 7.0 Hz, 3 H), 1.33 – 1.41 (m, 4 H), 1.46 – 1.52 
(m, 2 H), 2.17 (s, 3 H), 2.53 (t, J = 7.9 Hz, 2 H), 3.36 (br s, 2 H), 3.74 (s, 3 H), 6.53 (d, J = 8.6 
Hz, 1 H), 6.59 (d, J = 8.6 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.66 (CH3), 14.07 (CH3), 22.59 (CH2), 28.00 
(CH2), 28.20 (CH2), 32.31 (CH2), 56.19 (CH3), 109.37 (CH), 113.37 (CH), 125.54 (C), 128.18 
(C), 137.73 (C), 151.26 (C) ppm.  
MS (20 °C): m/z (%) = 207 (M+, 100), 192 (58), 150 (87), 136 (45), 106 (14), 77 (4).  
HRMS: m/z [M+] calcd for C13H21NO: 207.1623; found: 207.1623.  
Anal. calcd for C13H21NO: C 75.32, H 10.21, N 6.76; found: C 75.41, H 10.40, N 6.73%. 
 
Tricarbonyl[η4-5-(2-amino-5-methoxy-4-methyl-3-pentylphenyl)cyclohexa-1,3-
diene]iron 39 a 
 
A solution of iron complex 34 (24.0 mg, 0.079 mmol), 
acetonitrile (10 mL) and arylamine 40 a (36.0 mg, 0.174 mmol) 
was stirred at reflux for 2 h. Then, the brownish solution was 
cooled to room temperature. Evaporation of the solvent and 
purification of the residue by flash chromatography on silica 
gel (PE/Et2O = 15/1) provided 39 a as an auburn oil. 
Yield: 33.5 mg, 0.0788 mmol, 100%. 
UV (MeOH): λ = 298 nm. 
IR (ATR): ν = 3471, 3385, 2955, 2929, 2859, 2038, 1949, 1621, 1600, 1462, 1119 cm–1. 
OMe
C5H11
H2N
OMe
C5H11
H2N
(OC)3Fe
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1H NMR (500 MHz, CDCl3): δ = 0.89 – 0.92 (m, 3 H), 1.33 – 1.48 (m, 6 H), 1.59 (br d, J = 
15.2 Hz, 1 H), 2.13 (s, 3 H), 2.39 (ddd, J = 15.1, 11.1, 3.9 Hz, 1 H), 2.48 – 2.52 (m, 2 H), 3.14 
– 3.20 (m, 2 H), 3.32 (br s, 2 H), 3.43 (dt, J = 7.3, 3.7 Hz, 1 H), 3.76 (s, 3 H), 5.51 – 5.53 (m, 
2 H), 6.58 (s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.59 (CH3), 14.06 (CH3), 22.56 (CH2), 28.05 
(CH2), 28.31 (CH2), 31.47 (CH2), 32.35 (CH2), 39.33 (CH), 56.51 (CH3), 60.25 (CH), 64.91 
(CH), 84.85 (CH), 85.65 (CH), 108.01 (CH), 123.66 (C), 128.20 (C), 128.58 (C), 135.07 (C), 
150.78 (C), 211.95 (3 C=O) ppm. 
MS (150 °C): m/z (%) = 425 (M+, 5), 369 (14), 341 (51), 339 (37), 284 (30), 283 (31), 261 
(100), 201 (32), 151 (10). 
HRMS: m/z [M+] calcd for C22H27FeNO4: 425.1290; found: 425.1295. 
Anal. calcd for C22H27FeNO4: C 62.13, H 6.40, N 3.29; found: C 62.40, H 6.65, N 3.07%. 
 
3-Methoxy-2-methyl-1-pentyl-9H-carbazole 41 a 
 
Ferrocenium hexafluorophosphate (763.0 mg, 2.304 mmol) was added 
to a solution of 39 a (980.0 mg, 2.304 mmol) in DCM (150 mL) and the 
mixture was stirred at room temperature. After 30 min and 90 min, 
more equivalents of ferrocenium hexafluorophosphate (3050 mg, 
9.216 mmol and 1525 mg, 4.608 mmol, respectively) were given to the reaction mixture. 
Additionally, after 90 min dry sodium carbonate (2440 mg, 23.04 mmol) was added. After 
19 h and 21 h more equivalents of ferrocenium hexafluorophosphate (1525 mg, 4.608 mmol 
and 1525 mg, 4.608 mmol, respectively) were added and after 21 h dry sodium carbonate 
(1464 mg, 13.82 mmol) was added, too. The suspension was stirred for further 3 d at room 
temperature. Filtration over celite® with EtOAc (500 mL), evaporation of the solvent and 
purification of the residue by flash chromatography on silica gel (PE/Et2O = 100/1 to 15/1) 
provided 41 a as a colourless solid. 
Yield: 405.5 mg, 1.441 mmol, 63%. 
Fluorescence (1 mg/100 mL MeOH): λex = 302 nm, λem = 381 nm. 
Melting point: 124 °C. 
UV (MeOH): λ = 216, 234, 253, 264, 291, 302, 336, 350 nm. 
IR (ATR): ν = 3419, 2956, 2918, 2872, 2855, 1610, 1454, 1427, 1309, 1255, 1206, 1161, 
1112, 821, 766, 735, 721 cm–1. 
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1H NMR (500 MHz, CDCl3): δ = 0.91 (t, J = 7.1 Hz, 3 H), 1.34 – 1.47 (m, 4 H), 1.62 – 1.68 
(m, 2 H), 2.34 (s, 3 H), 2.88 (t, J = 7.9 Hz, 2 H), 3.94 (s, 3 H), 7.17 (t, J = 7.3 Hz, 1 H), 7.33 – 
7.37 (m, 2 H), 7.42 (d, J = 8.0 Hz, 1 H), 7.77 (br s, 1 H), 7.98 (d, J = 7.8 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.00 (CH3), 14.07 (CH3), 22.69 (CH2), 28.73 
(CH2), 29.17 (CH2), 32.17 (CH2), 56.11 (CH3), 98.87 (CH), 110.64 (CH), 118.84 (CH), 
119.81 (CH), 120.26 (C), 123.72 (C), 124.05 (C), 124.13 (C), 124.91 (CH), 133.63 (C), 
139.47 (C), 152.64 (C) ppm. 
MS (130 °C): m/z (%) = 281 (M+, 100), 266 (14), 224 (37), 180 (12), 113 (4). 
HRMS: m/z [M+] calcd for C19H23NO: 281.1780; found: 281.1766. 
Anal. calcd for C19H23NO: C 81.10, H 8.24, N 4.98; found: C 80.90, H 8.41, N 4.82%. 
 
(S)-2-Methylbutanal 59 
 
(S)-2-methylbutanol (58, 406.0 mg, 4.598 mmol) in DCM (10 mL) was added to 
a solution of Dess-Martin periodinan (2.34 g, 5.517 mmol) in DCM (10 mL) and 
the mixture was stirred at room temperature for 50 min. The resulting precipitate was 
removed by the following work up. After addition of a saturated NaHCO3/Na2S2O3-solution 
(20 mL) the mixture was stirred at 0 °C for 10 min. The aqueous layer was extracted with 
DCM (3 x 10 mL), dried with MgSO4 and the solvent was removed under reduced pressure 
(40 °C, 800 mbar). Distillation at 70 °C provided compound 59 as a colourless liquid.  
Yield: 329.8 mg, 3.835 mmol, 83%. 
[α]20D = +29.3 (acetone, c = 2.5); lit. [α]20D = +33.1 (acetone, c = 2.5)[79]. 
1H NMR (500 MHz, CDCl3): δ = 0.93 (dt, J = 0.9, 7.5 Hz, 3 H), 1.07 (dd, J = 7.0, 1.0 Hz, 3 
H), 1.37 – 1.55 (m, 1 H), 1.68 – 1.75 (m, 1 H), 2.23 – 2.28 (m, 1 H), 9.60 (d, J = 1.8 Hz, 1H) 
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.33 (CH3), 12.83 (CH3), 23.48 (CH2), 47.73 
(CH), 205.42 (CH) ppm. 
Detailed spectroscopic data see in literature[79]. 
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P-(1-Diazo-2-oxopropyl)phosphonic acid dimethylester 61  
 
To a solution of sodium hydride (1.60 g, 17.4 mmol) in THF/benzene 
(15 mL/3 mL) p-tolylsulphonyl azide (63, 3.60 g, 18.0 mmol) and P-(2-
oxopropyl)phosphonic acid dimethylester (62, 2.3 mL, 16.6 mmol) were 
added and stirred at 0 °C. Then, the reaction mixture was stirred at room temperature for 18 h 
and filtrated over celite® with benzene (50 mL) and EtOAc (500 mL). The crude product was 
purified by column chromatography (EtOAc) to afford P-(1-diazo-2-oxopropyl)phosphonic 
acid dimethylester (61) as yellow oil.  
Yield: 2.3 g, 12.0 mmol, 66% (lit. 87%)[155]. 
1H NMR (500 MHz, CDCl3): δ = 2.25 (s, 3 H), 3.82 (s, 3 H), 3.84 (s, 3 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 27.13 (CH3), 53.55 (CH3), 53.59 (CH3) ppm. 
Detailed spectroscopic data see in literature[155]. 
 
p-Tolylsulphonyl azid 63 
 
To an ice-cold solution of p-tolylsulphonyl chloride (8.0 g, 42.0 mmol) in 
acetone/water (120 mL/120 mL) sodium azide (2.7 g, 42.0 mmol) was 
added. The reaction mixture was stirred at 0 °C for 2 h, then acetone was 
evaporated (30 °C, 150 mbar). The layers were separated and the aqueous layer was extracted 
with diethyl ether (3 x 50 mL). The combined organic layers were dried with magnesium 
sulphate and concentrated to afford p-tolylsulphonyl azide (63) as a pale yellow oil.  
Yield: 7.8 g, 39.4 mmol, 94% (lit. 94%)[94]. 
1H NMR (500 MHz, CDCl3): δ = 2.47 (s, 3 H), 7.39 (d, J = 8.0 Hz, 2 H), 7.83 (d, J = 8.4 Hz, 
2 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 21.73 (CH3), 127.49 (2 CH), 130.43 (2 CH), 
135.43 (C), 146.20 (C) ppm. 
Detailed spectroscopic data see in literature[94]. 
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(S)-1,1-Dibromo-3-methylpent-1-ene 64  
 
Triphenyl phosphine (3.05 g, 11.63 mmol) in DCM (10 mL) was added to a 
stirred mixture of carbon tetrabromide (3.856 g, 11.63 mmol) and zinc 
powder (760.0 mg, 11.63 mmol) in DCM (10 mL) at 0 °C. The suspension 
was stirred at room temperature for 60 min. After cooling to 0 °C a solution of the aldehyde 
(59, 500.0 mg, 5.814 mmol) in DCM (10 mL) was added. The reaction mixture was stirred at 
room temperature for 14 h and then diluted with pentane (20 mL). The precipitate was 
removed by filtration over florisil® with DCM (500 mL). The filtrate was concentrated under 
reduced pressure (600 mbar) to yield the crude residue, which was fractionally distilled 
(85 °C, 50 mbar) to give compound 64 as a colourless liquid. 
Yield: 1.089 g, 4.499 mmol, 77% (lit. 79%)[97]. 
[α]20D = +14.6 (n-heptane, c = 2.0); lit. [α]20D = +14.3 (n-heptane, c = 2.0). 
1H NMR (500 MHz, CDCl3): δ = 0.89 (t, J = 7.5 Hz, 3 H), 0.99 (d, J = 6.7 Hz, 3 H), 1.31 – 
1.41 (m, 2 H), 2.34 – 2.40 (m, 1 H), 6.16 (d, J = 9.4 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.62 (CH3), 18.84 (CH3), 28.95 (CH2), 39.90 
(CH), 87.29 (C), 144.22 (CH) ppm. 
Detailed spectroscopic data see in literature[97]. 
 
(S)-3-Methylpentyne 49 b and 1-methoxy-2-methyl-3-((S)-3-methylpent-1-yl)-4-nitro-
benzene 48 b  
 
Ohira-Bestmann protocol to (S)-3-methylpentyne 49 b  
 
Aldehyde 59 (309 mg, 3.593 mmol) and P-(1-diazo-2-oxopropyl)phosphonic 
acid dimethylester (61, 828.3 mg, 4.312 mmol) were added to a suspension of 
potassium carbonate (1.00 g, 7.186 mmol) and methanol (10 mL), and the 
resulting reaction mixture was stirred at room temperature for 19 h. Then the reaction was 
quenched by adding Na2CO3 (5%, 10 mL) at 0 °C and extracted with n-octane (3 x 10 mL). 
The combined organic layers were washed with brine (2 x 10 mL) and dried with magnesium 
sulphate. The crude product was fractionally distilled to give compound 49 b in a mixture 
with the solvent n-heptane and methyl acetate.  
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1H NMR (500 MHz, CDCl3): δ = 0.99 (t, J = 7.4 Hz, 3 H), 1.16 (d, J = 6.9 Hz, 3 H), 1.44 – 
1.48 (m, 2 H), 2.03 (d, J = 2.4 Hz, 1 H), 2.32 – 2.39 (m, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.58 (CH3), 20.52 (CH3), 27.26 (CH), 29.65 
(CH2), 68.09 (CH), 89.09 (C) ppm. 
Detailed spectroscopic data see in literature[75]. 
 
Corey-Fuchs protocol to (S)-3-methylpentyne 49 b  
 
(S)-1,1-Dibromo-3-methylpent-1-ene (64, 2.044 g, 8.45 mmol) was dissolved in THF (20 mL) 
and cooled down to –78 °C. n-Butyllithium (1.6 M in hexanes, 17.4 mL, 27.9 mmol) was 
added dropwise and the mixture was stirred at –78 °C for 60 min and at room temperature for 
2.5 h. Then the reaction was quenched by adding NH4Cl-solution (sat., 10 mL) at 0 °C and 
extracted with n-heptane (3 x 10 mL). The combined organic layers were washed with brine 
(10 mL) and dried with magnesium sulphate. The crude product in heptane was introduced to 
the Sonogashira protocol.  
 
Sonogashira protocol to 1-methoxy-2-methyl-3-((S)-3-methylpent-1-ynyl)-4-nitro-
benzene 48 b 
 
Acetonitrile (80 mL) was added to a mixture of 3-methoxy-2-methyl-6-
nitrophenyl trifluoromethanesulphonate (47, 2.13 g, 6.760 mmol), 
bis(triphenylphosphine)palladium(II) dichloride (474.5 mg, 0.676 mmol), 
tetra(n-butyl)ammonium iodide (2.497 g, 6.760 mmol) and copper(I) 
iodide (257.6 mg, 1.352 mmol). Triethylamine (16 mL) was added to the 
solution and (S)-3-methylpentyne (49 b, in heptane from Corey Fuchs protocol) was added 
dropwise over 3 h. The reaction mixture was stirred at reflux for overall 4.5 h. The mixture 
was cooled down to room temperature and quenched with ammonium chloride (15%, 50 mL), 
extracted with DCM (3 x 30 mL). The combined organic layers were washed with sodium 
hydroxide (sat., 20 mL) and were dried with magnesium sulphate. Evaporation of the solvent 
and purification of the residue by flash chromatography on silica gel (PE/Et2O = 15/1) 
provided 48 b as a yellow solid.  
Yield: 753.5 mg, 3.047 mmol, 45% over two steps based on alkene 64. 
Melting point: 43 °C. 
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[α]20D = +27.8 (CHCl3, c = 1.0). 
IR (ATR): ν = 2966, 2928, 2874, 2225, 1570, 1514, 1462, 1340, 1275, 1121, 817, 760, 665 
cm–1. 
1H NMR (500 MHz, CDCl3): δ = 1.08 (t, J = 7.4 Hz, 3 H), 1.29 (d, J = 6.9 Hz, 3 H), 1.58 – 
1.62 (m, 2 H), 2.35 (s, 3 H), 2.68 – 2.72 (m, 1 H), 3.90 (s, 3 H), 6.78 (d, J = 9.1 Hz, 1 H), 7.89 
(d, J = 9.1 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.85 (CH3), 14.15 (CH3), 20.41 (CH3), 28.84 
(CH), 29.71 (CH2), 55.98 (CH3), 75.10 (C), 107.86 (C), 108.14 (CH), 120.40 (C), 123.97 
(CH), 131.21 (C), 143.76 (C), 160.97 (C) ppm. 
GC-MS (EI): m/z (%) = 232 (M+ – 15, 4), 230 (10), 218 (10), 202 (15), 190 (22), 188 (27), 
174 (27), 173 (25), 172 (12), 160 (23), 148 (39), 134 (32), 128 (27), 120 (100), 115 (41), 105 
(11), 91 (35), 77 (63), 65 (14), 57 (13), 51 (19).  
Anal. calcd for C14H17NO3: C 68.00, H 6.93, N 5.66; found: C 68.14, H 7.12, N 5.73%. 
 
4-Methoxy-3-methyl-2-((S)-3-methylpent-1-yl)aniline 40 b 
 
Nitrobenzene 48 b (134.0 mg, 0.5419 mmol) was added to a suspension of 
palladium on activated charcoal (30 wt%, 57.4 mg) in EtOAc (20 mL). 
The reaction mixture was stirred under hydrogen atmosphere (1013 mbar) 
at room temperature for 7 d. Filtration over celite® with Et2O (300 mL), 
evaporation of the solvent and purification of the residue by flash 
chromatography on silica gel (PE/Et2O = 2/1) provided 40 b as a colourless oil.  
Yield: 108.7 mg, 0.4782 mmol, 88%. 
[α]20D = +7.2 (CHCl3, c = 0.5). 
IR (ATR): ν = 3447, 3360, 2956, 2923, 2872, 1619, 1481, 1464, 1255, 1221, 1114, 798 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 – 0.91 (m, 3 H), 0.98 (d, J = 6.3 Hz, 3 H), 1.18 – 1.31 
(m, 2 H), 1.39 – 1.47 (m, 2 H), 1.48 – 1.58 (m, 1 H), 2.17 (s, 3 H), 2.44 –2.59 (m, 2 H), 3.35 
(br s, 2 H), 3.74 (s, 3 H), 6.53 (d, J = 8.6 Hz, 1 H), 6.59 (d, J = 8.6 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.44 (CH3), 11.52 (CH3), 19.09 (CH3), 25.62 
(CH2), 29.31 (CH2), 35.10 (CH2), 35.16 (CH), 56.21 (CH3), 109.37 (CH), 113.40 (CH), 
125.41 (C), 128.37 (C), 137.60 (C), 151.29 (C) ppm. 
GC-MS (EI): m/z (%) = 221 (M+, 100), 206 (27), 150 (90), 136 (67), 120 (13), 106 (21), 91 
(6), 77 (7). 
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Anal. calcd for C14H23NO: C 75.97, H 10.47, N 6.33; found: C 75.71, H 10.65, N 6.18%. 
 
Tricarbonyl[η4-5-(2-amino-5-methoxy-4-methyl-3-((S)-3-methylpent-1-yl)-
phenyl)cyclohexa-1,3-diene]iron 39 b 
 
Arylamine 40 b (131.0 mg, 0.592 mmol) in acetonitrile (15 
mL) was added to a solution of iron complex 34 (82.0 mg, 
0.269 mmol) in acetonitrile (15 mL) and stirred at reflux for 
1.5 h. The solution was cooled down to room temperature. 
Evaporation of the solvent and purification of the residue by 
flash chromatography on silica gel (PE/Et2O = 15/1) provided 
39 b as an auburn oil. 
Yield: 111.8 mg, 0.255 mmol, 95%. 
[α]20D = +2.8 (CHCl3, c = 1.0). 
IR (ATR): ν = 2957, 2928, 2872, 2039, 1952, 1462, 1118, 613 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 – 0.91 (m, 3 H), 0.98 (d, J = 13.0 Hz, 3 H), 1.18 –
 1.29 (m, 3 H), 1.40 – 1.46 (m, 2 H), 1.60 (br d, J = 15.1 Hz, 1 H), 2.14 (s, 3 H), 2.40 (ddd, J 
= 15.2, 11.3, 3.9 Hz, 1 H), 2.45 – 2.55 (m, 2 H), 3.15 – 3.20 (m, 2 H), 3.32 (br s, 2 H), 3.42 –
3.46 (m, 1 H), 3.77 (s, 3 H), 5.49 – 5.54 (m, 2 H), 6.59 (s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.44 (2 CH3), 19.05 (CH3), 25.89 (CH2), 
29.28 (CH2), 31.44 (CH2), 34.92 (CH2), 35.17 (CH), 39.33 (CH), 56.49 (CH3), 60.23 (CH), 
64.89 (CH), 84.85 (CH), 85.63 (CH), 107.98 (CH), 123.52 (C), 128.33 (C), 128.60 (C), 
134.94 (C), 150.80 (C), 211.93 (3 C=O) ppm. 
MS (150 °C): m/z (%) = 439 (M+, 5), 383 (12), 355 (50), 353 (33), 298 (87), 283 (25), 275 
(100), 207 (28), 182 (8).  
HRMS: m/z [M+] calcd for C23H29FeNO4: 439.1446; found: 439.1439. 
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3-Methoxy-2-methyl-1-((S)-3-methylpent-1-yl)-9H-carbazole 41 b 
 
Ferrocenium hexafluorophosphate (29.4 mg, 0.089 mmol) was added 
to a solution of 39 b (39.0 mg, 0.888 mmol) in DCM (10 mL) and the 
resulting mixture was stirred at room temperature. After 30 min and 
90 min additional equivalents of ferrocenium hexafluorophosphate 
(117.5 mg, 0.3551 mmol and 58.8 mg, 0.1775 mmol, respectively) 
were added. Additionally, after 90 min dry sodium carbonate (94.1 g, 0.8877 mmol) was 
added. After 14 h additional ferrocenium hexafluorophosphate (117.5 mg, 0.3551 mmol) and 
sodium carbonate (56.5 mg, 0.533 mmol) were added and the suspension was stirred for 
further 2 d at room temperature. Filtration over silica gel with EtOAc (250 mL), evaporation 
of the solvent and purification of the residue by flash chromatography on silica gel (PE/Et2O 
= 100/1 to 15/1) provided 41 b as a colourless solid. 
Yield: 24.5 mg, 0.0829 mmol, 93%. 
Melting point: 71 °C. 
[α]20D = +6.4 (CHCl3, c = 1.0). 
UV (MeOH): λ = 234, 253, 264, 291, 303, 336, 349 nm.  
IR (ATR): ν = 3422, 2961, 2911, 2873, 2851, 1453, 1427, 1308, 1208, 1160, 1145, 1111, 
1093, 830, 766, 734 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.91 – 0.94 (m, 3 H), 1.04 (t, J = 6.4 Hz, 3 H), 1.24 – 1.29 
(m, 2 H), 1.42 – 1.53 (m, 2 H), 1.60 – 1.66 (m, 1 H), 2.34 (s, 3 H), 2.80 – 2.92 (m, 2 H), 3.94 
(s, 3 H), 7.16 – 7.19 (m, 1 H), 7.34 – 7.37 (m, 2 H), 7.43 (d, J = 8.0 Hz, 1 H), 7.73 (br s, 1 H), 
7.98 (d, J = 7.7 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.46 (CH3), 11.87 (CH3), 19.21 (CH3), 26.38 
(CH2), 29.40 (CH2), 35.01 (CH), 36.18 (CH2), 56.13 (CH3), 98.86 (CH), 110.66 (CH), 118.87 
(CH), 119.81 (CH), 120.33 (C), 123.54 (C), 124.09 (C), 124.38 (C), 124.92 (CH), 133.50 (C), 
139.48 (C), 152.67 (C) ppm.  
GC–MS (EI): m/z (%) = 295 (M+, 100), 280 (12), 224 (56), 210 (46), 194 (17), 180 (33), 167 
(11). 
MS (170 °C): m/z (%) = 295 (M+, 100), 280 (7), 225 (14), 224 (39), 210 (22), 194 (7), 180 
(13), 167 (4). 
HRMS: m/z [M+] calcd for C20H25NO: 295.1936; found: 295.1925.  
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1-Methoxy-2-methyl-3-(5-methylhex-1-ynyl)-4-nitrobenzene 48 c 
 
Acetonitrile (120 mL) was added to a mixture of 3-methoxy-2-methyl-6-
nitrophenyl trifluoromethanesulphonate (47, 8.00 g, 25.4 mmol), 
bis(triphenylphosphine)palladium(II) dichloride (1.78 g, 2.54 mmol), 
tetra(n-butyl)ammonium iodide (9.34 g, 25.4 mmol) and copper(I) iodide 
(967.0 mg, 5.08 mmol). Triethylamine (24 mL) and 6-methyl-1-hexyne 
(49 c, 7.3 g, 10 µL, 76.1 mmol) were added to the solution and the 
reaction mixture was stirred at reflux for 6 h. The mixture was cooled down to room 
temperature and quenched with ammonium chloride (15%, 100 mL), extracted with DCM 
(3 x 50 mL) and the combined organic layers were dried with magnesium sulphate. 
Evaporation of the solvent and purification of the residue by flash chromatography on silica 
gel (PE/Et2O = 15/1) provided 48 c as a brown oil.  
Yield: 6.50 g, 24.9 mmol, 98%. 
IR (ATR): ν = 2955, 2927, 2869, 2228, 1604, 1570, 1514, 1464, 1339, 1278, 1120, 817, 760, 
670 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.93 (d, J = 6.6 Hz, 6 H), 1.53 – 1.57 (m, 2 H), 1.76 – 1.80 
(m, 1 H), 2.35 (s, 3 H), 2.53 (t, J = 7.4 Hz, 2 H), 3.90 (s, 3 H), 6.78 (d, J = 9.1 Hz, 1 H), 7.89 
(d, J = 9.1 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 14.15 (CH3), 18.00 (CH2), 22.17 (2 CH3), 
27.28 (CH), 37.31 (CH2), 55.99 (CH3), 74.70 (C), 103.70 (C), 108.14 (CH), 120.40 (C), 
123.98 (CH), 131.31 (C), 143.79 (C), 160.98 (C) ppm. 
MS (50 °C): m/z (%) = 261 (M+, 41), 205 (67), 190 (100), 183 (53), 164 (48), 163 (65), 148 
(72), 146 (58), 134 (42), 120 (99), 91 (60), 77 (58), 43 (79), 41 (54). 
HRMS: m/z [M+] calcd for C15H19NO3: 261.1398; found: 261.1345. 
Anal. calcd for C15H19NO3: C 68.94, H 7.33, N 5.36; found: C 69.08, H 6.96, N 5.59%. 
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4-Methoxy-3-methyl-2-(5-methylhexyl)aniline 40 c 
 
Palladium on activated charcoal (10 wt%, 6.97 g) in DCM (20 mL) was 
added to a solution of 48 c (3.44 g, 13.15 mmol) in MeOH (100 mL). The 
reaction was stirred under hydrogen atmosphere (1013 mbar) at room 
temperature over night. Filtration over celite® with Et2O (500 mL) and 
subsequent evaporation of the solvent provided 40 c as a colourless oil.  
Yield: 2.926 g, 0.012 mmol, 95%. 
IR (ATR): ν = 3442, 3365, 2951, 2926, 2867, 1619, 1481, 1467, 1254, 1115, 797, 690, 612 
cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.87 (d, J = 6.6 Hz, 6 H), 1.20 – 1.24 (m, 2 H), 1.39 – 1.48 
(m, 4 H), 1.51 – 1.57 (m, 1 H), 2.17 (s, 3 H), 2.52 – 2.55 (m, 2 H), 3.42 (br s, 2 H), 3.76 (s, 
3 H), 6.63 (d, J = 8.6 Hz, 1 H), 6.59 (d, J = 8.6 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.66 (CH3), 22.64 (2 CH3), 27.97 (CH2), 
28.01 (CH), 28.10 (CH2), 28.75 (CH2), 38.79 (CH2), 56.18 (CH3), 109.36 (CH), 113.40 (CH), 
125.52 (C), 128.22 (C), 137.63 (C), 151.28 (C) ppm. 
GC-MS (EI): m/z (%) = 235 (M+, 100), 220 (45), 150 (73), 136 (33), 120 (10), 106 (12), 77 
(4), 55 (3). 
Anal. calcd for C15H25NO: C 76.55, H 10.71, N 5.95; found: C 76.80, H 10.66, N 6.04%. 
 
Tricarbonyl[η4-5-(2-amino-5-methoxy-4-methyl-1-(5-methylhexyl)phenyl)cyclohexa-1,3-
diene]iron 39 c 
 
Arylamine 40 c (1.00 g, 4.249 mmol) was added to a solution 
of iron complex 34 (589.0 mg, 1.931 mmol) in acetonitrile 
(80 mL) and the resulting mixture was stirred at reflux for 1 h. 
Then the solution was cooled down to room temperature. 
Evaporation of the solvent and purification of the residue by 
flash chromatography on silica gel (PE/Et2O = 15/1) provided 39 c as an auburn oil. 
Yield: 776.0 mg, 1.713 mmol, 89%. 
IR (ATR): ν = 2951, 2927, 2867, 2038, 1951, 1462, 1118, 611 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.87 (d, J = 6.6 Hz, 6 H), 1.19 – 1.28 (m, 2 H), 1.39 – 1.44 
(m, 4 H), 1.49 – 1.56 (m, 1 H), 1.60 (br d, J = 15.2 Hz, 1 H), 2.13 (s, 3 H), 2.40 (ddd, J = 
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15.1, 11.1, 3.9 Hz, 1 H), 2.45 – 2.52 (m, 2 H), 3.14 – 3.20 (m, 2 H), 3.32 (br s, 2 H), 3.42 – 
3.45 (m, 1 H), 3.77 (s, 3 H), 5.49 – 5.54 (m, 2 H), 6.58 (s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3):  δ = 11.59 (CH3), 22.64 (2 CH3), 28.00 (CH), 
28.39 (CH2), 28.59 (CH2), 29.05 (CH2), 31.45 (CH2), 38.75 (CH2), 39.33 (CH), 56.50 (CH3), 
60.25 (CH), 64.90 (CH), 84.85 (CH), 85.64 (CH), 108.00 (CH), 123.64 (C), 128.20 (C), 
128.57 (C), 135.05 (C), 150.78 (C), 211.94 (3 C=O) ppm. 
MS (200 °C): m/z (%) = 453 (M+, 8), 397 (17), 369 (85), 367 (66), 312 (35), 289 (100), 283 
(19), 247 (16), 207 (40), 151 (13), 112 (10), 84 (8), 56 (8), 28 (5). 
HRMS: m/z [M+] calcd for C24H31FeNO4: 453.1603; found: 453.1605. 
Anal. calcd for C24H31FeNO4: C 63.58, H 6.89, N 3.09; found: C 63.69, H 6.72, N 3.05%. 
 
3-Methoxy-2-methyl-1-(5-methylhexyl)-9H-carbazole 41 c 
 
To a solution of 39 c (500.0 mg, 1.103 mmol) in DCM (50 mL) 
ferrocenium hexafluorophosphate (365.0 mg, 1.103 mmol) was added 
and the mixture was stirred at room temperature. After 30 min and 
90 min more equivalents of ferrocenium hexafluorophosphate (1.460 g, 
4.411 mmol and 730.0 mg, 2.206 mmol, respectively) were added. 
Additionally, after 90 min dry sodium carbonate (1.169 g, 11.03 mmol) was added. After 20 h 
further ferrocenium hexafluorophosphate (1.460 g, 4.411 mmol) and sodium carbonate (701.0 
mg, 6.618 mmol) were added and the suspension was stirred for additional 3 d at room 
temperature. Filtration over silica gel with EtOAc (1 L), evaporation of the solvent and 
purification of the residue by flash chromatography on silica gel (PE/Et2O = 100/1 to 15/1) 
provided 41 c as a colourless solid. 
Yield: 317.8 mg, 1.027 mmol, 93%. 
Melting point: 88 °C. 
UV (MeOH): λ = 234, 253, 264, 303 nm.  
IR (ATR): ν = 3418, 3061, 2920, 2870, 1451, 1427, 1309, 1256, 1209, 1146, 1113, 1096, 
830, 766, 736 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 (d, J = 6.6 Hz, 6 H), 1.22 – 1.26 (m, 2 H), 1.43 – 1.49 
(m, 2 H), 1.50 – 1.60 (m, 2 H), 1.61 – 1.66 (m, 1 H), 2.34 (s, 3 H), 2.88 (t, J = 8.0 Hz, 2 H), 
3.94 (s, 3 H), 7.17 (t, J = 7.4 Hz, 1 H), 7.33 – 7.37 (m, 2 H), 7.42 (d, J = 8.1 Hz, 1 H), 7.77 (br 
s, 1 H), 7.98 (d, J = 7.8 Hz, 1 H) ppm.  
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13C NMR and DEPT (125 MHz, CDCl3): δ = 12.03 (CH3), 22.67 (2 CH3), 27.89 (CH2), 
28.03 (CH), 28.83 (CH2), 29.74 (CH2), 38.91 (CH2), 56.14 (CH3), 98.90 (CH), 110.64 (CH), 
118.86 (CH), 119.82 (CH), 120.28 (C), 123.72 (C), 124.07 (C), 124.15 (C), 124.92 (CH), 
133.63 (C), 139.49 (C), 152.66 (C) ppm. 
GC-MS (EI): m/z (%) = 309 (M+, 100), 294 (13), 224 (38), 210 (20), 194 (10), 180 (16), 181 
(10), 167 (5). 
Anal. calcd for C21H27NO: C 81.51, H 8.79, N 4.53; found: C 81.70, H 8.96, N 4.64%. 
 
2-(Hept-1-ynyl)-4-methoxy-3-methyl-nitrobenzene 48 d  
 
Acetonitrile (30 mL) was added to a mixture of 3-methoxy-2-methyl-6-
nitrophenyl trifluoromethanesulphonate (47, 200.0 mg, 0.634 mmol), 
bis(triphenylphosphine)palladium(II) dichloride (44.6 mg, 0.063 mmol), 
tetra(n-butyl)ammonium iodide (703.7 mg, 1.903 mmol) and copper(I) 
iodide (24.2 mg, 0.127 mmol). Triethylamine (6 mL) and 1-heptyne 
(183.1 mg, 250 µL, 1.903 mmol) were added to the brownish solution, which was heated at 
reflux for 2.5 h. The mixture was cooled to room temperature and quenched with ammonium 
chloride (15%, 20 mL), extracted with DCM (3 x 20 mL) and the combined organic layers 
were dried with magnesium sulphate. Evaporation of the solvent and purification of the 
residue by flash chromatography on silica gel (PE/Et2O = 15/1) provided 48 d as a yellow oil.  
Yield: 163.8 mg, 0.627 mmol, 99%.  
IR (ATR): ν = 2931, 2860, 2226, 1570, 1514, 1340, 1276, 1120, 760 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.91 (t, J = 7.3 Hz, 3 H), 1.33 – 1.39 (m, 2 H), 1.43 – 1.49 
(m, 2 H), 1.62 – 1.68 (m, 2 H), 2.36 (s, 3 H), 2.52 (t, J = 7.1 Hz, 2 H), 3.90 (s, 3 H), 6.77 (d, 
J = 9.1 Hz, 1 H), 7.89 (d, J = 9.1 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.97 (CH3), 14.16 (CH3), 19.93 (CH2), 22.19 
(CH2), 28.14 (CH2), 31.08 (CH2), 55.98 (CH3), 74.80 (C), 103.71 (C), 108.14 (CH), 120.40 
(C), 123.97 (CH), 131.33 (C), 143.80 (C), 160.97 (C) ppm. 
MS (20 °C): m/z (%) = 261 (M+, 1), 246 (17), 244 (25), 190 (34), 189 (20), 188 (23), 183 
(62), 176 (20), 174 (33), 164 (30), 148 (66), 146 (37), 136 (21), 135 (27), 134 (26), 121 (21), 
120 (100), 115 (33), 91 (36), 77 (51), 65 (21), 55 (28), 43 (43), 41 (25), 29 (22). 
Anal. calcd for C15H19NO3: C 68.94, H 7.33, N 5.36; found: C 68.95, H 7.45, N 5.44%. 
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2-Heptyl-4-methoxy-3-methylaniline 40 d 
 
To a solution of 48 d (544 mg, 2.07 mmol) in MeOH (15 mL) palladium 
on activated charcoal (10 wt%, 195 mg) in DCM (5 mL) was added. The 
reaction was conducted under hydrogen atmosphere (1013 mbar) at room 
temperature for 24 h. Filtration over celite® with Et2O (500 mL) provided 40 d as a colourless 
oil.  
Yield: 489 mg, 2.07 mmol, 100%. 
1H NMR (500 MHz, CDCl3): δ = 0.88 (t, J = 7.1 Hz, 3 H), 1.25 – 1.50 (m, 10 H), 2.17 (s, 
3 H), 2.52 – 2.55 (m, 2 H), 3.75 (s, 3 H), 6.53 (d, J = 8.6 Hz, 1 H), 6.59 (d, J = 8.6 Hz, 1 H) 
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.65 (CH3), 14.10 (CH3), 22.65 (CH2), 28.07 
(CH2), 28.57 (CH2), 29.20 (CH2), 30.12 (CH2), 31.86 (CH2), 56.16 (CH3), 109.31 (CH), 
113.68 (CH), 125.57 (C), 128.50 (C), 137.12 (C), 151.50 (C) ppm. 
Detailed spectroscopic data see in literature[62]. 
 
Tricarbonyl[η4-5-(2-amino-3-heptyl-5-methoxy-4-methylphenyl)cyclohexa-1,3-
diene]iron 39 d  
 
To a solution of iron complex 34 (2.120 g, 6.96 mmol) and 
acetonitrile (100 mL) arylamine 40 d (3.600 g, 0.015 mol) was 
added and the solution was stirred at reflux for 1 h. Then the 
brownish solution was cooled to room temperature. 
Evaporation of the solvent and purification of the residue by flash chromatography on silica 
gel (PE/Et2O = 15/1) provided 39 d as an auburn oil. 
Yield: 3.097 g, 6.831 mmol, 98%. 
1H NMR (500 MHz, CDCl3): δ = 0.87 (t, J = 6.7 Hz, 3 H), 1.24 – 1.46 (m, 10 H), 1.60 (br d, 
J = 15.2 Hz, 1 H), 2.13 (s, 3 H), 2.42 (ddd, J = 15.2, 13.6, 3.9 Hz, 1 H), 2.48 – 2.52 (m, 2 H), 
3.15 – 3.20 (m, 2 H), 3.32 (br s, 2 H), 3.43 (dt, J = 11.1, 3.6 Hz, 1 H), 3.77 (s, 3 H), 5.49 – 
5.54 (m, 2 H), 6.58 (s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.57 (CH3), 14.09 (CH3), 22.64 (CH2), 28.35 
(2 CH2), 29.15 (CH2), 30.14 (CH2), 31.45 (CH2), 31.83 (CH2), 39.31 (CH), 56.47 (CH3), 
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60.24 (CH), 64.91 (CH), 84.83 (CH), 85.62 (CH), 107.98 (CH), 123.63 (C), 128.19 (C), 
128.56 (C), 135 05 (C), 150.77 (C), 211.93 (3 C=O) ppm. 
Detailed spectroscopic data see in literature[62]. 
 
1-Heptyl-3-methoxy-2-methyl-9H-carbazole 41 d 
 
Ferrocenium hexafluorophosphate (458.0 mg, 1.384 mmol) was added 
to a solution of 39 d (627.0 mg, 1.384 mmol) in DCM (150 mL) and 
the mixture was stirred at room temperature. After 30 min and 90 min 
more equivalents of ferrocenium hexafluorophosphate (1.832 g, 5.535 
mmol and 916.0 mg, 2.767 mmol, respectively) were added. Additionally, after 90 min dry 
sodium carbonate (1.467 g, 13.84 mmol) was added and the suspension was stirred for 
another 18 h at room temperature. Filtration over silica gel with EtOAc (500 mL), evaporation 
of the solvent and purification of the residue by flash chromatography on silica gel (PE/Et2O 
= 100/1 to 15/1) provided 41 d as a colourless solid. 
Yield: 412.7 mg, 1.330 mmol, 96%.  
1H NMR (500 MHz, CDCl3): δ = 0.88 (t, J = 6.7 Hz, 3 H), 1.26 – 1.38 (m, 6 H), 1.42 – 1.48 
(m, 2 H), 1.61 – 1.68 (m, 2 H), 2.34 (s, 3 H), 2.88 (t, J = 7.9 Hz, 2 H), 3.94 (s, 3 H), 7.16 – 
7.19 (m, 1 H), 7.33 – 7.37 (m, 1 H), 7.37 (s, 1 H), 7.42 (d, J = 8.1 Hz, 1 H), 7.98 (d, J = 7.8 
Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.02 (CH3), 14.11 (CH3), 22.67 (CH2), 28.77 
(CH2), 29.31 (CH2), 29.50 (CH2), 30.02 (CH2), 31.86 (CH2), 56.13 (CH3), 98.89 (CH), 110.62 
(CH), 118.85 (CH), 119.81 (CH), 120.27 (C), 123.73 (C), 124.06 (C), 124.16 (C), 124.91 
(CH), 133.65 (C), 139.48 (C), 152.65 (C) ppm. 
Detailed spectroscopic data see in literature[62].  
 
3-(Hex-1-ynyl)-1-methoxy-2-methyl-4-nitrobenzene 48 e 
 
Acetonitrile (100 mL) was added to a mixture of 3-methoxy-2-methyl-6-
nitrophenyl trifluoromethanesulphonate (47, 6.400 g, 20.300 mmol), 
bis(triphenylphosphine)palladium(II) dichloride (1.425 g, 2.030 mmol), 
tetra(n-butyl)ammonium iodide (7.500 mg, 20.300 mmol) and copper(I) 
iodide (773.0 mg, 4.060 mmol). Triethylamine (20 mL) and 1-hexyne 
OMe
O2N
C4H9
N
H
OMe
C7H15
 EXPERIMENTAL PART 
 
 - 88 -  
(49 e, 5.004 g, 7 mL, 60.90 mmol) were added to the solution. The reaction mixture was 
stirred at reflux for 5 h. The mixture was cooled to room temperature and quenched with 
ammonium chloride (15%, 50 mL), extracted with DCM (3 x 100 mL) and the combined 
organic layers were dried with magnesium sulphate. Evaporation of the solvent and 
purification of the residue by flash chromatography on silica gel (PE/Et2O = 15/1) provided 
48 e as a brown oil.  
Yield: 4.119 g, 16.70 mmol, 82%. 
IR (ATR):  ν = 2958, 2932, 2872, 2226, 1570, 1514, 1463, 1340, 1277, 1120, 760 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.93 (t, J = 7.3 Hz, 3 H), 1.47 –1.53 (m, 2 H), 1.59 – 1.65 
(m, 2 H), 2.34 (s, 3 H), 2.51 (t, J = 7.1 Hz, 2 H), 3.88 (s, 3 H), 6.76 (d, J = 9.1 Hz, 1 H), 7.87 
(d, J = 9.1 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.61 (CH3), 14.14 (CH3), 19.64 (CH2), 22.01 
(CH2), 30.51 (CH2), 55.98 (CH3), 74.78 (C), 103.63 (C), 108.14 (CH), 120.38 (C), 123.96 
(CH), 131.31 (C), 143.77 (C), 160.97 (C) ppm. 
GC-MS (EI): m/z (%) = 232 (M+ – 15, 4), 230 (17), 214 (5), 204 (17), 202 (30), 190 (22), 188 
(19), 174 (30), 164 (19), 160 (22), 148 (51), 146 (44), 134 (29), 120 (100), 115 (44), 103 (20), 
91 (47), 89 (30), 77 (64), 65 (21), 63 (21), 57 (26), 55 (22).   
Anal. calcd for C14H17NO3: C 68.00, H 6.93, N 5.66; found: C 67.78, H 7.05, N 5.39%. 
 
2-Hexyl-4-methoxy-3-methylaniline 40 e 
 
Palladium on activated charcoal (10 wt%, 214.3 mg) in DCM (5 mL) was 
added to a solution of 48 e (100 mg, 0.4043 mmol) in MeOH (20 mL). 
The reaction occurs at 1013 mbar hydrogen atmosphere over night at 
room temperature. Filtration over celite® with Et2O (0.5 L), evaporation of the solvent and 
purification of the residue by flash chromatography on silica gel (PE/Et2O = 2/1) provided 
40 e as a colourless oil.  
Yield: 86.0 mg, 0.3886 mmol, 96%. 
IR (ATR): ν = 3444, 3360, 2955, 2925, 2855, 1619, 1480, 1439, 1254, 1218, 1113, 1082, 
798 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 – 0.91 (m, 3 H), 1.30  1.35 (m, 4 H), 1.40 – 1.49 (m, 4 
H), 2.17 (s, 3 H), 2.51 – 2.55 (m, 2 H), 3.36 (br s, 2 H), 3.75 (s, 3 H), 6.53 (d, J = 8.6 Hz, 1 
H), 6.59 (d, J = 8.6 Hz, 1 H) ppm. 
OMe
C6H13
H2N
 EXPERIMENTAL PART 
 
 - 89 -  
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.64 (CH3), 14.09 (CH3), 22.66 (CH2), 28.04 
(CH2), 28.46 (CH2), 29.82 (CH2), 31.72 (CH2), 56.17 (CH3), 109.35 (CH), 113.36 (CH), 
125.52 (C), 128.18 (C), 135.70 (C), 151.25 (C) ppm.  
GC-MS (EI): m/z (%) = 221 (M+, 100), 206 (60), 150 (85), 136 (48), 120 (13), 107 (13), 106 
(17), 91 (5), 77 (6).  
Anal. calcd for C14H23NO: C 75.97, H 10.47, N 6.33; found: C 76.06, H 10.47, N 6.10%. 
 
Tricarbonyl[η4-5-(2-amino-3-hexyl-5-methoxy-4-methylphenyl)cyclohexa-1,3-diene]iron 
39 e  
 
To a solution of iron complex 34 (993 mg, 4.486 mmol) 
and acetonitrile (60 mL) arylamine 40 e (622 mg, 
2.039 mmol) was added and stirred at reflux for 1 h. Then 
the solution was cooled to room temperature. Evaporation 
of the solvent and purification of the residue by flash chromatography on silica gel (PE/Et2O 
= 15/1) provided 39 e as an auburn oil. 
Yield: 861.6 mg, 1.961 mmol, 96%. 
UV (MeOH): λ = 303 nm. 
IR (ATR): ν = 2955, 2929, 2857, 2040, 1957, 1463, 1120, 613 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 – 0.90 (m, 3 H), 1.30 – 1.33 (m, 4 H), 1.41 – 1.46 (m, 
4 H), 1.60 (br d, J = 15.5 Hz, 1 H), 2.13 (s, 3 H), 2.40 (ddd, J = 15.1, 11.2, 3.9 Hz, 1 H), 2.49 
– 2.52 (m, 2 H), 3.15 – 3.20 (m, 2 H), 3.32 (br s, 2 H), 3.42 – 3.45 (m, 1 H), 3.77 (s, 3 H), 
5.49 – 5.54 (m, 2 H), 6.58 (s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.58 (CH3), 14.09 (CH3), 22.65 (CH2), 28.32 
(CH2), 28.34 (CH2), 29.86 (CH2), 31.45 (CH2), 31.68 (CH2), 39.32 (CH), 56.49 (CH3), 60.24 
(CH), 64.90 (CH), 84.84 (CH), 85.63 (CH), 107.99 (CH), 123.64 (C), 128.19 (C), 128.56 (C), 
135.05 (C), 150.77 (C), 211.94 (3 C=O) ppm. 
MS (170 °C): m/z (%) = 439 (M+, 6), 383 (15), 355 (60), 353 (40), 299 (20), 298 (29), 283 
(19), 275 (100), 207 (37), 151 (11), 112 (6), 84 (5), 56 (5), 28 (1). 
HRMS: m/z [M+] calcd for C23H29FeNO4: 439.1446; found: 439.1447.  
Anal. calcd for C23H29FeNO4: C 62.88, H 6.65, N 3.19; found: C 63.05, H 6.80, N 3.03%. 
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1-Hexyl-3-methoxy-2-methyl-9H-carbazole 41 e  
 
To a solution of 39 e (400.0 mg, 0.9105 mmol) in DCM (40 mL) 
ferrocenium hexafluorophosphate (301.4 mg, 0.9105 mmol) was added 
and the mixture was stirred at room temperature. After 30 min and 
90 min more equivalents of ferrocenium hexafluorophosphate 
(1.2055 g, 3.642 mmol and 602.7 mg, 1.821 mmol, respectively) were added. Additionally, 
after 90 min dry sodium carbonate (965.1 mg, 9.105 mmol) was added. After stirring the 
reaction mixture for 18 h at room temperature more equivalents of ferrocenium 
hexafluorophosphate (1.2055 g, 3.642 mmol) and dry sodium carbonate (579.1 mg, 5.463 
mmol) were added. Filtration over celite® with EtOAc (1 L), evaporation of the solvent and 
purification of the residue by flash chromatography on silica gel (PE/Et2O = 100/1 to 15/1) 
provided 41 e as a colourless solid. 
Yield: 218.1 mg, 0.738 mmol, 81%. 
Melting point: 55 – 56 °C. 
UV (MeOH): λ = 234, 253, 264, 291 (sh), 303 nm.  
IR (ATR): ν = 3421, 2949, 2855, 1453, 1427, 1146, 1112, 1095, 822, 767, 737 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.89 (t, J = 7.0 Hz, 3 H), 1.30 – 1.36 (m, 4 H), 1.43 – 1.49 
(m, 2 H), 1.62 – 1.68 (m, 2 H), 2.34 (s, 3 H), 2.88 (t, J = 8.0 Hz, 2 H), 3.94 (s, 3 H), 7.16 – 
7.19 (m, 1 H), 7.34 – 7.37 (m, 2 H), 7.42 (d, J = 8.1 Hz, 1 H), 7.77 (br s, 1 H), 7.98 (d, J = 
7.7 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.00 (CH3), 14.10 (CH3), 22.65 (CH2), 28.78 
(CH2), 29.44 (CH2), 29.72 (CH2), 31.82 (CH2), 56.11 (CH3), 98.87 (CH), 110.63 (CH), 
118.82 (CH), 119.79 (CH), 120.24 (C), 123.70 (C), 124.03 (C), 124.12 (C), 124.89 (CH), 
133.61 (C), 139.45 (C), 152.62 (C) ppm.  
GC–MS: m/z (%) = 295 (M+, 100), 280 (17), 224 (36), 210 (26), 194 (10), 180 (18), 167 (5). 
Anal. calcd for C20H25NO: C 81.31, H 8.53, N 4.74; found: C 81.26, H 8.67, N 4.79%. 
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1-(Trimethylsilyl)-6-methylhept-1-yne 51  
 
At a temperature of –78 °C n-BuLi (1.6 M in hexanes, 30.4 mL, 
48.8 mol) was added to a stirred solution of (trimethylsilyl)acetylene 
(5.74 g, 58.4 mmol) and THF (30 mL). After 45 min DMPU (2.35 g, 19.5 mmol) and 1-
bromo-4-methylpentane (50, 3.21 g, 19.5 mmol) were added dropwise to the stirred solution 
at –78 °C. After the reaction mixture was stirred for another 24 h at room temperature, it was 
poured into water and extracted with Et2O. The combined organic layers were washed with 
brine and dried with MgSO4. Filtration, evaporation of the solvent and fractionating 
distillation at a pressure of 0.4 mbar afforded compound 51 as a colourless liquid[73].  
Yield: 1.979 g, 0.011 mol, 56%. 
IR (ATR): ν = 2956, 2174, 1248, 837, 758, 638 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.14 (s, 9 H), 0.87 (d, J = 6.6 Hz, 6 H), 1.22 – 1.26 (m, 2 
H), 1.48 – 1.56 (m, 3 H), 2.18 (t, J = 7.2 Hz, 2 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 0.17 (3 CH3), 20.88 (CH2), 22.53 (2 CH3), 
26.56 (CH2), 27.56 (CH), 38.15 (CH2), 84.21 (C), 107.82 (C) ppm. 
GC-MS (EI): m/z (%) = 167 (M+ – 15, 100), 108 (30), 73 (79), 59 (28), 43 (13). 
 
6-Methylhept-1-yne 49 f  
 
A solution of NaOH in methanol (0.1 M, 460 mL) and compound 51 
(2.242 g, 12.29 mmol) was stirred for 3 d at room temperature 
Hydrochloric acid (2 N) was added to the reaction mixture until neutal pH. The aqueous layer 
was extracted with Et2O and and dried with MgSO4. The residue was fractionally distilled to 
afford compound 49 f as a colourless liquid[73]. 
Yield: 2.58 g, 0.235 mol, 94%. 
IR (ATR): ν = 3402, 3313, 2931, 2866, 1718, 1655, 1541, 1448, 1245, 1107, 758, 738, 621 
cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.86 (d, J = 6.6 Hz, 6 H), 1.23 – 1.28 (m, 2 H), 1.48 – 1.55 
(m, 3 H), 1.92 (t, J = 2.6 Hz, 1 H), 2.14 – 2.17 (m, 2 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 18.65 (CH2), 22.52 (2 CH3), 26.40 (CH2), 
27.62 (CH), 38.05 (CH2), 68.03 (C), 84.84 (C) ppm. 
GC-MS (EI): m/z (%) = 109 (M+ – 1, 2), 95 (100), 81 (26), 69 (99), 67 (96), 55 (70). 
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1-Methoxy-2-methyl-4-nitro-3-(6-methylhept-1-ynyl)benzene 48 f  
 
Acetonitrile (15 mL) was added to a mixture of 3-methoxy-2-methyl-6-
nitrophenyl trifluoromethanesulphonate (47, 197.0 mg, 0.625 mmol), 
bis(triphenylphosphine)palladium(II) dichloride (46.0 mg, 
0.063 mmol), tetra(n-butyl)ammonium iodide (231.0 mg, 0.625 mmol) 
and copper(I) iodide (25.0 mg, 0.125 mmol). Triethylamine (3 mL) and 
6-methylhept-1-yne (49 f, 90.0 mg, 0.817 mmol) were added to the 
solution, which was then stirred at reflux for 2 h. The mixture was cooled to room 
temperature and quenched with ammonium chloride (15%, 10 mL), extracted with DCM (3 x 
10 mL) and the combined organic layers were dried with magnesium sulphate. Evaporation of 
the solvent and purification of the residue by flash chromatography on silica gel (PE/Et2O = 
15/1) provided 48 f as a yellow oil.  
Yield: 146.0 mg, 0.531 mmol, 85%. 
IR (ATR): ν = 2954, 2870, 2224, 1571, 1517, 1466, 1342, 1280, 1122, 761 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.90 (d, J = 6.6 Hz, 6 H), 1.33 – 1.39 (m, 2 H), 1.57 – 1.68 
(m, 3 H), 2.36 (s, 3 H), 2.53 (t, J = 7.1 Hz, 2 H), 3.90 (s, 3 H), 6.78 (d, J = 9.1 Hz, 1 H), 7.89 
(d, J = 9.1 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 14.18 (CH3), 20.20 (CH2), 22.54 (2 CH3), 
26.36 (CH2), 27.64 (CH), 38.19 (CH2), 55.99 (CH3), 74.81 (C), 103.72 (C), 108.14 (CH), 
120.40 (C), 123.97 (CH), 131.33 (C), 143.81 (C), 160.96 (C) ppm. 
GC-MS (EI): m/z (%) = 258 (M+ – 17, 14), 206 (49), 190 (62), 176 (35), 164 (27), 148 (43), 
120 (100), 103 (17), 69 (31), 55 (42). 
Anal. calcd for C16H21NO3: C 69.79, H 7.69, N 5.09; found: C 69.78, H 7.46, N 5.17%. 
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4-Methoxy-3-methyl-2-(6-methylheptyl)aniline 40 f 
 
To a solution of 48 f (546 mg, 1.98 mmol) in EtOAc (70 mL) palladium 
on activated charcoal (10 wt%, 1.057 mg) was added. The reaction was 
conducted under hydrogen atmosphere (4 – 5 bar) at room temperature for 
2 d. Filtration over celite® with Et2O (500 mL), evaporation of the solvent 
and purification of the residue by flash chromatography on silica gel (PE/Et2O = 2/1) 
provided 40 f as a colourless oil.  
Yield: 415.0 mg, 1.680 mmol, 84%. 
IR (ATR): ν = 3444, 3366, 2924, 2855, 1619, 1481, 1255, 1115, 797 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.85 (d, J = 6.6 Hz, 6 H), 1.14 – 1.19 (m, 2 H), 1.29 – 1.54 
(m, 7 H), 2.17 (s, 3 H), 2.51 – 2.54 (m, 2 H), 3.44 (br s, 2 H), 3.74 (s, 3 H), 6.54 (d, J = 
8.6 Hz, 1 H), 6.59 (d, J = 8.6 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.67 (CH3), 22.65 (2 CH3), 27.28 (CH2), 
27.96 (CH), 28.06 (CH2), 28.55 (CH2), 30.40 (CH2), 38.98 (CH2), 56.19 (CH3), 109.36 (CH), 
113.44 (CH), 125.55 (C), 128.26 (C), 135.59 (C), 151.31 (C) ppm. 
GC-MS (EI): m/z (%) = 249 (M+, 100), 234 (40), 150 (68), 136 (30), 120 (9), 106 (11). 
MS (20 °C): m/z (%) = 249 (M+, 100), 234 (25), 150 (51), 136 (17). 
HRMS: m/z [M+] calcd for C16H27NO: 249.2093; found: 249.2099. 
 
Tricarbonyl[η4-5-(2-amino-5-methoxy-4-methyl-3-(6-methylheptyl)phenyl)cyclohexa-
1,3-diene]iron 39 f  
 
Arylamine 40 f (392.0 mg, 1.570 mmol) was added to a 
solution of iron complex 34 (218.0 mg, 0.715 mmol) in 
acetonitrile (150 mL) and stirred at reflux for 2 h. Then the 
solution was cooled to room temperature. Evaporation of the 
solvent and purification of the residue by flash chromatography 
on silica gel (PE/Et2O = 15/1) provided 39 f as an auburn oil. 
Yield: 335.0 mg, 0.715 mmol, 100%. 
IR (ATR): ν = 2926, 2855, 2360, 2042, 1962, 621cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.86 (d, J = 6.6 Hz, 6 H), 1.10 – 1.23 (m, 2 H), 1.27 – 1.54 
(m, 7 H), 1.60 (br d, J = 15.3 Hz, 1 H), 2.13 (s, 3 H), 2.40 (ddd, J = 15.2, 11.1, 3.9 Hz, 1 H), 
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2.49 – 2.52 (m, 2 H), 3.15 – 3.20 (m, 2 H), 3.34 (br s, 2 H), 3.44 (dt, J = 7.3, 3.7 Hz, 1 H), 
3.77 (s, 3 H), 5.49 – 5.54 (m, 2 H), 6.58 (s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.59 (CH3), 22.64 (2 CH3), 27.23 (CH2), 
28.35 (CH), 28.38 (CH2), 29.65 (CH2), 30.43 (CH2), 31.50 (CH2), 38.95 (CH2), 39.31 (CH), 
56.49 (CH3), 60.24 (CH), 64.90 (CH), 84.84 (CH), 85.64 (CH), 107.98 (CH), 123.64 (C), 
128.19 (C), 128.57 (C), 135.04 (C), 150.77 (C), 211.93 (3 C=O) ppm. 
MS (180 °C): m/z (%) = 467 (M+, 5), 411 (10), 383 (68), 379 (43), 326 (31), 323 (14), 303 
(100), 283 (19), 207 (33), 151 (11), 149 (11). 
HRMS: m/z [M+] calcd for C25H33FeNO4: 467.1759; found: 467.1747. 
 
3-Methoxy-2-methyl-1-(6-methylheptyl)-9H-carbazole 41 f 
 
To a solution of 39 f (321.0 mg, 0.686 mmol) in DCM (30 mL) 
ferrocenium hexafluorophosphate (227.0 mg, 0.686 mmol) was added 
and the mixture was stirred at room temperature. After 30 min and 
90 min supplemental equivalents of ferrocenium hexafluorophosphate 
(909.0 mg, 2.744 mmol and 455.0 mg, 1.372 mmol, respectively) were 
added. Additionally, after 90 min dry sodium carbonate (728.0 mg, 6.860 mmol) was added. 
After 22 h further ferrocenium hexafluorophosphate (909.0 mg, 2.744 mmol) and sodium 
carbonate (437.0 mg, 4.116 mmol) were added and the suspension was stirred for another 3 d 
at room temperature. Filtration over silica gel with EtOAc (1 L), evaporation of the solvent 
and purification of the residue by flash chromatography on silica gel (PE/Et2O = 100/1 to 
15/1) provided  41 f as a colourless solid. 
Yield: 203.0 mg, 0.628 mmol, 92%. 
Melting point: 80 – 81 °C. 
UV (MeOH): λ = 234, 253, 264, 303, 336, 350 nm.  
IR (ATR): ν = 3416, 3056, 2951, 2924, 2855, 1582, 1454, 1426, 1309, 1207, 1146, 1112, 
1096, 822, 766, 738 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.85 (d, J = 6.6 Hz, 6 H), 1.14 – 1.19 (m, 2 H), 1.24 – 1.37 
(m, 2 H), 1.40 – 1.49 (m, 2 H), 1.50 – 1.53 (m, 1 H), 1.58 – 1.68 (m, 2 H), 2.34 (s, 3 H), 2.86 
– 2.89 (m, 2 H), 3.94 (s, 3 H), 7.16 – 7.19 (m, 1 H), 7.29 – 7.37 (m, 2 H), 7.42 (d, J = 7.8 Hz, 
1 H), 7.77 (br s, 1 H), 7.98 (d, J = 7.8 Hz, 1 H) ppm. 
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13C NMR and DEPT (125 MHz, CDCl3): δ = 12.02 (CH3), 22.64 (2 CH3), 27.38 (CH2), 
27.97 (CH), 28.78 (CH2), 29.50 (CH2), 30.29 (CH2), 38.97 (CH2), 56.12 (CH3), 98.89 (CH), 
110.62 (CH), 118.85 (CH), 119.81 (CH), 120.26 (C), 123.72 (C), 124.06 (C), 124.14 (C), 
124.91 (CH), 133.64 (C), 139.48 (C), 152.65 (C) ppm. 
GC-MS (EI): m/z (%) = 323 (M+, 100), 308 (12), 224 (40), 210 (20), 194 (11), 180 (17), 167 
(55). 
Anal. calcd for C22H29NO: C 81.69, H 9.04, N 4.33; found: C 80.88, H 9.14, N 4.26%. 
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5.3 Attempts in the synthesis of antiostatin A4 (31 d) 
 
4-Chloro-1-heptyl-3-methoxy-2-methyl-9H-carbazole 69  
 
Three drops of HCl (conc.) were added to a solution of carbazole 41 d 
(50.0 mg, 0.162 mmol) in acetonitrile (30 mL) and the mixture was 
stirred at –20 °C. Over a period of 30 min NCS (22.6 mg, 0.170 
mmol) dissolved in acetonitrile (15 mL) was added dropwise to the 
solution. After stirring for one further hour at –20 °C two spatula tips of Na2CO3 were added 
and the solvent was removed by distillation. The residue was dissolved in water (20 mL) and 
extracted with DCM (3 x 20 mL). Then the combined organic layers were washed with water 
and subsequently dried with Na2SO4. The solvent was evaporated and the residue purified by 
flash chromatography on silica gel (PE/Et2O = 10/1) to provide 69 as a brown oil. 
Yield: 55.7 mg, 0.162 mmol, 100%. 
UV (MeOH): λ = 218, 227, 242, 250, 262, 286 (sh), 296, 330, 344 nm. 
Fluorescence (0.3 mg/100 mL MeOH): λex = 296 nm, λem = 383 nm. 
IR (ATR): ν = 3364, 2925, 2854, 1607, 1452, 1395, 1110, 739, 702 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 (t, J = 6.7 Hz, 3 H), 1.26 – 1.38 (m, 6 H), 1.41 – 1.47 
(m, 2 H), 1.61 – 1.66 (m, 2 H), 2.43 (s, 3 H), 2.84 (t, J = 8.0 Hz, 2 H), 3.87 (s, 3 H), 7.22 – 
7.24 (m, 1 H), 7.41 – 7.43 (m, 2 H), 7.89 (br s, 1 H), 8.54 (d, J = 8.0 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.67 (CH3), 14.09 (CH3), 22.65 (CH2), 28.68 
(CH2), 29.27 (CH2), 29.30 (CH2), 29.98 (CH2), 31.82 (CH2), 60.76 (CH3), 110.33 (CH), 
118.66 (C), 119.14 (C), 119.46 (CH), 122.28 (C), 122.71 (CH), 123.25 (C), 125.77 (CH), 
128.28 (C), 135.94 (C), 139.57 (C), 148.30 (C) ppm. 
MS (150 °C): m/z (%) = 343 (M+, 100), 328 (79), 309 (16), 258 (63), 244 (23), 215 (12), 180 
(17). 
HRMS: m/z [M+] calcd for C21H26ClNO: 343.1703; found: 343.1704. 
Anal. calcd for C21H26ClNO: C 73.34, H 7.62, N 4.07; found: C 73.45, H 7.78, N 3.76%. 
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6-Bromo-1-heptyl-3-methoxy-2-methyl-9H-carbazole 70 
 
One drop of HBr (48%) was added to a solution of carbazole 41 d 
(49.0 mg, 0.159 mmol) in acetonitrile (5 mL). Over a period of 30 
min NBS (30.0 mg, 0.1665 mmol) dissolved in acetonitrile (7 mL) 
was added dropwise to the solution. After stirring 45 min at room 
temperature. 2 spatula tips of Na2CO3 and CCl4 (5 mL) were added and the resulting 
precipitate was filtered off. The solvent of the mother liquor was removed by distillation and 
the residue was purified by flash chromatography on silica gel (PE/Et2O = 10/1) to provide 70 
as a grey solid. 
Yield: 53.1 mg, 0.137 mmol, 86%. 
Melting point: 111 °C. 
UV (MeOH): λ = 256, 270, 303 (sh), 309, 344, 360 nm. 
Fluorescence (1.6 mg/100 mL MeOH): λex =  309 nm, λem =  380 nm. 
IR (ATR): ν = 3434, 3005, 2956, 2926, 2851, 1586, 1494, 1456, 1447, 1420, 1311, 1289, 
1204, 1154, 1123, 1097, 826, 800, 763, 722, 684, 663 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.87 (t, J = 6.6 Hz, 3 H), 1.24 – 1.28 (m, 4 H), 1.30 – 1.36 
(m, 2 H), 1.41 – 1.46 (m, 2 H), 1.60 – 1.66 (m, 2 H), 2.33 (s, 3 H), 2.86 (t, J = 7.9 Hz, 2 H), 
3.92 (s, 3 H), 7.28 – 7.30 (m, 2 H), 7.42 (dd, J = 8.5, 1.6 Hz, 1 H), 7.78 (br s, 1 H), 8.10 (d, 
J = 1.6 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12. 07 (CH3), 14.10 (CH3), 22.66 (CH2), 28.76 
(CH2), 29.29 (CH2), 29.46 (CH2), 30.01 (CH2), 31.84 (CH2), 56.03 (CH3), 98.65 (CH), 111.61 
(C), 112.07 (CH), 119.33 (C), 122.56 (CH), 124.37 (C), 124.72 (C), 125.86 (C), 127.51 (CH), 
134.06 (C), 138.00 (C), 152.90 (C) ppm.  
MS (220 °C): m/z (%) = 387 (M+, 69), 372 (10), 309 (100), 302 (20), 294 (15), 288 (10), 224 
(33), 210 (19), 180 (12). 
HRMS: m/z [M+] calcd for C21H26BrNO: 387.1198; found: 387.1184. 
Anal. calcd for C21H26BrNO: C 64.95, H 6.75, N 3.61; found: C 65.19, H 6.90, N 3.41%. 
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4,6-Dibromo-1-heptyl-3-methoxy-2-methyl-9H-carbazole 73 
 
Two drops of HBr (conc.) were added to a solution of carbazole 41 d 
(17.7 mg, 0.057 mmol) in acetonitrile (3 mL). Over a period of 10 
min NBS (21.4 mg, 0.120 mmol) in acetonitrile (3 mL) was added 
dropwise to the solution. After stirring 3.5 h at room temperature one 
spatula tip of Na2CO3, DCM (15 mL) and NH4Cl-solution (15%, 15 mL) were added. The 
aqueous layer was extracted with DCM (3 x 15 mL). Drying of the combined organic layers 
with MgSO4, evaporation of the solvent and purification of the residue by flash 
chromatography on silica gel (PE/Et2O = 15/1) provided 73 as a colourless solid. 
Yield: 24.4 mg, 0.052 mmol, 91%. 
Melting point: 104 °C. 
UV (MeOH): λ = 226, 248, 258, 268, 292, 303, 339, 353 nm.  
Fluorescence (2 mg/100 mL MeOH): λex =  353 nm, λem = 403 nm.  
IR (ATR): ν = 3435, 3359, 2954, 2924, 2852, 1482, 1451, 1384, 1286, 1152, 1123, 1082, 
1000, 874, 799, 672 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 (t, J = 6.9 Hz, 3 H), 1.25 – 1.37 (m, 6 H), 1.41 – 1.47 
(m, 2 H), 1.58 – 1.64 (m, 2 H), 2.44 (s, 3 H), 2.81 (t, J = 8.1 Hz, 2 H), 3.85 (s, 3 H), 7.29 (d, 
J = 8.5 Hz, 1 H), 7.49 (dd, J = 8.5, 1.9 Hz, 1 H), 7.92 (br s, 1 H), 8.83 (d, J = 1.9 Hz, 1 H) 
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.01 (CH3), 14.10 (CH3), 22.65 (CH2), 28.70 
(CH2), 29.19 (CH2), 29.26 (CH2), 29.99 (CH2), 31.82 (CH2), 60.78 (CH3), 108.39 (C), 111.75 
(CH), 111.88 (C), 119.17 (C), 123.34 (C), 124.86 (CH), 125.56 (C), 128.54 (CH), 129.15 (C), 
136.59 (C), 138.22 (C), 149.60 (C) ppm. 
MS (180 °C): m/z (%) = 465 (M+, 52), 450 (16), 380 (12), 43 (11). 
HRMS: m/z [M+] calcd for C21H25Br2NO: 465.0303; found: 465.0290. 
Anal. calcd for C21H25Br2NO: C 53.98, H 5.39, N 3.00; found: C 53.65, H 5.14, N 2.79%. 
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tert-Butyl 4-bromo-1-heptyl-3-methoxy-2-methyl-9H-carbazole-9-carboxylate 72 
 
To a solution of carbazole 71 d (82.4 mg, 0.201 mmol) in acetonitrile 
(5 mL) NBS (35.8 mg, 0.201 mmol) was added. After stirring 18 h at 
room temperature acetonitrile was removed by distillation and the 
residue was purified by flash chromatography on silica gel (PE/Et2O = 
15/1) to provide 72 as a colourless oil. 
Yield: 93.8 mg, 0.193 mmol, 96%. 
UV (MeOH): λ = 236, 238, 267, 291, 311, 323 nm. 
Fluorescence (1.3 mg/100 mL MeOH): λex = 291 nm, λem = 378 nm. 
IR (ATR): ν = 2951, 2927, 2853, 1736, 1467, 1445, 1381, 1370, 1271, 1227, 1147, 1116, 
744 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.85 (t, J = 6.8 Hz, 3 H), 1.20 – 1.30 (m, 8 H), 1.46 – 1.49 
(m, 2 H), 1.68 (s, 9 H), 2.46 (s, 3 H), 2.92 (t, J = 8.0 Hz, 2 H), 3.82 (s, 3 H), 7.35 (ddd, 
J = 8.0, 7.5, 1.0 Hz, 1 H), 7.45 (ddd, J = 8.3, 7.5, 1.0 Hz, 1 H), 7.98 (d, J = 8.3 Hz, 1 H), 8.77 
(d, J = 8.0 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.77 (CH3), 14.08 (CH3), 22.61 (CH2), 28.21 
(3 CH3), 28.35 (CH2), 29.10 (CH2), 29.98 (CH2), 30.51 (CH2), 31.82 (CH2), 60.54 (CH3), 
84.13 (C), 108.29 (C), 114.53 (CH), 122.36 (CH), 122.60 (CH), 124.89 (C), 126.52 (C), 
126.99 (CH), 130.37 (C), 130.59 (C), 136.36 (C), 140.97 (C), 151.50 (C), 152.52 (C=O). 
MS (100 °C): m/z (%) = 487 (M+, 14), 431 (48), 387 (47), 372 (20), 353 (16), 309 (13), 302 
(18), 71 (10), 57 (100), 43 (12), 41 (15). 
HRMS: m/z [M+] calcd for C26H34BrNO3: 487.1722; found: 487.1719. 
 
 
1-Heptyl-3-methoxy-2-methyl-4-nitro-9H-carbazole 77 c and 1-heptyl-3-methoxy-2-
methyl-4,8-dinitro-9H-carbazole 77 e 
 
Nitronium tetrafluoroborate (91.0 mg, 
0.6857 mmol) was added to a solution of 
carbazole 41 d (163.0 mg, 0.527 mmol) in 
DME (20 mL) at a temperature of –50 °C. 
The reaction mixture was stirred at –50 °C 
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for 1 h; then the temperature was increased to –20 °C for 1 h. After cooling to room 
temperature, the mixture was filtered over celite® with diethyl ether (500 mL). Then the 
solvent was removed under reduced pressure. The residue was purified by flash 
chromatography on silica gel (PE/Et2O = 9/1) and provided 77 c and 77 e as yellow solids. 
Yield 77 c: 33.0 mg, 0.093 mmol, 18%. 
Yield 77 e: 21.0 mg, 0.080 mmol, 15%. 
Spectroscopic data of 77 c: 
Melting point: 103 °C. 
UV (MeOH): λ = 254 (sh), 279, 296, 326, 343, 388 nm. 
IR (ATR): ν = 3365, 2918, 2851, 1570, 1521, 1457, 1356, 1312, 1281, 1260, 1148, 1115, 
1093, 1011, 771, 744, 726, 690, 635 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 (t, J = 6.8 Hz, 3 H) , 1.20 – 1.33 (m, 4 H), 1.33 – 1.39 
(m, 2 H), 1.42 – 1.49 (m, 2 H), 1.61 – 1.67 (m, 2 H), 2.43 (s, 3 H), 2.89 (t, J = 8.1 Hz, 2 H), 
3.91 (s, 3 H), 7.20 (dt, J = 2.0, 6.1 Hz, 1 H), 7.42 – 7.46 (m, 2 H), 7.87 (d, J = 8.1 Hz, 1 H), 
8.04 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.35 (CH3), 14.08 (CH3), 22.63 (CH2), 29.03 
(2 CH2), 29.22 (CH2), 29.99 (CH2), 31.79 (CH2), 63.01 (CH3), 110.89 (CH), 112.55 (C), 
119.78 (C), 120.24 (CH), 121.89 (CH), 126.98 (CH), 127.67 (C), 128.30 (C), 135.55 (C), 
136.87 (C), 139.90 (C), 144.43 (C) ppm.  
MS (150 °C): m/z (%) = 354 (M+, 100), 339 (13), 269 (9), 224 (6), 194 (13), 180 (8), 149 (6). 
HRMS: m/z [M+] calcd for C21H26N2O3: 354.1943; found: 354.1933.  
Anal. calcd for C21H26N2O3: C 71.16, H 7.39, N 7.90; found: C 71.07, H 7.56, N 7.40%. 
Spectroscopic data of 77 e: 
Melting point: 111 – 112 °C.  
UV (MeOH): λ = 227, 304, 339, 398 nm.  
IR (ATR): ν = 3361, 2996, 2952, 2922, 2856, 1616, 1526, 1468, 1341, 1296, 1241, 1010, 
931, 731, 646 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.81 – 0.90 (m, 3 H), 1.22 –1.33 (m, 4 H), 1.37 – 1.42 (m, 
2 H), 1.45 –1.50 (m, 2 H), 1.67 –1.70 (m, 2 H), 2.47 (s, 3 H), 2.98 (t, J = 8.0 Hz, 2 H), 3.93 (s, 
3 H), 7.30 (t, J = 8.0 Hz, 1 H), 8.20 (d, J = 7.8 Hz, 1 H), 8.37 (d, J = 7.8 Hz, 1 H), 10.03 (s, 1 
H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.58 (CH3), 14.05 (CH3), 22.61 (CH2), 28.90 
(CH2), 28.99 (CH2), 29.11 (CH2), 29.79 (CH2), 31.71 (CH2), 63.08 (CH3), 111.74 (C), 119.62 
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(CH), 123.13 (CH), 123.72 (C), 129.30 (C), 129.67 (CH), 130.96 (C), 132.30 (C), 134.03 (C), 
135.70 (C), 136.82 (C), 145.89 (C) ppm. 
MS (ESI): m/z (%) = 400 (M+ + 1). 
 
1-Heptyl-3-hydroxy-2-methyl-4-nitro-9H-carbazole 80  
 
A solution of carbazole 77 c (51.0 mg, 0.144 mmol) in DCM (10 mL) 
was cooled to –78 °C and BBr3 (1 M in DCM, 158 µL, 0.158 mmol) 
was added to the solution. After 45 min the solution was allowed to 
warm to –20 °C and the mixture was stirred for 18 h and additional 
1.5 h at 0 °C. It was then quenched with methanol (2 mL) and water (5 mL), extracted with 
DCM (3 x 10 mL) and the combined organic layers were dried with sodium sulphate. 
Evaporation of the solvent and purification of the residue by flash chromatography on silica 
gel (PE/Et2O = 2/1) provided 80 as red solid.  
Yield: 47.8 mg, 0.140 mmol, 98%. 
Melting point: 146 °C. 
UV (MeOH): λ = 276 (sh), 297 (sh), 308 (sh), 325 (sh), 407 nm.  
IR (ATR): ν = 3376, 2922, 2852, 1733, 1619, 1575, 1502, 1457, 1376, 1327, 1269, 1181, 
1147, 1121, 1030, 726, 637 cm–1.  
1H NMR (500 MHz, CDCl3): δ = 0.88 (t , J = 6.7 Hz, 3 H), 1.19 – 1.39 (m, 6 H), 1.42 – 1.50 
(m, 2 H), 1.63 – 1.70 (m, 2 H), 2.41 (s, 3 H), 2.94 (t, J = 8.0 Hz, 2 H), 7.24 – 7.27 (m, 1 H), 
7.47 – 7.50 (m, 2 H), 8.23 (s, 1 H), 8.70 (d, J = 8.4 Hz, 1 H), 11.95 (s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.06 (CH3), 14.06 (CH3), 22.61 (CH2), 29.06 
(CH2), 29.35 (CH2), 29.42 (CH2), 29.68 (CH2), 29.95 (CH2), 110.81 (CH), 112.78 (C), 119.96 
(CH), 121.27 (C), 124.23 (C), 125.81 (CH), 126.88 (CH), 127.20 (C), 132.74 (C), 135.21 (C), 
139.96 (C), 151.99 (C) ppm.  
MS (300 °C): m/z (%) = 340 (M+, 100), 309 (12), 195 (7), 180 (18), 43 (10), 29 (7). 
HRMS: m/z [M+] calcd for C20H24N2O3: 340.1787; found: 340.1769. 
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1-Heptyl-2-methyl-4-nitro-9H-carbazol-3-yl-acetate 81  
 
To a solution of carbazole 80 (20.5 mg, 0.060 mmol) and DMAP 
(16.0 mg, 0.132 mmol) in toluene (5 mL), acetic anhydride (6 µl, 
0.090 mmol) was added and the resulting mixture was warmed to 
50 °C and stirred for 14.5 h. After cooling down to room temperature 
the reaction mixture was washed with NH4Cl-solution (15%, 3 x 10 mL), and the combined 
aqueous layers were extracted with diethyl ether (3 x 5 mL). The combined organic layers 
were dried with magnesium sulphate. Evaporation of the solvent and purification of the 
residue by flash chromatography on silica gel (PE/Et2O = 2/1) provided 81 as a brown oil. 
Yield: 8.1 mg, 0.021 mmol, 35%. 
UV (MeOH): λ = 233 (sh), 248 (sh), 276, 296, 368 nm.  
IR (ATR): ν = 3376, 2923, 2854, 1773, 1613, 1571, 1520, 1458, 1346, 1316, 1195, 1111, 
1087, 1011, 940, 739, 685, 634 cm–1.  
1H NMR (300 MHz, CDCl3): δ = 0.88 (t, J = 6.8 Hz, 3 H), 1.21 – 1.44 (m, 8 H), 1.48 – 1.56 
(m, 2 H), 2.16 (s, 3 H), 2.43 (s, 3 H), 2.67 (t, J = 6.0 Hz, 2 H), 7.15 (t, J = 7.3 Hz, 1 H), 7.37 – 
7.43 (m, 2 H), 7.82 (d, J = 8.1 Hz, 1 H), 8.27 (s, 1 H) ppm.  
13C NMR and DEPT (75 MHz, CDCl3): δ = 12.56 (CH3), 14.06 (CH3), 20.66 (CH3), 22.62 
(CH2), 28.70 (CH2), 28.83 (CH2), 29.08 (CH2), 29.82 (CH2), 31.74 (CH2), 111.14 (CH), 
112.94 (C), 119.52 (C), 120.29 (CH), 122.60 (CH), 127.04 (C), 127.31 (CH), 128.52 (C), 
134.74 (C), 135.71 (C), 137.14 (C), 140.18 (C), 169.79 (C=O) ppm. 
MS (50 °C): m/z (%) = 382 (M+, 5), 340 (100), 310 (4), 149 (19), 97 (12), 83 (12), 71 (16), 69 
(15), 57 (28), 43 (17), 41 (11), 28 (35). 
HRMS: m/z [M+] calcd for C22H26N2O4: 382.1926; found: 382.1876. 
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1-Heptyl-3-hydroxy-2-methyl-9H-carbazole 38 
 
Carbazole 41 d (51.0 mg, 0.165 mmol) in DCM (10 mL) was cooled to 
–20 °C and boron tribromide (1 M in DCM, 330 µL, 0.330 mmol) was 
added to the solution. After 15 min at –20 °C the solution was stirred 50 
min at 0 °C and 2.5 h at room temperature The mixture was quenched 
with water, extracted with DCM (3 x 10 mL) and the combined organic layers were dried 
with magnesium sulphate. Evaporation of the solvent and purification of the residue by flash 
chromatography on silica gel (PE/EtOAc = 6/1) provided 38 as a colourless solid. 
Yield:  48.0 mg, 0.163 mmol, 99% (lit. 100%)[62].  
1H NMR (500 MHz, CDCl3): δ = 0.89 (t, J = 6.7 Hz, 3 H), 1.26 – 1.38 (m, 6 H), 1.42 – 1.48 
(m, 2 H), 1.61 – 1.68 (m, 2 H), 2.37 (s, 3 H), 2.88 (t, J = 8.0 Hz, 2 H), 7.31 (s, 1 H), 7.15 – 
7.18 (m, 1 H), 7.34 – 7.38 (m, 1 H), 7.41 (d, J = 8.1 Hz, 1 H), 7.75 (s, 1 H), 7.91 (d, J = 7.8 
Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.96 (CH3), 14.10 (CH3), 22.66 (CH2), 28.75 
(CH2), 29.30 (CH2), 29.51 (CH2), 29.98 (CH2), 31.84 (CH2), 102.95 (CH), 110.59 (CH), 
118.87 (CH), 120.04 (CH), 120.78 (C), 121.37 (C), 123.64 (C), 124.11 (C), 125.21 (CH), 
133.95 (C), 139.73 (C), 148.06 (C) ppm. 
Detailed spectroscopic data see in literature[62].  
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5.4 Synthesis of antiostatin A4 (31 d) 
 
tert-Butyl 1-heptyl-3-methoxy-2-methyl-9H-carbazole-9-carboxylate 71 d  
 
A solution of di-tert-butyl oxydiformate (31.5 mg, 0.144 mmol) in 
acetonitrile (1 mL) was added to a solution of carbazole 41 d (22.3 mg, 
0.072 mmol) in acetonitrile (0.5 mL). 4-(Dimethylamino)pyridine 
(8.8 mg, 0.072 mmol) was added to the colourless solution and the reaction mixture was 
stirred at room temperature for 20 h. Evaporation of the solvent and purification of the residue 
by flash chromatography on silica gel (PE/Et2O = 15/1) provided 71 d as a colourless solid. 
Yield: 29.1 mg, 0.071 mmol, 99%. 
Decomposition: 72 °C.  
UV (MeOH): λ = 231, 233, 265, 296, 325 nm. 
Fluorescence (1 mg/100 mL MeOH): λex = 296 nm, λem = 360 nm. 
IR (ATR): ν = 2960, 2920, 2851, 1737, 1612, 1595, 1447, 1417, 1393, 1367, 1348, 1290, 
1200, 1146, 1117, 1099, 849, 835, 830, 771, 748 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.85 (t, J = 7.0 Hz, 3 H), 1.20 – 1.32 (m, 8 H), 1.42 – 1.49 
(m, 2 H), 1.68 (s, 9 H), 2.33 (s, 3 H), 2.99 (t, J = 8.0 Hz, 2 H), 3.93 (s, 3 H), 7.24 (s, 1 H), 
7.29 (dt, J = 0.7, 7.4 Hz, 1 H), 7.37 (dt, J = 1.2, 7.8 Hz, 1 H), 7.86 (d, J = 7.4 Hz, 1 H), 7.97 
(d, J = 7.4 Hz, 1 H) ppm.  
13C NMR and DEPT (125 MHz, CDCl3): δ =12.68 (CH3), 14.09 (CH3), 22.63 (CH2), 28.22 
(3 CH3), 28.69 (CH2), 29.14 (CH2), 30.04 (CH2), 30.37 (CH2), 55.90 (CH3), 83.40 (C), 98.17 
(CH), 115.26 (CH), 119.06 (CH), 122.63 (CH), 125.53 (C), 125.56 (C), 126.14 (C), 126.99 
(CH), 131.57 (C), 132.98 (C), 140.66 (C), 151.82 (C), 155.38 (C=O) ppm. 
MS (80 °C): m/z (%) = 409 (25, M+), 353 (100), 309 (89), 224 (36), 57 (39). 
HRMS: m/z [M+] calcd for C26H35NO3: 409.2617; found: 409.2605.  
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tert-Butyl 1-heptyl-3-methoxy-2-methyl-4-nitro-9H-carbazole-9-carboxylate 82 d 
 
Acetic anhydride (302.4 mg, 2.960 mmol) was added to a suspension 
of claycop (110 mg) and Et2O (7 mL). Carbazole 71 d (45.5 mg, 
0.111 mmol) dissolved in Et2O (4 mL) was added dropwise over 15 
min. The suspension was allowed to stir 20 h. After filtration over 
silica gel and celite® with Et2O (0.5 L) the solvent was evaporated and the residue purified by 
flash chromatography on silica gel (PE/Et2O = 15/1) to afford compound 82 d as a yellow 
solid. 
Yield: 45.7 mg, 0.100 mmol, 91%. 
Decomposition: 103 °C. 
UV (MeOH): λ = 226 (sh), 230, 234 (sh), 264 (sh), 291, 325 (sh) nm. 
Fluorescence (1 mg/100 mL MeOH): λex = 230 nm, λem = 383 nm. 
IR (ATR): ν = 2956, 2923, 2852, 1737, 1527, 1466, 1449, 1371, 1338, 1279, 1236, 1248, 
1133, 1118, 1099, 989, 847, 768, 743, 699 cm–1.  
1H NMR (500 MHz, CDCl3): δ = 0.86 (t, J = 7.2 Hz, 3 H), 1.23 – 1.31 (m, 8 H), 1.50 – 1.53 
(m, 2 H), 1.70 (s, 9 H), 2.44 (s, 3 H), 2.98 (t, J = 8.0 Hz, 2 H), 3.88 (s, 3 H), 7.30 (t, J = 
7.2 Hz, 1 H), 7.47 (t, J = 7.3 Hz, 1 H), 7.68 (d, J = 7.7 Hz, 1 H), 7.97 (d, J = 8.4 Hz, 1 H) 
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.17 (CH3), 14.08 (CH3), 22.61 (CH2), 28.14 
(CH2), 28.24 (3 CH3), 29.08 (CH2), 30.02 (CH2), 30.80 (CH2), 31.80 (CH2), 62.92 (CH3), 
84.71 (C), 114.95 (CH), 117.32 (C), 121.14 (CH), 121.90 (C), 123.56 (CH), 128.11 (CH), 
130.74 (C), 134.68 (C), 135.35 (C), 136.70 (C), 141.04 (C), 146.77 (C), 151.19 (C=O) ppm. 
MS (130 °C): m/z (%) = 454 (M+, 15), 398 (45), 354 (68), 353 (15), 309 (12), 224 (10), 57 
(100), 41 (10). 
HRMS: m/z [M+] calcd for C26H34N2O5: 454.2468; found: 454.2479. 
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tert-Butyl 4-amino-1-heptyl-3-methoxy-2-methyl-9H-carbazole-9-carboxylate 83 d 
 
Carbazole 82 d (290.5 mg, 0.639 mmol) in MeOH (60 mL) was added 
to a suspension of palladium on activated charcoal (30 wt%, 113.4 mg) 
in DCM (10 mL). The reaction mixture was shaken under hydrogen 
pressure (5 bar) at room temperature. After 3 d it was filtered over 
celite® with Et2O (1.5 L), the solvent was evaporated and the residue purified by flash 
chromatography on silica gel (PE/Et2O = 2/1) to afford compound 83 d as a yellow oil. 
Yield: 250.6 mg, 0.588 mmol, 92%. 
UV (MeOH): λ = 239, 273, 284, 332 nm. 
Fluorescence (1 mg/100 mL MeOH): λex =  332 nm, λem = 398 nm. 
IR (ATR): ν = 3363, 2955, 2925, 2854, 1729, 1613, 1447, 1406, 1349, 1272, 1253, 1204, 
1140, 1113, 1000, 846, 781, 741 cm–1.  
1H NMR (500 MHz, CDCl3): δ = 0.85 (t, J = 6.9 Hz, 3 H), 1.21 – 1.33 (m, 8 H), 1.45 – 1.48 
(m, 2 H), 1.68 (s, 9 H), 2.39 (s, 3 H), 2.86 (t, J = 8.0 Hz, 2 H), 3.77 (s, 3 H), 4.27 (br s, 2 H), 
7.31 (dt, J = 1.4, 7.4 Hz, 1 H), 7.36 (dt, J = 1.3, 7.4 Hz, 1 H), 7.87 (dd, J = 7.5, 0.8 Hz, 1 H), 
7.94 (dd, J = 8.2, 0.6 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.03 (CH3), 14.10 (CH3), 22.63 (CH2), 28.20 
(3 CH3), 28.74 (CH2), 29.20 (CH2), 29.88 (CH2), 30.03 (CH2), 31.86 (CH2), 59.85 (CH3), 
83.54 (C), 113.67 (C), 114.68 (CH), 120.34 (CH), 120.68 (C), 122.74 (CH), 125.11 (CH), 
126.61 (C), 129.34 (C), 132.22 (C), 135.56 (C), 140.24 (C), 142.84 (C), 151.71 (C=O) ppm. 
MS (150 °C): m/z (%) = 424 (M+, 45), 368 (100), 324 (20), 309 (62), 283 (39), 239 (52), 224 
(34), 195 (19), 57 (59), 41 (12). 
HRMS: m/z [M+] calcd for C26H36N2O3: 424.2726; found: 424.2702. 
Anal. calcd for C26H36N2O3: C 73.55, H 8.55, N 6.60; found: C 73.73, H 8.36, N 6.84%. 
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tert-Butyl 4-acetamido-1-heptyl-3-methoxy-2-methyl-9H-carbazole-9-carboxylate 84 d 
 
A solution of carbazole 83 d (176.0 mg, 0.4145 mmol) in THF 
(10 mL) was cooled down to 0 °C. After addition of triethylamine 
(35.8 mg, 32.5 µL, 0.456 mmol) and acetyl chloride (46.1 mg, 63 µL, 
0.456 mmol) the solution was warmed up and refluxed for 13 h. After 
cooling down to room temperature, ammonium chloride (15%, 
10 mL) was added and the combined aqueous layers were extracted with Et2O (3 x 10 mL). 
Then the organic layers were combined and dried with magnesium sulphate. The solvent was 
evaporated and the residue purified by flash chromatography on silica gel (PE/Et2O = 1/4) to 
afford 84 d as a colourless solid.  
Yield: 161.7 mg, 0.3465 mmol, 84%. 
Decomposition: 126 °C.  
UV (MeOH): λ = 236, 267, 291, 326 nm. 
Fluorescence (1 mg/100 mL MeOH): λex = 291 nm, λem = 372 nm. 
IR (ATR): ν = 3324, 2954, 2922, 2852, 1728, 1654, 1530, 1447, 1391, 1347, 1301, 1267, 
1252, 1157, 1137, 1115, 998, 850, 774, 755, 746, 724, 656 cm –1. 
1H NMR (500 MHz, CDCl3 , T = –8 °C): δ = 0.84 (t, J = 6.9 Hz, 3 H), 1.20 – 1.27 (m, 8 H), 
1.42 – 1.47 (m, 2 H), 1.67 and 1.70 (s, ∑ 9 H), 1.905 and 2.412 (s, ∑ 3 H), 2.360 and 2.406 (s, 
∑ 3 H), 2.90 – 2.97 (m, 2 H), 3.71 and 3.73 (s, ∑ 3 H), 7.27 (t, J = 7.5 Hz) and 7.29 (t, J = 7.5 
Hz, ∑ 1 H), 7.32 and 7.56 (s, ∑ 1 H), 7.38 (t, J = 7.8 Hz) and 7.44 (t, J = 7.8 Hz, ∑ 1 H), 7.68 
(d, J = 7.8 Hz) and 8.01 (d, J = 7.8 Hz, ∑ 1 H), 7.96 (d, J = 8.5 Hz) and 7.98 (d, J = 8.5 Hz, ∑ 
1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.11 (CH3), 13.24 (CH3), 14.08 and 23.77 (∑ 
1 CH3), 22.60 (CH2), 28.18 (3 CH3), 28.26 and 28.39 (∑ 1 CH2), 29.12 (CH2), 30.03 and 
30.12 (∑ 1 CH2), 30.55 (CH2), 31.82 and 31.85 (∑ 1 CH2), 60.76 and 61.04 (∑ 1 CH3), 83.73 
and 84.22 (∑ 1 C), 114.86 and 115.03 (∑ 1 CH), 120.88 and 121.99 (∑ 1 C), 121.57 and 
121.95 (∑ 1 CH), 122.95 and 123.38 (∑ 1 CH), 123.11 and 123.22 (∑ 1 C), 125.09 and 
125.45 (∑ 1 C), 126.52 and 127.03 (∑ 1 CH), 130.33 and 130.52 (∑ 1 C), 131.56 and 132.10 
(∑ 1 C), 135.44 and 135.80 (∑ 1 C), 140.73 and 140.95 (∑ 1 C), 150.37 and 151.54 (∑ 1 C), 
151.45 (C=O), 169.49 and 174.03 (∑ 1 C=O) ppm. 
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MS (220 °C): m/z (%) = 466 (M+, 20), 410 (100), 366 (81), 353 (5), 309 (97), 239 (62), 224 
(23), 209 (5), 195 (13), 57 (63), 43(11). 
HRMS: m/z [M+] calcd for C28H38N2O4: 466.2832; found: 466.2817. 
Anal. calcd for C28H38N2O4: C 72.07, H 8.21, N 6.60; found: C 72.48, H 8.48, N 5.45%. 
 
4-Acetamido-1-heptyl-3-methoxy-2-methyl-9H-carbazole 79 d 
 
Carbazole 84 d (52.0 mg, 0.111 mmol) was heated neat to 180 – 190°C 
under an argon atmosphere for 45 min. After cooling to room 
temperature compound 79 d was provided as a colourless solid without 
further purification. 
Yield: 40.6 mg, 0.111 mmol, 100%. 
Melting point: 206 °C. 
UV (MeOH): λ = 219, 240, 264 (sh), 287 (sh), 298, 331, 344 nm.  
Fluorescence (1 mg/100 mL MeOH): λex =  298 nm, λem = 371 nm. 
IR (ATR):  ν =3325, 3179, 3053, 2952, 2924, 2853, 1652, 1452, 1394, 1315, 1289, 1140, 
1106, 1061, 1004, 739, 639, 613 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.87 (t, J = 6.8 Hz, 3 H), 1.24 – 1.36 (m, 6 H), 1.43 – 1.49 
(m, 2 H), 1.58 – 1.68 (m, 2 H), 1.92 and 2.41 (s, ∑ 3 H), 2.36 and 2.41 (s, ∑ 3 H), 2.77 (t, J = 
7.9 Hz) and 2.86 (t, J = 7.9 Hz, ∑ 2 H), 3.767 and 3.775 (s, ∑ 3 H), 7.14 (t, J = 7.1 Hz) and 
7.19 (t, J = 7.1 Hz, ∑ 1 H), 7.26 and 7.34 (br s, ∑ 1 H), 7.31 – 7.39 (m, ∑ 1 H), 7.40 – 7.45 
(m, ∑ 1 H), 7.76 (d, J = 7.8 Hz) and 8.06 (d, J = 7.8 Hz, 1 H), 8.01 and 8.06 (br s, ∑ 1 H) 
ppm.  
13C NMR and DEPT (125 MHz, CDCl3)  δ = 12.31 and 12.42 (∑ 1 CH3), 14.10 (CH3), 
20.28 and 23.74 (∑ 1 CH3), 22.65 (CH2), 28.74 and 28.86 (∑ 1 CH2), 29.22 (CH2), 29.26 
(CH2), 30.03 and 30.08 (∑ 1 CH2), 31.82 and 31.85 (∑ 1 CH2), 60.99 and 61.25 (∑ 1 CH3), 
110.36 and 110.70 (∑ 1 CH), 117.94 and 118.16 (∑ 1 C), 119.31 and 119.85 (∑ 1 CH), 
121.01 and 122.01 (∑ 1 C), 121.81 and 122.31 (∑ 1 CH), 122.40 and 122.63 (∑ 1 C), 123.06 
and 124.00 (∑ 1 C), 125.32 and 125.90 (∑ 1 CH), 127.06 and 127.97 (∑ 1 C), 135.71 and 
135.97 (∑ 1 C), 139.66 and 139.83 (∑ 1 C), 147.21 and 148.33 (∑ 1 C), 169.62 and 174.22 (∑ 
1 C=O) ppm. 
MS (280 °C): m/z (%) = 366 (M+, 79), 309 (100), 281 (6), 239 (21), 224 (15), 195 (12), 43 
(16).  
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HRMS: m/z [M+] calcd for C23H30N2O2: 366.2307; found: 366.2291. 
Anal. calcd for C23H30N2O2: C 75.37, H 8.25, N 7.64; found: C 75.41, H 8.42, N 7.06%. 
 
4-Acetamido-1-heptyl-3-hydroxy-2-methyl-9H-carbazole 31 d 
 
Carbazole 79 d (31.0 mg, 0.085 mmol) in DCM (5 mL) was cooled to 
–78 °C and boron tribromide (1 M in DCM, 93 µL, 0.093 mmol) was 
added to the solution. After 1 h at –78 °C the brown solution was 
stirred at –20 °C for 20 h. The mixture was quenched with water, 
extracted with DCM (3 x 10 mL) and the combined organic layers 
were dried with magnesium sulphate. Evaporation of the solvent and purification of the 
residue by flash chromatography on silica gel (PE/Et2O = 1/4) provided 31 d as a yellow 
solid.  
Yield: 28.0 mg, 0.079 mmol, 94%. 
Melting point: 180 – 183 °C (lit. 191 – 193 °C)[57]. 
UV (MeOH): λ = 219, 238, 255 (sh), 267 (sh), 302, 340, 351 nm.  
Fluorescence (1 mg/100 mL MeOH): λem =  302 nm, λem = 381 nm. 
IR (ATR): ν = 3326, 3054, 2925, 2855, 2476, 1736, 1616, 1530, 1510, 1459, 1370, 1284, 
1111, 1035, 729, 643 cm–1.  
1H NMR (500 MHz, acetone-d6): δ = 0.90 (t, J = 6.9 Hz, 3 H), 1.30 – 1.42 (m, 6 H), 1.46 – 
1.51 (m, 2 H), 1.65 – 1.69 (m, 2 H), 2.41 (s, 3 H), 2.50 (s, 3 H), 2.88 – 3.02 (m, 2 H), 7.12 (dt, 
J = 0.8, 7.5 Hz, 1 H), 7.33 (dt, J = 0.8, 7.6 Hz, 1 H), 7.46 (d, J = 8.1 Hz, 1 H), 8.08 (br s, 1 H), 
8.16 (d, J = 7.9 Hz, 1 H), 9.72 (br s, 1 H), 10.21 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.68 (CH3), 14.31 (CH3), 23.17 (CH3), 
23.27 (CH2), 29.16 (CH2), 30.05 (CH2), 30.44 (CH2), 30.55 (CH2), 32.63 (CH2), 111.47 (CH), 
115.08 (C), 117.93 (C), 118.85 (CH), 122.50 (CH), 122.89 (C), 123.39 (C), 125.34 (CH), 
125.43 (C), 134.68 (C), 140.97 (C), 143.95 (C), 171.78 (C=O) ppm. 
MS (220 °C): m/z (%) = 353 (M+ + 1, 43), 352 (M+, 45), 334 (15), 311 (64), 310 (100), 309 
(77), 267 (4), 249 (31), 226 (52), 225 (68), 224 (14), 196 (15), 195 (15), 43 (11).  
HRMS: m/z [M+] calcd for C22H28N2O2: 352.2151; found: 352.2139. 
Anal. calcd for C22H28N2O2: C 74.97, H 8.01, N 7.95; found: C 74.31, H 7.72, N 7.35%. 
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5.5 Synthesis of antiostatins A1 and A3 (31 a and 31 c) 
 
tert-Butyl 3-methoxy-2-methyl-1-pentyl-9H-carbazole-9-carboxylate 71 a  
 
A solution of di-tert-butyl oxydiformate (146.7 mg, 0.670 mmol) in 
acetonitrile (10 mL) was added to a solution of carbazole 41 a 
(94.3 mg, 0.335 mmol) in acetonitrile (10 mL). 4-
(Dimethylamino)pyridine (40.9 mg, 0.335 mmol) was added to the 
colourless solution and the reaction mixture was stirred at room temperature for 27 h. 
Evaporation of the solvent and purification of the residue by flash chromatography on silica 
gel (PE/Et2O = 15/1) provided 71 a as a colourless solid. 
Yield: 118.3 mg, 0.310 mmol, 93%. 
Decomposition: 97 °C. 
UV (MeOH): λ = 232, 265, 296, 325 nm. 
Fluorescence (0.6 mg/100 mL MeOH): λex = 325 nm, λem = 361 nm. 
IR (ATR): ν = 2959, 2928, 2876, 2835, 1738, 1612, 1595, 1447, 1417, 1291, 1145, 1117, 
770, 747 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.85 (t, J = 6.8 Hz, 3 H), 1.20 – 1.32 (m, 4 H), 1.46 – 1.51 
(m, 2 H), 1.68 (s, 9 H), 2.34 (s, 3 H), 2.97 – 3.00 (m, 2 H), 3.93 (s, 3 H), 7.24 (s, 1 H), 7.27 – 
7.30 (m, 1 H), 7.35 – 7.39 (m, 1 H), 7.86 (d, J = 7.4 Hz, 1 H), 7.97 (d, J = 8.3 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ =12.67 (CH3), 14.07 (CH3), 22.51 (CH2), 28.21 
(3 CH3), 28.38 (CH2), 30.33 (CH2), 32.26 (CH2), 55.91 (CH3), 83.42 (C), 98.18 (CH), 115.25 
(CH), 119.06 (CH), 122.63 (CH), 125.53 (C), 125.56 (C), 126.14 (C), 126.98 (CH), 131.57 
(C), 132.97 (C), 140.66 (C), 151.83 (C), 155.37 (C=O) ppm. 
GC-MS (EI): m/z (%) = 281 (M+ – 100, 100), 266 (22), 224 (57), 210 (51), 194 (22), 180 
(60), 167 (17), 152 (9), 139 (4), 127 (3), 112 (5).  
Anal. calcd for C24H31NO3: C 75.56, H 8.19, N 3.67; found: C 75.78, H 8.36, N 3.44%. 
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tert-Butyl 3-methoxy-2-methyl-4-nitro-1-pentyl-9H-carbazole-9-carboxylate 82 a and  
tert-butyl 3-methoxy-2-methyl-4,6-dinitro-1-pentyl-9H-carbazole-9-carboxylate 82 g 
 
Acetic anhydride (1.2 mL, 1311 mg, 12.843 
mmol) was added to a suspension of 
claycop (1616 mg) and Et2O (75 mL). 
Carbazole 71 a (490 mg, 1.284 mmol) 
dissolved in Et2O (50 mL) was added over 
30 min. The suspension was allowed to stir 13.5 h. After filtration over silica gel and celite® 
with Et2O (1 L) the solvent was evaporated and the residue purified by flash chromatography 
on silica gel (PE/Et2O = 15/1) to afford compound 82 a and 82 g as yellow solids. 
Yield 82 a: 441.9 mg, 1.037 mmol, 81%. 
Yield 82 g: 76.6 mg, 0.163 mmol, 13%. 
Spectroscopic data of 82 a: 
Decomposition: 117°C. 
UV (MeOH): λ = 230, 263, 290 nm.  
Fluorescence (1.6 mg/100 mL): λex = 290 nm, λem = 362 nm. 
IR (ATR): ν = 2956, 2925, 2851, 1743, 1527, 1370, 1234, 1149, 1132, 1116, 741 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.86 – 0.88 (m, 3 H), 1.24 – 1.34 (m, 4 H), 1.45 – 1.53 (m, 
2 H), 1.69 (s, 9 H), 2.43 (s, 3 H), 2.98 (t, J = 8.1 Hz, 2 H), 3.88 (s, 3 H), 7.28 – 7.31 (m, 1 H), 
7.45 – 7.48 (m, 1 H), 7.68 (d, J = 7.9 Hz, 1 H), 7.97 (d, J = 8.4 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.15 (CH3), 14.01 (CH3), 22.46 (CH2), 27.92 
(CH2), 28.12 (3 CH3), 30.74 (CH2), 32.20 (CH2), 62.92 (CH3), 84.71 (C), 114.93 (CH), 
117.31 (C), 121.13 (CH), 121.89 (C), 123.55 (CH), 128.11 (CH), 130.73 (C), 134.66 (C), 
135.34 (C), 136.70 (C), 141.04 (C), 146.76 (C), 151.18 (C=O) ppm. 
GC-MS (EI): m/z (%) = 326 (M+ – 100, 100), 311 (25), 269 (12), 253 (10), 238 (17), 224 
(17), 210 (12), 194 (38), 180 (35), 167 (23), 152 (13), 139 (8). 
Anal. calcd for C24H30N2O5: C 67.59, H 7.09, N 6.57; found: C 67.46, H 7.25, N 6.50%. 
Spectroscopic data of 82 g: 
Melting point: 119 – 120 °C. 
UV (MeOH): λ = 218, 241 (sh), 254 (sh), 280, 304 nm.  
N
Boc
OMe
O2N
C5H11
N
Boc
OMe
O2N
C5H11
O2N
82 a 82 g
 EXPERIMENTAL PART 
 
 - 112 -  
IR (ATR): ν = 2953, 2928, 2870, 1769, 1752, 1520, 1369, 1463, 1369, 1336, 1292, 1243, 
1141, 1102, 1073, 992, 893, 832, 822, 746, 731 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 (t, J = 7.1 Hz, 3 H), 1.26-1.35 (m, 4 H), 1.51–1.55 (m, 
2 H), 1.72 (s, 9 H), 2.47 (s, 3 H), 2.98 (t, J = 8.1 Hz, 2 H), 3.92 (s, 3 H), 8.05 (d, J = 9.2 Hz, 1 
H), 8.38 (dd, J = 9.2, 2.3 Hz, 1 H), 8.61 (d, J = 2.3 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.36 (CH3), 13.99 (CH3), 22.45 (CH2), 28.06 
(3 CH3), 29.69 (CH2), 30.73 (CH2), 32.17 (CH2), 63.03 (CH3), 86.35 (C), 114.59 (CH), 
116.14 (C), 117.68 (CH), 122.00 (C), 123.32 (CH),  133.01 (C), 135.00 (C), 135.97 (C), 
143.82 (C), 144.08 (C), 147.61 (C), 150.06 (C) ppm. 
MS (ESI):  m/z (%) = 489 (M+ + 18). 
 
tert-Butyl 4-amino-3-methoxy-2-methyl-1-pentyl-9H-carbazole-9-carboxylate 83 a 
 
Carbazole 82 a (65.5 mg, 0.152 mmol) in MeOH (15 mL) was added to 
a suspension of palladium on activated charcoal (30 wt%, 27.0 mg) in 
DCM (3 mL). The reaction mixture was stirred at room temperature 
under hydrogen atmosphere (1013 atm) for 4 d. The reaction mixture 
was filtered over celite® with Et2O (1.5 L). Evaporation of the solvent provided compound 83 
a as a yellow oil. 
Yield: 60.4 mg, 0.152 mmol, 100%. 
UV (MeOH): λ = 239, 274, 284, 333 nm. 
Fluorescence (1 mg/100 mL MeOH): λex = 284 nm, λem = 399 nm. 
IR (ATR): ν = 3368, 2955, 2927, 2856, 1727, 1613, 1446, 1271, 1252, 1139, 1111, 781, 740 
cm–1.  
1H NMR (500 MHz, CDCl3): δ = 0.85 (t, J = 6.9 Hz, 3 H), 1.24 – 1.33 (m, 4 H), 1.44 – 1.48 
(m, 2 H), 1.69 (s, 9 H), 2.40 (s, 3 H), 2.86 (t, J = 8.0 Hz, 2 H), 3.77 (s, 3 H), 4.27 (br s, 2 H), 
7.29 – 7.37 (m, 2 H), 7.86 – 7.88 (m, 1 H), 7.97 – 7.99 (m, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.01 (CH3), 14.09 (CH3), 22.56 (CH2), 28.19 
(3 CH3), 28.42 (CH2), 29.83 (CH2), 32.26 (CH2), 59.84 (CH3), 83.54 (C), 113.66 (C), 114.66 
(CH), 120.34 (CH), 120.67 (C), 122.74 (CH), 125.10 (CH), 126.59 (C), 129.33 (C), 132.22 
(C), 135.55 (C), 140.24 (C), 142.83 (C), 151.71 (C) ppm. 
GC-MS (EI): m/z (%) = 296 (M+ – 100, 36), 281 (100), 239 (47), 224 (35), 195 (36), 180 (7), 
167 (9). 
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Anal. calcd for C24H32N2O3: C 72.70, H 8.13, N 7.06; found: C 72.39, H 8.38, N 6.89%. 
 
tert-Butyl 4-acetamido-3-methoxy-2-methyl-1-pentyl-9H-carbazole-9-carboxylate 84 a 
 
Carbazole 83 a (250.0 mg, 0.6301 mmol) was dissolved in THF 
(8 mL) and cooled down to 0 °C. After addition of triethylamine 
(54.4 mg, 49 µL, 0.6935 mmol) and acetyl chloride (70.1 mg, 96 µL, 
0.6935 mmol) to the solution it was warmed to reflux temperatures 
and stirred for 24 h. After cooling down to room temperature 
ammonium chloride (15%, 10 mL) was added and the aqueous layer was extracted with Et2O 
(3 x 10 mL). Then the organic layers were combined and dried with magnesium sulphate. The 
solvent was evaporated and the residue purified by flash chromatography on silica gel 
(PE/Et2O = 1/2) to afford 84 a as a colourless solid.  
Yield: 253.9 mg, 0.5789 mmol, 92%. 
Decomposition: 151 °C.  
UV (MeOH): λ = 231 (sh), 237, 268 (sh), 281 (sh), 291 nm.  
Fluorescence (1 mg/100 mL): λex = 292 nm, λem = 353 nm. 
IR (ATR): ν = 3227, 3000, 2947, 2923, 2868, 1726, 1655, 1594, 1535, 1446, 1390, 1348, 
1271, 1253, 1138, 1114, 1070, 1102, 751, 724, 656 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.86 (m, 3 H), 1.23 – 1.33 (m, 4 H), 1.46 – 1.53 (m, 2 H), 
1.67 and 1.70 (s, ∑ 9 H), 1.900 and 2.381 (s, ∑ 3 H), 2.376 and 2.419 (s, ∑ 3 H), 2.92 – 2.98 
(m, 2 H), 3.73 and 3.76 (s, ∑ 3 H), 7.24 – 7.44 (m, 3 H), 7.70 (d, J = 7.5 Hz) and 8.02 (d, J = 
7.8 Hz, ∑ 1 H), 7.95 – 7.99 (m, 1 H) ppm.  
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.08 and 13.22 (∑ 1 CH3), 14.05 and 14.17 
(∑ 1 CH3), 20.32 and 23.71 (∑ 1 CH3), 21.04 (CH2), 27.95 and 28.05 (∑ 1 CH2), 28.17 (3 
CH3), 31.28 (CH2), 32.34 (CH2), 60.77 and 61.03 (∑ 1 CH3), 83.74 and 84.22 (∑ 1 C), 114.83 
and 115.00 (∑ 1 CH), 120.90 and 121.95 (∑ 1 C), 121.56 and 121.95 (∑ 1 CH), 122.94 and 
123.38 (∑ 1 CH), 123.12 and 123.20 (∑ 1 C), 125.06 and 125.43 (∑ 1 C), 126.52 and 127.03 
(∑ 1 CH), 129.26 and 130.31 (∑ 1 C), 130.49 and 131.56 (∑ 1 C), 135.42 and 135.78 (∑ 1 C), 
140.72 and 140.94 (∑ 1 C), 150.37 and 151.52 (∑ 1 C), 151.45 (C=O), 169.56 and 174.22 (∑ 
1 C=O) ppm. 
GC-MS (EI): m/z (%) = 338 (M+ – 100, 39), 281 (100), 239 (20), 224 (18), 195 (22), 207 (7), 
180 (7), 167 (8). 
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Anal. calcd for C26H34N2O4: C 71.21, H 7.81, N 6.39; found: C 70.92, H 8.02, N 6.34%. 
 
4-Acetamido-3-methoxy-2-methyl-1-pentyl-9H-carbazole 79 a 
 
Carbazole 84 a (50.0 mg, 0.144 mmol) was heated neat to 180 – 190°C 
(oil bath temperature) under argon atmosphere for 45 min. Cooling to 
room temperature provided compound 79 a as a colourless solid 
without further purification. 
Yield: 38.5 mg, 0.114 mmol, 100%. 
Melting point: 226 – 228 °C. 
UV (MeOH): λ = 219, 240, 263 (sh), 286 (sh), 298, 331, 344 nm.  
Fluorescence (1 mg/100 mL MeOH): λex = 300 nm, λem = 371 nm. 
IR (ATR): ν = 3289, 3181, 3046, 2928, 2852, 1651, 1611, 1505, 1455, 1397, 1315, 1295, 
1190, 1142, 1105, 1060, 1009, 879, 864, 737, 661, 639, 614 cm–1. 
1H NMR (500 MHz, CDCl3):  δ = 0.90 – 0.93 (m, 3 H), 1.36 – 1.48 (m, 4 H), 1.61 – 1.68 (m, 
2 H), 1.92 and 2.41 (s, ∑ 3 H), 2.37 and 2.41 (s, ∑ 3 H), 2.78 – 2.81 and 2.85 – 2.88 (m, ∑ 2 
H), 3.77 and 3.78 (s, ∑ 3 H), 7.14 –7.19 (m, 1 H), 7.15 and 7.41 (br s, ∑ 1 H), 7.33 – 7.35 (m, 
1 H), 7.39 – 7.46 (m, 1 H), 7.77 (d, J = 7.9 Hz) and 8.07 (d, J = 7.9 Hz, ∑ 1 H), 7.92 and 7.98 
(br s, ∑ 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3):  δ = 12.32 and 12.42 (∑ 1 CH3), 14.07 (CH3), 
20.33 and 23.76 (∑ 1 CH3), 22.66 (CH2), 28.71 and 28.83 (∑ 1 CH2), 28.92 and 28.98 (∑ 1 
CH2), 29.69 and 32.24 (∑ 1 CH2), 60.98 and 61.26 (∑ 1 CH3), 110.36 and 110.71 (∑ 1 CH), 
117.96 and 118.21 (∑ 1 C), 119.35 and 119.87 (∑ 1 CH), 121.06 and 122.21 (∑ 1 C), 121.83 
and 122.35 (∑ 1 CH), 122.44 and 122.66 (∑ 1 C), 123.03 and 123.94 (∑ 1 C), 125.35 and 
125.90 (∑ 1 CH), 127.10 and 128.00 (∑ 1 C), 135.72 and 135.98 (∑ 1 C), 139.66 and 139.84 
(∑ 1 C), 147.23 and 148.38 (∑ 1 C), 169.59 and 174.05 (∑ 1 C=O) ppm. 
GC-MS (EI): m/z (%) = 338 (M+, 50), 323 (3), 281 (100), 239 (15), 224 (12), 195 (10).  
Anal. calcd for C21H26N2O2: C 74.52, H 7.74, N 8.28; found: C 74.58, H 7.73, N 8.31%. 
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4-Acetamido-3-hydroxy-2-methyl-1-pentyl-9H-carbazole 31 a 
 
Carbazole 79 a (20.0 mg, 0.059 mmol) in DCM (5 mL) was cooled to     
–78 °C and boron tribromide (1 M in DCM, 130 µL, 0.130 mmol) was 
added to the solution. After 4 h at –78 °C the solution was stirred at –20 
°C for 24 h. The mixture was quenched with ammonium chloride (15%, 
10 mL), extracted with DCM (3 x 10 mL) and the combined organic 
layers were dried with magnesium sulphate. Evaporation of the solvent and purification of the 
residue by flash chromatography on silica gel (PE/Et2O = 1/4) provided 31 a as a yellow 
solid.  
Yield: 13.7 mg, 0.042 mmol, 71%. 
Melting point: 190 – 192 °C (lit. 180 – 183 °C)[57]. 
UV (MeOH): λ = 254 (sh), 266 (sh), 302, 341, 351 nm.  
Fluorescence (0.5 mg/100 mL MeOH): λex = 302 nm, λem = 385 nm. 
IR (ATR): ν = 3340, 3053, 2958, 2926, 2855, 2490, 1703, 1614, 1531, 1509, 1463, 1417, 
1281, 1109, 1035, 891, 727 cm–1. 
1H NMR (500 MHz, acetone-d6):  δ = 0.92 (t, J = 7.2 Hz, 3 H), 1.37 – 1.42 (m, 2 H), 1.43 – 
1.51 (m, 2 H), 1.65 – 1.71 (m, 2 H), 2.41 (s, 3 H), 2.50 (s, 3 H), 2.98 – 3.01 (m, 2 H), 7.10 – 
7.13 (m, 1 H), 7.31 –7.34 (m, 1 H), 7.46 (d, J = 8.1 Hz, 1 H), 8.08 (br s, 1 H), 8.16 (d, J = 
7.9 Hz, 1 H), 9.72 (br s, 1 H), 10.21 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.68 (CH3), 14.35 (CH3), 23.13 and 
23.18 (∑ 1 CH3), 23.35 (CH2), 29.12 (CH2), 30.05 (CH2), 32.77 (CH2), 111.43 and 111.48 (∑ 
1 CH), 115.07 (C), 117.80 and 117.95 (∑ 1 C), 118.85 (CH), 122.51 (CH), 122.90 (C), 123.35 
and 123.39 (∑ 1 C), 125.36 (CH), 125.40 and 125.46 (∑ 1 C), 134.57 and 134.71 (∑ 1 C), 
140.85 and 140.98 (∑ 1 C), 143.82 and 143.95 (∑ 1 C), 171.71 and 171.78 (∑ 1 C=O) ppm. 
MS (230 °C): m/z (%) = 325 (M+ + 1, 44), 324 (29), 306 (14), 284 (30), 283 (78), 282 (100), 
250 (18), 227 (28), 226 (57), 225 (47), 224 (11), 196 (14), 195 (10). 
HRMS: m/z [M+] calcd for C20H24N2O2: 324.1838; found: 324.1842. 
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tert-Butyl 3-methoxy-2-methyl-1-(5-methylhexyl)-9H-carbazole-9-carboxylate 71 c  
 
A solution of di-tert-butyl oxydiformate (283.1 mg, 1.294 mmol) in 
acetonitrile (3 mL) was added to a solution of carbazole 41 c (200.0 
mg, 0.647 mmol) in acetonitrile (2 mL). 4-(Dimethylamino)pyridine 
(79.0 mg, 0.647 mmol) was added to the colourless solution and the 
reaction mixture was stirred at room temperature for 20 h. Evaporation 
of the solvent and purification of the residue by flash chromatography on silica gel (PE/Et2O 
= 15/1) provided 71 c as a colourless solid. 
Yield: 260.9 mg, 0.637 mmol, 98%. 
Decomposition: 90 °C. 
UV (MeOH): λ =  232, 265, 296 nm. 
IR (ATR): ν = 2957, 2903, 2866, 1737, 1447, 1417, 1348, 1292, 1145, 1118, 1099, 771, 748 
cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.83 (d, J = 6.6 Hz, 6 H), 1.15 – 1.19 (m, 2 H), 1.24 – 1.32 
(m, 2 H), 1.45 –1.50 (m, 3 H), 1.68 (s, 9 H), 2.34 (s, 3 H), 2.97 (t, J = 8.0 Hz, 2 H), 3.93 (s, 3 
H), 7.24 (s, 1 H), 7.27 – 7.30 (m, 1 H), 7.35 – 7.39 (m, 1 H), 7.86 (d, J = 7.6 Hz, 1 H), 7.97 
(d, J = 8.3 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.67 (CH3), 22.60 (2 CH3), 27.87 (CH2), 
27.95 (CH), 28.21 (3 CH3), 28.88 (CH2), 30.38 (CH2), 38.72 (CH2), 55.90 (CH3), 83.40 (C), 
98.18 (CH), 115.24 (CH), 119.05 (CH), 122.62 (CH), 125.53 (C), 125.56 (C), 126.13 (CH), 
126.97 (CH), 131.53 (C), 132.97 (C), 140.64 (C), 151.82 (C), 155.37 (C=O) ppm. 
GC-MS (EI):  m/z (%) = 309 (M+ – 100, 100), 294 (14), 224 (38), 194 (10), 181 (10), 180 
(18). 
Anal. calcd for C26H35NO3: C 76.25, H 8.61, N 3.42; found: C 75.46, H 8.75, N 3.47%. 
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tert-Butyl 3-methoxy-2-methyl-1-(5-methylhexyl)-4-nitro-9H-carbazole-9-carboxylate 
82 c  
 
Acetic anhydride (311.6 mg, 3.052 mmol) was added to a suspension 
of claycop (228.9 mg) and Et2O (10 mL). Carbazole 71 c (125.0 mg, 
0.3052 mmol) dissolved in Et2O (5 mL) was added dropwise over a 
period of 10 min. The suspension was allowed to stir 4.5 h at room 
temperature. After filtration over silica gel and celite® with Et2O 
(0.5 L) the solvent was evaporated and the residue purified by flash chromatography on silica 
gel (PE/Et2O = 15/1) to afford compound 82 c as a yellow solid. 
Yield: 115.3 mg, 0.254 mmol, 83%. 
Decomposition: 109 °C. 
UV (MeOH): λ = 230, 265 (sh), 293 (sh) nm.  
IR (ATR): ν = 2954, 2933, 2870, 1733, 1525, 1451, 1371, 1286, 1235, 1149, 1136, 1119, 
988, 846, 742 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.84 (d, J = 6.6 Hz, 6 H), 1.15 – 1.21 (m, 2 H), 1.25 – 1.34 
(m, 2 H), 1.45 – 1.52 (m, 3 H), 1.70 (s, 9 H), 2.44 (s, 3 H), 2.97 – 3.00 (m, 2 H), 3.88 (s, 3 H), 
7.28 – 7.31 (m, 1 H), 7.45 – 7.48 (m, 1 H), 7.68 (d, J = 7.9 Hz, 1 H), 7.97 (d, J = 8.4 Hz, 1 H) 
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.16 (CH3), 22.57 (2 CH3), 27.85 (CH2), 
27.94 (CH), 28.13 (3 CH3), 28.44 (CH2), 30.81 (CH2), 38.66 (CH2), 62.91 (CH3), 84.71 (C), 
114.93 (CH), 117.31 (C), 121.13 (CH), 121.89 (C), 123.55 (CH), 128.11 (CH), 130.74 (C), 
134.65 (C), 135.35 (C), 136.70 (C), 141.02 (C), 146.76 (C), 151.19 (C=O) ppm. 
GC-MS (EI): m/z (%) = 354 (M+ – 100, 100), 339 (18), 320 (6), 281 (5), 269 (16), 238 (7), 
235 (11), 224 (11), 210 (5), 194 (17), 180 (12), 167 (8), 152 (4), 77 (3), 55 (3). 
Anal. calcd for C26H34N2O5: C 68.70, H 7.54, N 6.16; found: C 68.65, H 7.75, N 6.22%. 
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tert-Butyl 4-amino-3-methoxy-2-methyl-1-(5-methylhexyl)-9H-carbazole-9-carboxylate 
83 c 
 
Carbazole 82 c (75.0 mg, 0.165 mmol) in MeOH (10 mL) was added to 
a suspension of palladium on activated charcoal (30 wt%, 29.1 mg) in 
DCM (10 mL). The reaction mixture was stirred under hydrogen 
atmosphere (1013 mbar) at room temperature for 7 d. It was then 
filtered over celite® with Et2O (0.5 L) and the solvent was evaporated 
to afford compound 83 c as a yellow oil. 
Yield: 69.0 mg, 0.1625 mmol, 99%. 
UV (MeOH): λ = 238, 274, 284, 333 nm.  
IR (ATR): ν = 3368, 2952, 2928, 2867, 1728, 1613, 1447, 1272, 1253, 1141, 1114, 999, 740 
cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.83 (d, J = 6.6 Hz, 6 H), 1.14 – 1.19 (m, 2 H), 1.24 – 1.30 
(m, 2 H), 1.42 – 1.50 (m, 3 H) 1.69 (s, 9 H), 2.40 (s, 3 H), 2.86 (t, J = 8.0 Hz, 2 H), 3.77 (s, 3 
H), 4.27 (br s, 2 H), 7.29 – 7.37 (m, 2 H), 7.86 – 7.87 (m, 1 H), 7.97 (d, J = 8.0 Hz, 1 H)  
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.02 (CH3), 22.60 (2 CH3), 27.85 (CH2), 
27.97 (CH), 28.20 (3 CH3), 28.94 (CH2), 29.89 (CH2), 38.80 (CH3), 59.84 (CH3), 83.54 (C), 
113.67 (C), 114.66 (CH), 120.34 (CH), 120.66 (C), 122.73 (CH), 125.11 (CH), 126.59 (C), 
129.34 (C), 132.21 (C), 135.56 (C), 140.22 (C), 142.84 (C), 151.72 (C=O) ppm. 
GC-MS (EI): m/z (%) = 324 (M+ – 100, 38), 309 (100), 239 (38), 224 (19), 195 (15). 
MS (180 °C): m/z (%) = 424 (M+, 25), 368 (100), 324 (17), 309 (65), 283 (39), 239 (48), 224 
(25), 195 (14), 57 (31). 
HRMS: m/z [M+] calcd for C26H36N2O3: 424.2726; found: 424.2718. 
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tert-Butyl 4-acetamido-3-methoxy-2-methyl-1-(5-methylhexyl)-9H-carbazole-9-
carboxylate 84 c 
 
Carbazole 83 c (75.0 mg, 0.177 mmol) was dissolved in THF (15 mL) 
and cooled to 0 °C. After addition of triethylamine (19.6 mg, 30 µL, 
0.194 mmol) and acetyl chloride (15.3 mg, 14 µL, 0.194 mmol) the 
solution was refluxed for 24 h. After cooling down to room 
temperature ammonium chloride (15%, 10 mL) was added and the 
aqueous layer was extracted with DCM (3 x 20 mL). The organic 
layers were combined and dried with magnesium sulphate. Then the solvent was evaporated 
and the residue purified by flash chromatography on silica gel (PE/Et2O = 1/10) to afford 84 c 
as a colourless solid.  
Yield: 74.6 mg, 0.160 mmol, 91%. 
Decomposition: 116 °C. 
UV (MeOH): λ = 236, 267 (sh), 280 (sh), 291 nm.  
IR (ATR): ν = 3229, 2953, 2928, 2866, 1728, 1655, 1527, 1268, 1251, 1138, 1115, 1031, 
755 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.83 (d, J = 6.6 Hz, 6 H), 1.15 – 1.19 (m, 2 H), 1.24 – 1.32 
(m, 2 H), 1.45 – 1.51 (m, 3 H), 1.68 and 1.71 (s, ∑ 9 H), 1.90 and 2.39 (s, ∑ 3 H), 2.39 and 
2.42 (s, ∑ 3 H), 2.93 – 2.98 (m, 2 H), 3.74 and 3.76 (s, ∑ 3 H), 7.07 and 7.35 (br s, 1 H), 7.25 
– 7.31 (m, ∑ 2 H), 7.71 (d, J = 7.7 Hz) and 8.03 (d, J = 7.7 Hz, ∑ 1 H), 7.95 – 7.99 (m, 1 H) 
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.11 and 13.25 (∑ 1 CH3), 20.36 and 23.76 
(∑ 1 CH3), 22.59 (2 CH3), 27.85 and 27.94 (∑ 1 CH2), 27.96 (CH), 28.19 (∑ 3 CH3), 28.47 
and 28.59 (∑ 1 CH2), 30.58 (CH2), 38.71 (CH2), 60.77 and 61.04 (∑ 1 CH3), 83.74 and 84.22 
(∑ 1 C), 114.86 and 115.02 (∑ 1 CH), 120.89 and 121.95 (∑ 1 C), 121.58 and 121.95 (∑ 1 
CH), 122.95 and 123.39 (∑ 1 CH), 123.12 and 123.23 (∑ 1 C), 125.09 and 125.44 (∑ 1 C), 
126.52 and 127.04 (∑ 1 CH), 129.27 and 130.33 (∑ 1 C), 130.50 and 131.53 (∑ 1 C), 135.45 
and 135.81 (∑ 1 C), 140.72 and 140.94 (∑ 1 C), 150.37 and 151.55 (∑ 1 C), 151.46 (∑ 1 
C=O), 169.49 and 174.03 (∑ 1 C=O) ppm. 
GC-MS (EI): m/z (%) = 366 (M+ – 100, 53), 351 (4), 335 (4), 323 (3), 309 (100), 239 (19), 
224 (15), 195 (12).  
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MS (200 °C): m/z (%) = 466 (M+, 21), 410 (100), 366 (65), 323 (12), 309 (86), 239 (62), 224 
(25), 195 (14), 57 (67). 
HRMS: m/z [M+] calcd for C28H38N2O4: 466.2832; found: 466.2829. 
 
4-Acetamido-3-methoxy-2-methyl-1-(5-methylhexyl)-9H-carbazole 79 c 
 
Carbazole 84 c (14.3 mg, 0.031 mmol) was heated neat to 180 °C – 
190 °C under argon atmosphere for 45 min and then cooled down to 
room temperature to provide compound 79 c as a colourless solid. 
Yield: 11.2 mg, 0.031 mmol, 100%. 
Melting point: 210 – 212 °C. 
UV (MeOH): λ = 218, 240, 263 (sh), 286, 298 (sh), 331, 344 nm.  
IR (ATR): ν = 3290, 3049, 2951, 2926, 2855, 1650, 1455, 1398, 1317, 1300, 1142, 1106, 
1062, 1010, 875, 734, 640, 613 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 (d, J = 6.6 Hz, 6 H), 1.20 – 1.71 (m, 7 H), 1.92 and 
2.41 (s, ∑ 3 H), 2.37 and 2.42 (s, ∑ 3 H), 2.78 – 2.80 (m) and 2.81 – 2.89 (m, ∑ 2 H), 3.77 
and 3.78 (s, ∑ 3 H), 7.14 – 7.19 (m, 1 H), 7.21 and 7.42 (br s, ∑ 1 H), 7.32 – 7.37 (m, 1 H), 
7.39 – 7.46 (m, 1 H) 7.77 (d, J = 7.9 Hz) and 8.06 (d, J = 7.9 Hz, ∑ 1 H), 7.94 and 8.06 (br s, 
∑ 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.31 and 12.42 (∑ 1 CH3), 20.32 and 23.74 
(∑ 1 CH3), 22.65 (∑ 2 CH3), 27.86 and 27.93 (∑ 1 CH2), 27.98 and 28.03 (∑ 1 CH), 28.78 
and 28.89 (∑ 1 CH2), 29.46 and 29.51 (∑ 1 CH2), 38.84 (∑ 1 CH2), 60.98 and 61.25 (∑ 1 
CH3), 110.36 and 110.69 (∑ 1 CH), 117.95 and 118.19 (∑ 1 C), 119.32 and 119.85 (∑ 1 CH), 
121.04 and 122.17 (∑ 1 C), 121.81 and 122.32 (∑ 1 CH), 122.42 and 122.64 (∑ 1 C),123.05 
and 123.95 (∑ 1 C), 125.33 and 125.89 (∑ 1 CH), 127.06 and 127.96 (∑ 1 C), 135.70 and 
135.95 (∑ 1 C), 139.66 and 139.83 (∑ 1 C), 147.21 and 148.35 (∑ 1 C), 169.62 and 174.13 (∑ 
1 C=O) ppm. 
GC-MS (EI): m/z (%) = 366 (M+, 58), 335 (5), 323 (4), 309 (100), 281 (6), 239 (18), 224 
(12), 207 (5), 195 (12), 182 (3). 
MS (260 °C): m/z (%) = 366 (M+, 77), 352 (3), 335 (3), 323 (4), 309 (100), 295 (6), 281 (6), 
239 (18), 224 (13), 195 (10), 43 (6). 
HRMS: m/z [M+] calcd for C23H30N2O2: 366.2307; found: 366.2289. 
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4-Acetamido-3-hydroxy-2-methyl-1-(5-methylhexyl)-9H-carbazole 31 c 
 
Carbazole 79 c (21.0 mg, 0.057 mmol) in DCM (5 mL) was cooled to 
–78 °C and boron tribromide (1 M in DCM, 126 µL, 0.126 mmol) 
was added to the solution. After 1 h at –78 °C the brown solution was 
stirred at 0 °C for 6 h. Then, the mixture was quenched with water, 
extracted with DCM (3 x 10 mL) and the combined organic layers 
were dried with magnesium sulphate. Evaporation of the solvent and 
purification of the residue by flash chromatography on silica gel (PE/Et2O = 1/10) provided 
31 c as a yellow solid.  
Yield: 13.2 mg, 0.038 mmol, 65%. 
Melting point: 191 – 192 °C (lit. 190 – 192 °C)[57]. 
UV (MeOH): λ = 218, 238, 255 (sh), 267 (sh), 302, 340, 352 nm.  
IR (ATR): ν = 3342, 2923, 2860, 2482, 1616, 1529, 1511, 1466, 1419, 1367, 1283, 728, 642 
cm–1. 
1H NMR (500 MHz, acetone-d6): δ = 0.91 (d, J = 6.6 Hz, 6 H), 1.26 – 1.45 (m, 2 H), 1.49 – 
1.61 (m, 3 H), 1.64 – 1.71 (m, 2 H), 2.43 (s, 3 H), 2.51 (s, 3 H), 3.02 (t, J = 8.0 Hz, 2 H), 7.11 
– 7.14 (m, 1 H), 7.31 – 7.35 (m, 1 H), 7.47 (d, J = 8.5 Hz, 1 H), 8.10 (d, J = 7.9 Hz, 1 H), 8.17 
(d, J = 7.9 Hz, 1 H), 9.72 (br d, J = 5.9 Hz, 1 H), 10.22 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.69 (CH3), 22.90 (2 CH3), 23.13 and 
23.18 (∑ 1 CH3), 28.41 (CH2), 28.74 (CH), 29.21 (CH2), 30.68 (CH2), 39.67 (CH2), 111.42 
and 111.47 (∑ 1 CH), 115.04 and 115.08 (∑ 1 C), 117.83 and 117.94 (∑ 1 C), 118.85 (CH), 
122.51 (CH), 122.85 and 122.90 (∑ 1 C), 123.36 and 123.40 (∑ 1 C), 125.35 (CH), 125.40 
and 125.45 (∑ 1 C), 134.60 and 134.69 (∑ 1 C), 140.84 and 140.97 (∑ 1 C), 143.81 and 
143.95 (∑ 1 C), 171.70 and 171.78 (∑ 1 C=O) ppm. 
MS (220 °C): m/z (%) = 353 (40), 352 (M+, 37), 334 (20), 311 (62), 310 (100), 309 (60), 296 
(8), 267 (5), 249 (40), 226 (52), 225 (59), 196 (13), 180 (6), 167 (3), 71 (3), 57 (4).    
HRMS: m/z [M+] calcd for C22H28N2O2: 352.2151; found: 352.2145. 
Anal. calcd for C22H28N2O2: C 74.97, H 8.01, N 7.95; found: C 74.35, H 7.82, N 7.05%. 
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5.6 Synthesis of antiostatin A2 (31 b) 
 
tert-Butyl 3-methoxy-2-methyl-1-((S)-3-methylpent-1-yl)-9H-carbazole-9-carboxylate 
71 b  
 
A solution of di-tert-butyl oxydiformate (49.0 mg, 0.224 mmol) in 
acetonitrile (10 mL) was added to a solution of carbazole 41 b (33.2 
mg, 0.112 mmol) in acetonitrile (5 mL). 4-(Dimethylamino)pyridine 
(13.7 mg, 0.112 mmol) was added to the colourless solution and the 
reaction mixture was stirred at room temperature for 24 h. 
Evaporation of the solvent and purification of the residue by flash chromatography on silica 
gel (PE/Et2O = 15/1) provided 71 b as a colourless solid. 
Yield: 44.6 mg, 0.112 mmol, 100%. 
Decomposition: 81 °C. 
[α]20D = +7.2 (CHCl3, c = 1.0). 
UV (MeOH): λ = 232, 266, 296, 325 nm.  
IR (ATR): ν = 2962, 2925, 2853, 1737, 1447, 1416, 1347, 1226, 1200, 1144, 1118, 769, 748 
cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.83 – 0.86 (m, 3 H), 0.92 (d, J = 6.6 Hz, 3 H), 1.13 – 1.39 
(m, 4 H), 1.45 – 1.52 (m, 1 H), 1.68 (s, 9 H), 2.34 (s, 3 H), 2.93 – 3.08 (m, 2 H), 3.93 (s, 3 H), 
7.24 (s, 1 H), 7.27 – 7.31 (m, 1 H), 7.35 – 7.39 (m, 1 H), 7.85 – 7.86 (m, 1 H), 7.98 (d, J = 
8.3 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.45 (CH3), 12.59 (CH3), 19.16 (CH3), 28.12 
(CH2), 28.24 (3 CH3), 29.40 (CH2), 35.20 (CH), 35.59 (CH2), 55.90 (CH3), 83.41 (C), 98.14 
(CH), 115.46 (CH), 119.05 (CH), 122.71 (CH), 125.45 (C), 125.73 (C), 126.15 (CH), 127.11 
(C), 132.02 (C), 133.00 (C), 140.78 (C), 151.92 (C), 155.48 (C=O) ppm. 
GC-MS (EI): m/z (%) = 295 (M+ – 100, 100), 280 (12), 224 (54), 210 (44), 194 (18), 181 
(18), 180 (31), 167 (10), 152 (4), 55 (2). 
MS (200 °C): m/z (%) = 395 (M+, 27), 339 (100), 295 (91), 280 (7), 224 (57), 210 16), 194 
(10), 181 (11), 180 (14), 167 (4), 57 (64). 
HRMS: m/z [M+] calcd for C25H33NO3: 395.2460; found: 395.2469. 
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Anal. calcd for C25H33NO3: C 75.91, H 8.41, N 3.54; found: C 75.74, H 8.52, N 3.42%.  
 
tert-Butyl 3-methoxy-2-methyl-1-((S)-3-methylpent-1-yl)-4-nitro-9H-carbazole-9-
carboxylate 82 b 
 
Acetic anhydride (613.8 mg, 6.0177 mmol) was added to a 
suspension of claycop (451.3 mg) and Et2O (20 mL). Carbazole 71 b 
(238.0 mg, 0.6017 mmol) dissolved in Et2O (20 mL) was added over 
a period of 10 min. The suspension was allowed to stir for 18 h at 
room temperature. After filtration over silica gel with Et2O (0.5 L) the 
solvent was evaporated and the residue purified by flash 
chromatography on silica gel (PE/Et2O = 15/1) to afford compound 82 b as a yellow solid. 
Yield: 213.5 mg, 0.4847 mmol, 81%. 
Decomposition: 120 °C. 
[α]20D = +4.5 (CHCl3, c = 1.0). 
UV (MeOH): λ = 229, 264 (sh), 290 (sh) nm.  
IR (ATR): ν = 2959, 2926, 2873, 1743, 1526, 1370, 1282, 1241, 1148, 1134, 1118, 1098, 
992, 846, 742, 695 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.84 – 0.87 (m, 3 H), 0.93 (d, J = 6.4 Hz, 3 H), 1.17 – 1.41 
(m, 4 H), 1.45 – 1.50 (m, 1 H), 1.69 (s, 9 H), 2.43 (s, 3 H), 2.92 – 3.06 (m, 2 H), 3.88 (s, 3 H), 
7.28 – 7.31 (m, 1 H), 7.45 – 7.48 (m, 1 H), 7.68 (d, J = 7.9 Hz, 1 H), 7.99 (d, J = 8.4 Hz, 1 H) 
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.43 (CH3), 13.04 (CH3), 19.11 (CH3), 28.15 
(3 CH3), 28.49 (CH2), 29.33 (CH2), 35.14 (CH2), 35.20 (CH), 62.91 (CH3), 84.72 (C), 115.17 
(CH), 117.49 (C), 121.12 (CH), 122.05 (C), 123.64 (CH), 128.11 (CH), 130.64 (C), 135.22 
(C), 135.41 (C), 136.66 (C), 141.16 (C), 146.90 (C), 151.30 (C=O) ppm. 
GC-MS (EI): m/z (%) = 340 (M+ – 100, 100), 325 (13), 310 (3), 295 (6), 269 (13), 238 (10), 
224 (13), 210 (7), 194 (19), 180 (16), 167 (10), 152 (6), 139 (5), 77 (3). 
MS (220 °C): m/z (%) = 440 (M+, 12), 385 (11), 384 (38), 340 (66), 325 (4), 269 (8), 238 (4), 
224 (5), 210 (3), 194 (7), 180 (5), 57 (100). 
HRMS: m/z [M+] calcd for C25H32N2O5: 440.2311; found: 440.2315. 
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tert-Butyl 4-amino-3-methoxy-2-methyl-1-((S)-3-methylpent-1-yl)-9H-carbazole-9-
carboxylate 83 b 
 
To a suspension of palladium on activated charcoal (30 wt%, 
10.6 mg) in EtOAc (6 mL) carbazole 82 b (26.4 mg, 0.060 mmol) 
was added. The reaction mixture was stirred under hydrogen 
atmosphere (1013 mbar) 3.5 d at room temperature. Then the solvent 
was removed under reduced pressure and the residue purified by flash 
chromatography with a combined column of celite® and silica gel 
(PE/Et2O = 2/1) to afford 83 b as a colourless oil.  
Yield: 24.8 mg, 0.060 mmol, 100%. 
[α]20D = +9.3 (CHCl3, c = 1.0). 
UV (MeOH): λ = 273, 284, 333 nm.  
IR (ATR): ν = 3449, 3373, 2958, 2926, 2872, 1728, 1614, 1446, 1272, 1252, 1203, 1141, 
1115, 998, 845, 781, 741 cm–1.  
1H NMR (500 MHz, CDCl3): δ = 0.84 (t, J = 7.4 Hz, 3 H), 0.90 (d, J = 6.4 Hz, 3 H), 1.12 – 
1.40 (m, 4 H), 1.44 – 1.48 (m, 1 H), 1.68 (s, 9 H), 2.39 (s, 3 H), 2.82 – 2.93 (m, 2 H), 3.77 (s, 
3 H), 4.26 (br s, 2 H), 7.29 – 7.37 (m, 2 H), 7.86 – 7.87 (m, 1 H), 7.97 (d, J = 8.2 Hz, 1 H)  
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.47 (CH3), 12.93 (CH3), 19.21 (CH3), 27.65 
(CH2), 28.23 (3 CH3), 28.45 (CH2), 35.17 (CH), 35.70 (CH2), 59.84 (CH3), 83.55 (C), 113.82 
(C), 114.93 (CH), 120.33 (CH), 121.13 (C), 122.83 (CH), 125.11 (CH), 126.77 (C), 129.26 
(C), 132.18 (C), 135.62 (C), 140.37 (C), 142.99 (C), 151.82 (C=O) ppm. 
GC-MS (EI): m/z (%) = 310 (M+ – 100, 42), 295 (100), 239 (45), 224 (26), 195 (22). 
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tert-Butyl 4-acetamido-3-methoxy-2-methyl-1-((S)-3-methylpent-1-yl)-9H-carbazole-9-
carboxylate 84 b 
 
Triethylamine (6.2 mg, 0.062 mmol) and acetyl chloride (5.7 mg, 
0.073 mmol) were added to a solution of carbazole 83 b (23.0 mg, 
0.056 mmol) in THF (5 mL) at 0 °C. After 10 min the reaction 
mixture was warmed up to room temperature and stirred for 3 h. 
The reaction was quenched with ammonium chloride (15%, 10 mL) 
and extracted with DCM (3 x 10 mL) and the combined organic 
layer was dried with magnesium sulphate. The solvent was 
evaporated and the residue purified by flash chromatography on silica gel (PE/Et2O = 1/10) to 
afford 84 b as a colourless solid.  
Yield: 24.5 mg, 0.054 mmol, 97%. 
Decomposition: 165 – 168 °C. 
[α]20D = +8.5 (CHCl3, c = 1.0). 
UV (MeOH): λ = 236, 268, 291, 320 nm.  
IR (ATR): ν = 3435, 3229, 2961, 2921, 2850, 1726, 1657, 1447, 1270, 1160, 1139, 1114, 
747, 721, 699 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.83 – 0.86 (m, 3 H), 0.91 – 0.93 (m, 3 H), 1.15 – 1.54 (m, 
5 H), 1.67 and 1.70 (s, ∑ 9 H), 1.90 and 2.39 (s, ∑ 3 H), 2.39 and 2.42 (s, ∑ 3 H), 2.90 – 3.03 
(m, 2 H), 3.74 and 3.76 (s, ∑ 3 H), 7.09 and 7.34 (br s, ∑ 1 H), 7.26 – 7.44 (m, 2 H), 7.70 (d, 
J = 7.8 Hz) and 7.97 – 8.03 (m, ∑ 2 H) ppm.  
13C NMR and DEPT (125 MHz, CDCl3):  δ = 11.46 (CH3), 13.01 and 13.14 (∑ 1 CH3), 
19.16 (CH3), 20.36 and 23.76 (∑ 1 CH3), 28.21 (3 CH3), 28.30 and 28.378 (∑ 1 CH2), 29.380 
(CH2), 35.20 and 35.31 (∑ 1 CH2), 35.26 (CH), 60.77 and 61.05 (∑ 1 CH3), 83.75 and 84.24 
(∑ 1 C), 115.11 and 115.27 (∑ 1 CH), 120.82 and 121.93 (∑ 1 C), 121.56 and 121.93 (∑ 1 
CH), 123.04 and 123.48 (∑ 1 CH), 123.27 and 123.39 (∑ 1 C), 125.24 and 125.59 (∑ 1 C), 
126.53 and 127.05 (∑ 1 CH), 129.17 and 130.24 (∑ 1 C), 131.02 and 132.08 (∑ 1 C), 135.51 
and 135.87 (∑ 1 C), 140.86 and 140.08 (∑ 1 C), 150.48 and 151.67 (∑ 1 C), 151.55 (C=O), 
169.51 and 174.13 (∑ 1 C=O) ppm. 
GC-MS (EI): m/z (%) =352 (M+ – 100, 53), 337 (3), 321 (5), 295 (100), 281 (7), 239 (24), 
224 (18) 195 (16).  
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Anal. calcd for C27H36N2O4: C 71.65, H 8.02, N 6.19; found: C 75.75, H 8.20, N 6.07%. 
 
4-Acetamido-3-methoxy-2-methyl-1-((S)-3-methylpent-1-yl)-9H-carbazole 79 b 
 
Carbazole 84 b (13.4 mg, 0.0296 mmol) was heated neat to 180 °C – 
190 °C under argon atmosphere for 45 min and then cooled down to 
room temperature to provide compound 79 b as a colourless solid. 
Yield: 10.4 mg, 0.0295 mmol, 100%. 
Melting point: 206 °C. 
[α]20D = +5.2 (CHCl3, c = 1.0).  
UV (MeOH): λ = 240, 263, 286 (sh), 298, 331, 344 nm.  
IR (ATR): ν = 3316, 3164, 3040, 2923, 2872, 1643, 1610, 1387, 1316, 1294, 1008, 740, 633, 
539 cm–1. 
1H NMR (500 MHz, CDCl3):  δ = 0.91 – 0.95 (m, 3 H), 1.03 – 1.06 (m, 3 H), 1.21 – 1.30 (m, 
2 H), 1.38 – 1.64 (m, 3 H), 1.92 and 2.41 (s, ∑ 3 H), 2.36 and 2.41 (s, ∑ 3 H), 2.72 – 2.89 (m, 
2 H), 3.77 and 3.78 (s, ∑ 3 H), 7.13 – 7.21 and 7.31 – 7.46 (m, ∑ 4 H), 7.77 (d, J = 7.8 Hz) 
and 8.07 (d, J = 7.9 Hz, ∑ 1 H), 7.90 and 7.94 (br s, ∑ 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 11.45 (CH3), 12.16 and 12.29 (∑ 1 CH3), 
19.16 (CH3), 20.13 and 23.72 (∑ 1 CH3), 26.32 and 26.49 (∑ 1 CH2), 29.36 (CH2), 35.34 
(CH), 35.88 and 36.00 (∑ 1 CH2), 60.98 and 61.26 (∑ 1 CH3), 110.40 and 110.72 (∑ 1 CH), 
118.00 and 118.25 (∑ 1 C), 119.33 and 119.87 (∑ 1 CH), 120.97 and 122.14 (∑ 1 C), 121.81 
and 122.29 (∑ 1 CH), 122.45 and 122.66 (∑ 1 C), 123.29 and 124.19 (∑ 1 C), 125.33 and 
125.90 (∑ 1 CH), 126.89 and 127.80 (∑ 1 C), 135.59 and 135.86 (∑ 1 C), 139.66 and 139.84 
(∑ 1 C), 147.25 and 148.39 (∑ 1 C), 169.65 and 174.11 (∑ 1 C=O) ppm. 
GC-MS (EI): m/z (%) =352 (M+, 49), 337 (5), 321 (4), 295 (100), 281 (10), 239 (20), 224 
(14), 196 (12), 195 (10).  
MS (160 °C): m/z (%) = 352 (M+, 71), 337 (2), 321 (3), 295 (100), 281 (7), 239 (17), 224 
(11), 196 (4), 195 (7), 145 (10), 43 (3), 28 (5). 
HRMS: m/z [M+] calcd for C22H28N2O2: 352.2151; found: 352.2142. 
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4-Acetamido-3-hydroxy-2-methyl-1-((S)-3-methylpent-1-yl)-9H-carbazole 31 b 
 
Carbazole 79 b (20.0 mg, 0.0567 mmol) in DCM (5 mL) was cooled 
to –78 °C and boron tribromide (1 M in DCM, 170 µL, 0.170 mmol) 
was added to the solution. After 1 h at –78 °C the solution was stirred 
1 h at 0 °C. The mixture was quenched with NH4Cl (15%, 5 mL), 
extracted with DCM (3 x 10 mL) and the combined organic layers 
were dried with magnesium sulphate. Evaporation of the solvent and 
purification of the residue by flash chromatography on silica gel (PE/Et2O = 1/10) provided 
31 b as a yellow solid.  
Yield: 17.0 mg, 0.0502 mmol, 89%. 
Melting point: 185 °C (lit. 195 – 197 °C)[57]. 
[α]20D = +5.0 (CHCl3, c = 0.5). 
UV (MeOH): λ = 241 (sh), 255 (sh), 267 (sh), 302, 341, 351 nm.  
1H NMR (500 MHz, acetone-d6): δ = 0.93 – 0.96 (m, 3 H), 1.06 (d, J = 6.5 Hz, 3 H), 1.23 – 
1.39 (m, 1 H), 1.44 – 1.61 (m, 2 H), 1.65 – 1.71 (m, 2 H), 2.42 (s, 3 H), 2.51 (s, 3 H), 2.93 – 
3.08 (m, 2 H), 7.12 (dt, J = 0.9, 8.0 Hz, 1 H), 7.33 (dt, J = 1.0, 8.1 Hz, 1 H), 7.47 (d, J = 
7.9 Hz, 1 H), 8.17 (d, J = 7.9 Hz, 1 H), 9.74 (br s, 1 H), 10.20 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, acetone-d6): δ = 11.79 (CH3), 12.58 (CH3), 19.37 (CH3), 
23.13 (CH3), 27.02 (CH2), 30.13 (CH2), 35.82 (CH), 37.22 (CH2), 111.47 (CH), 115.14 (C), 
117.77 (C), 118.87 (CH), 122.51 (CH), 122.90 (C), 123.61 (C), 125.25 (C), 125.36 (CH), 
134.50 (C), 140.90 (C), 143.85 (C), 171.72 (C=O) ppm. 
MS (220 °C): m/z (%) = 338 (M+, 70), 320 (11), 296 (75), 295 (100), 267 (8), 249 (22), 225 
(86), 195 (3), 43 (2). 
HRMS: m/z [M+] calcd for C21H26N2O2: 338.1994; found: 338.1992. 
N
H
OH
HN
O
 EXPERIMENTAL PART 
 
 - 128 -  
 
5.7 Attempts in the synthesis of antiostatin B4 (32 c) 
 
iso-Butylurea 93  
 
After iso-butylamine (88, 5 mL, 3.657 g, 0.050 mol) was added dropwise 
over 10 min to ice cold sulphuric acid (35%, 11.1 mL, 0.050 mol), 
potassium cyanate (94, 4.056 g, 0.050 mol) was added to the reaction 
mixture at room temperature. It was stirred for 1 h at 85 °C. Then the resulting precipitate was 
filtered off and washed with ethanol (45 °C, 200 mL). Evaporation of the mother liquor under 
vacuum affords iso-butylurea 93 as a colourless solid. 
Yield: 5.155 g, 0.044 mol, 89%. 
Melting point: 260 – 262 °C. 
IR (ATR): ν = 3382, 2955, 2871, 1607, 1546, 1467, 1061, 610 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.71 (d, J = 6.7 Hz, 6 H), 1.50 – 1.59 (m 1 H), 2.75 – 2.79 
(m, 2 H), 4.06 (br s, 2 H), 4.22 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 20.02 (2 CH3), 28.79 (CH), 48.33 (CH2), 
158.64 (C=O) ppm. 
MS (50 °C): m/z (%) = 116 (M+, 10), 101 (8), 73 (34), 30 (100). 
HRMS: m/z [M+] calcd for C5H12N2O: 116.0950; found: 116.0969. 
 
4-(3-iso-Butylurea-1-yl)-1-heptyl-3-methoxy-2-methyl-9H-carbazole 95 
 
To a solution of 4-(dimethylamino)pyridine (3.8 mg, 0.031 mmol) in 
acetonitrile (1 mL), treated with a solution of di-tert-butyl 
dicarbonate (9.6 mg, 0.044 mmol) in acetonitrile (1 mL), a solution 
of carbazole 78 c (10.2 mg, 0.031 mmol) in acetonitrile (3 mL) was 
added. The reaction mixture was stirred for 60 min at room 
temperature. Then iso-butylurea (93, 7.3 mg, 0.063 mmol) was added 
and the reaction mixture was stirred for further 6 h at room temperature. Then the reaction 
was quenched with NH4Cl (15%, 10 mL) and the aqueous layer was extracted with DCM (3 x 
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10 mL) and dried with MgSO4. Evaporation of the solvent and purification of the residue by 
flash chromatography on silica gel (PE/Et2O = 1/10) provided 95 as a colourless solid. 
Yield: 10.6 mg, 0.025 mmol, 80%. 
Melting point: 105 – 107 °C. 
UV (MeOH): λ = 223, 241, 264 (sh), 297, 331, 344 nm.  
IR (ATR): ν = 3295, 2954, 2925, 2855, 1648, 1542, 1456, 1389, 1293, 1255, 1145, 1109, 
1008, 738 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.67 (d, J = 6.7 Hz, 6 H), 0.87 – 0.89 (m, 3 H), 1.22 – 1.39 
(m, 6 H), 1.43 – 1.49 (m, 2 H), 1.56 – 1.71 (m, 3 H), 2.41 (s, 3 H), 2.85 – 2.88 (m, 2 H), 2.98 
– 3.01 (m, 2 H), 3.80 (s, 3 H), 4.99 – 5.01 (m, 1 H), 6.33 (s, 1 H), 7.16 –7.20 (m, 1 H), 7.37 – 
7.40 (m, 1 H), 7.43 (d, J = 8.0 Hz, 1 H), 8.00 (br s, 1 H), 8.09 (d, J = 7.9 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.42 (CH3), 14.10 (CH3), 19.86 (2 CH3), 
22.65 (CH2), 28.20 (CH), 28.82 (CH2), 29.27 (CH2), 29.33 (CH2), 29.69 (CH2), 31.84 (CH2), 
47.80 (CH2), 61.08 (CH3), 110.41 (CH), 117.37 (C), 119.76 (CH), 122.03 (C), 122.24 (C), 
122.61 (CH), 122.80 (C), 125.79 (CH), 128.10 (C), 135.98 (C), 139.58 (C), 147.39 (C), 
157.20 (C=O) ppm. 
MS (250 °C): m/z (%) = 423 (M+, 41), 350 (18), 335 (23), 324 (21), 309 (100), 265 (10), 251 
(8), 239 (31), 224 (13), 195 (8), 28 (7). 
HRMS: m/z [M+] calcd for C26H37N3O2: 423.2886; found: 423.2884. 
 
tert-Butyl 4-(3-iso-butylurea-1-yl)-1-heptyl-3-methoxy-2-methyl-9H-carbazole-9-
carboxylate 90 
 
A) Reaction with chlorocarbonyl isocyanate 87 
Carbazole 83 d (105.0 mg, 0.2473 mmol) was dissolved in THF (10 
mL) and triethylamine (0.5 mL) and chlorocarbonyl isocyanate (87, 
100 µl, 130.0 mg, 1.236 mmol) were added at room temperature. 
After 2.5 h iso-butylamine (88, 173 µl, 126.6 mg, 1.731 mmol) was 
added and the reaction mixture was stirred for further 30 min at 
room temperature. Then the reaction was quenched with water (20 mL) and HCl (20%, 10 
mL). The aqueous layer was extracted with Et2O (3 x 20 mL) and the combined organic 
layers were dried with MgSO4. Evaporation of the solvent and purification of the residue by 
flash chromatography on silica gel (PE/EtOAc = 1/1) provided 90 as a colourless solid. 
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Yield: 38.5 mg, 0.068 mmol, 27%. 
 
B) Reaction with iso-butylurea (93) via 92  
To a solution of 4-(dimethylamino)pyridine (8.6 mg, 0.071 mmol) in acetonitrile (1 mL) 
treated with a solution of di-tert-butyl dicarbonate (21.6 mg, 0.099 mmol) in acetonitrile 
(1 mL), a solution of carbazole 83 d (30.0 mg, 0.071 mmol) in acetonitrile (2 mL) was added. 
The reaction mixture was stirred for 20 min at room temperature. Then iso-butylurea (93, 16.4 
mg, 0.141 mmol) in acetonitrile (6 mL) was added at –10 °C and the reaction mixture was 
stirred 20 h. It was quenched with ammonium chloride (15%, 10 mL) and the aqueous layer 
was extracted with DCM (3 x 10 mL) and dried with MgSO4. Evaporation of the solvent and 
purification of the residue by flash chromatography on silica gel (PE/Et2O = 2/1) provided 90 
as a colourless solid. 
Yield: 33.2 mg, 0.063 mmol, 88%. 
Decomposition: 175 – 177 °C. 
UV (MeOH): λ = 234, 268, 291 nm.  
IR (ATR): ν = 3316, 2955, 2924, 2854, 1731, 1639, 1564, 1447, 1271, 1249, 1144, 1115, 
1002, 849, 743 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.69 (d, J = 6.7 Hz, 6 H), 0.85 (t, J = 7.2 Hz, 3 H), 1.18 – 
1.29 (m, 8 H), 1.50 – 1.53 (m, 2 H), 1.58 – 1.68 (m, 1 H), 1.71 (s, 9 H), 2.40 (s, 3 H), 2.93 – 
2.96 (m, 4 H), 3.77 (s, 3 H) , 4.87 (t, J = 5.8 Hz 1 H), 6.34 (s, 1 H), 7.27 (dt, J = 0.6, 7.3 Hz, 1 
H), 7.40 (dt, J = 1.1, 7.7 Hz, 1 H), 7.95 (d, J = 7.7 Hz, 1 H), 8.06 (d, J = 7.7 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.20 (CH3), 14.07 (CH3), 19.85 (2 CH3), 
22.60 (CH2), 28.20 (3 CH3), 28.74 (CH), 29.11 (CH2), 29.68 (CH2), 30.06 (CH2), 30.52 
(CH2), 31.83 (CH2), 47.81 (CH2), 60.94 (CH3), 84.17 (C), 114.78 (CH), 121.72 (C), 122.34 
(C), 122.79 (CH), 123.32 (CH), 124.87 (C), 126.95 (CH), 130.47 (C), 130.60 (C), 135.69 (C), 
140.56 (C), 150.88 (C), 151.60 (C=O), 157.04 (C=O) ppm. 
MS (300 °C): m/z (%) = 523 (M+, 30), 467 (54), 423 (28), 368 (66), 324 (22), 309 (83), 283 
(29), 239 (71), 224 (30), 57 (100). 
HRMS: m/z [M+] calcd for C31H45N3O4: 523.3410; found: 523.3409. 
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(iso-Butylaminocarbonyl)carbamic acid benzyl ester 100 
 
Triethylamine (2.1 mL, 1.534 g, 15.17 mmol) was added to a suspension 
of iso-butylurea (93, 200 mg, 1.724 mmol) in DCM (10 mL). It was cooled 
down to 0 °C and CbzCl (271 µL, 323.5 mg, 1.897 mmol) was added. 
After the reaction mixture was stirred at room temperature for 21 h, it was quenched with 
ammonium chloride solution (15%, 10 mL). The aqueous layer was extracted with DCM (3 x 
10 mL) and dried with MgSO4. Evaporation of the solvent and purification of the residue by 
flash chromatography on silica gel (PE/Et2O = 2/1) provided 100 as a colourless oil. 
Yield: 27.6 mg, 0.110 mmol, 6%.  
IR (ATR): ν = 3336, 3066, 3033, 2958, 2922, 2871, 1695, 1527, 1455, 1239, 1139, 1008, 
735, 696 cm–1. 
1H NMR (500 MHz, DMSO-d6): δ = 0.82 (d, J = 6.7 Hz, 6 H), 1.64 – 1.67 (m, 1 H), 2.81 (t, 
J = 6.4 Hz, 2 H), 5.00 (s, 2 H), 7.29 – 7.38 (m, 5 H) ppm. 
13C NMR and DEPT (125 MHz, DMSO-d6): δ = 19.96 (2 CH3), 28.29 (CH), 47.88 (CH2), 
65.06 (CH2), 127.70 (2 CH), 127.74 (CH), 128.34 (2 CH), 137.34 (C), 156.27 (2 C=O) ppm. 
MS (GC-MS): m/z (%) = 207 (M+– 43, 8), 148 (6), 116 (11), 100 (6), 92 (8), 91 (100), 65 (8).  
NH
O
NH
Cbz
 EXPERIMENTAL PART 
 
 - 132 -  
 
5.8 Synthesis of antiostatin B4 (32 c) 
 
1-Nitrobiuret 105  
 
A mixture of nitric acid (67%, 6 mL) and sulphuric acid (97%, 25 mL) 
was cooled down to 0 °C. In portions of 1 g, biuret (106, 10.0 g, 
97.0 mmol) was added to the solution over a period of 10 min. The reaction mixture was 
stirred for 1 h at 0 °C and 40 min at room temperature and then poured into ice (200 mL). 
After warming to room temperature the colourless precipitate was filtered off. It was then 
carried into water and brought to a pH-value of eight with conc. NaOH. The resulting 
precipitate was filtered off and the mother liquor was acidified to a pH-value of two for the 
purpose of precipitation of the product. It was filtered off and washed with water to afford 
compound 105 as a colourless solid. 
Yield: 7.38 g, 50.0 mmol, 51% (lit. 90%)[146]. 
Melting point: 223 °C. 
IR (ATR): ν = 3430, 3286, 3063, 2961, 2800, 1728, 1626, 1566, 1486, 1427, 1376, 1330, 
1190, 1069, 1010, 956, 751, 681, 640 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 7.27 (br d, 2 H), 9.45 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 149.09 (C=O), 153.31 (C=O) ppm. 
 
1-iso-Butylbiuret 107  
 
1-iso-Butylamine (88, 4.7 mL, 3.38 g, 46.2 mmol) was added to a 
suspension of 1-nitrobiuret (105, 2.28 g, 15.4 mmol) in ethanol 
(20 mL). It was stirred at room temperature for 2.5 h. The solvent was 
evaporated and the neat residue was heated up until it melted (140 – 150 °C, emission of gas). 
This procedure afforded 107 as a colourless solid.  
Yield: 2.435 g, 15.30 mmol, 99%. 
Sublimation temperature: 120 °C (lit. 108 – 109 °C)[150]. 
IR (ATR): ν = 3433, 3291, 3250, 2960, 2873, 1683, 1561, 1473, 1253, 1222, 649 cm–1. 
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1H NMR (500 MHz, DMSO-d6): δ = 0.83 (d, J = 6.7 Hz, 6 H), 1.64 – 1.69 (m, 1 H), 2.91 – 
2.93 (m, 2 H), 6.74 (br s, 2 H), 7.48 and 7.59 (∑ 1 H), 8.52 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, DMSO-d6): δ = 19.88 (2 CH3), 28.22 (CH), 46.13 (CH2), 
154.53 (C=O), 155.62 (C=O) ppm. 
HRMS: m/z [M+] calcd for C6H13N3O2:159.1008; found: 159.1046. 
 
5-iso-Butyl-1-nitrobiuret 108  
 
A mixture of nitric acid (69%, 1 mL) and sulphuric acid (97%, 
4 mL) was cooled down to 0 °C. It was poured to 1-iso-
butylbiuret (107, 3.200 g, 0.020 mol) and the resulting mixture 
was stirred at 0 °C for 2 h. After completion of the reaction the solution was poured into ice (5 
mL) and the resulting precipitate was filtered off. Recrystallisation from ethanol provided 108 
as a colourless solid. 
Yield: 993.6 mg, 4.866 mmol, 24%. 
Melting point: 127 – 128 °C. 
IR (ATR): ν = 3364, 3296, 2956, 2934, 2873, 2771, 1703, 1603, 1332, 1189, 735, 636, 610 
cm–1. 
1H NMR (500 MHz, DMSO-d6): δ = 0.83 (d, J = 7.0 Hz, 6 H), 1.67 – 1.75 (m, 1 H), 2.95 – 
2.97 (m, 2 H), 7.71 – 7.72 (m, 1 H), 9.48 (br s, 1 H), 11.18 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, DMSO-d6): δ = 19.83 and 20.03 (∑ 2 CH3), 28.00 and 
28.58 (∑ 1 CH), 46.50 (CH2), 149.73 and 152.45 (∑ 1 C=O), 158.74 (C=O) ppm.  
MS (200 °C): m/z (%) = 204 (M+, 0.4), 100 (21), 99 (100), 87 (14), 70 (55), 56 (14), 46 (12), 
44 (14), 43 (22), 41 (17), 30 (16), 28 (10). 
HRMS: m/z [M+] calcd for C6H12N4O4: 204.0859; found: 204.0860. 
 
1-(2-Methoxyphenyl)biuret 111  
 
o-Anisidine (110, 166.4 mg, 1.351 mmol) was added to a suspension 
of 1-nitrobiuret (105, 400.0 mg, 2.701 mmol) in water (5 mL) and the 
reaction mixture was heated at reflux for 15 min. The resulting 
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precipitate was filtered hot and subsequently washed with water (20 mL, hot) and MeOH 
(3 mL, r.t.). The precipitate was dissolved in EtOAc and evaporation of the solvent afforded 
compound 111 as a grey solid.  
Yield: 266.9 mg, 1.276 mmol, 94%. 
Melting point: 214 °C. 
IR (ATR): ν = 3406, 3241, 3178, 1671, 1601, 1560, 1507, 1454, 1434, 1332, 1170, 1123, 
1051, 1026, 918, 735, 721, 666 cm–1. 
1H NMR (500 MHz, DMSO-d6): δ = 3.83 (s, 3 H), 6.52 (br s, 2 H), 6.87 – 6.90 (m, 1 H), 
6.97 – 7.03 (m, 2 H), 8.07 – 8.09 (m, 1 H), 9.08 (br s, 1 H), 10.28 (br s, 1 H)  ppm. 
13C NMR and DEPT (125 MHz, DMSO-d6): δ = 55.82 (CH3), 110.83 (CH), 118.94 (CH), 
120.48 (CH), 122.90 (CH), 127.55 (C), 148.10 (CH), 151.80 (C=O), 155.60 (C=O) ppm. 
MS (200 °C): m/z (%) = 209 (M+, 35), 166 (9), 149 (100), 134 (16), 123 (16), 108 (30), 80 
(18). 
HRMS: m/z  [M+] calcd for C9H11N3O3: 209.0800; found: 209.0791. 
Anal. calcd for C9H11N3O3: C 51.67, H 5.30, N 20.09; found: C 51.09, H 5.09, N 20.00%. 
 
5-iso-Butyl-1-(2-methoxybenzene)biuret 112 
 
o-Anisidine (110, 15.1 mg, 0.123 mmol) was added to a 
suspension of biuret 108 (50.0 mg, 0.245 mmol) in water 
(1 mL) and the reaction mixture was heated at reflux for 20 min. 
The resulting precipitate was filtered off (still hot) and washed 
with water (1 mL, hot), and MeOH (1 mL, r.t.). The precipitate was dissolved in EtOAc (50 
mL) and extracted with water once. The organic layer was dried wih MgSO4. Evaporation of 
the solvent afforded compound 112 as a colourless solid.  
Yield: 32.6 mg, 0.123 mmol, 100%. 
Melting point: 169 – 170 °C. 
IR (ATR): ν = 3292, 2950, 2871, 1691, 1606, 1530, 1498, 1459, 1434, 1248, 1197, 1174, 
1026, 737, 691 cm–1. 
1H NMR (500 MHz, DMSO-d6): δ = 0.87 (d, J = 6.7 Hz, 6 H), 1.67 – 1.75 (m, 1 H), 2.96 (d, 
J = 6.3 Hz, 2 H), 3.83 (s, 3 H), 6.88 (dt, J = 1.7, 7.5 Hz, 1 H), 6.90 – 7.03 (m, 2 H), 7.10 (s, 1 
H), 8.09 (dd, J = 8.0, 1.2 Hz, 1 H), 9.05 (s, 1 H), 10.23 (s, 1 H) ppm. 
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13C NMR and DEPT (125 MHz, DMSO-d6): δ = 19.86 (2 CH3), 28.15 (CH), 46.21 (CH2), 
55.82 (CH3), 110.79 (CH), 118.88 (CH), 120.49 (CH), 122.90 (CH), 127.53 (C), 148.07 (C), 
151.75 (C=O), 154.67 (C=O) ppm. 
MS (200 °C): m/z = 265 (M+, 48), 222 (6), 192 (3), 149 (100), 134 (9), 123 (20), 108 (18).  
HRMS: m/z  [M+] calcd for C13H19N3O3: 265.1426; found: 265.1411. 
 
1-Heptyl-3-methoxy-2-methyl-4-nitro-9H-carbazole 77 c 
 
A) Synthesis by cleavage of the Boc group of 82 d: 
Carbazole 82 d (22.1 mg, 0.049 mmol) was heated neat to 180 – 190 °C 
under argon atmosphere for 45 min. Cooling down to room temperature 
provided compound 77 c as a yellow solid without further purification. 
Yield: 17.2 mg, 0.049 mmol, 100%. 
 
B) Synthesis by nitration with nitronium tetrafluoroborate 
A solution of carbazole 41 d (98.4 mg, 0.318 mmol) in THF (15 mL) was added to a solution 
of nitronium tetrafluoroborate (67.7 mg, 0.509 mmol) in THF (15 mL) at a temperature of      
–50 °C. After 30 min a further portion of nitronium tetrafluoroborate (22.5 mg, 0.169 mmol) 
was added to the reaction mixture and the temperature was increased to –20 °C. After stirring 
for 17 h, the mixture was filtered over a celite®/silica gel column with diethyl ether (1 L) and 
the solvent was removed under reduced pressure. The residue was purified by flash 
chromatography on silica gel (PE/Et2O = 10/1) and provided 77 c as a yellow solid. 
Yield: 72.8 mg, 0.205 mmol, 65%. 
Spectroscopic data see chapter 5.3. 
 
4-Amino-1-heptyl-3-methoxy-2-methyl-9H-carbazole 78 c 
 
Palladium on activated charcoal (30 wt%, 19.4 mg) in EtOAc (5 mL) 
was added to a solution of carbazole 77 c (38.9 mg, 0.110 mmol) in 
EtOAc (5 mL). The reaction mixture was stirred under hydrogen 
atmosphere (1 atm) at room temperature for 5 d. Then the reaction 
mixture was filtered over celite® with Et2O (0.5 L). Evaporation of the solvent afforded 
compound 78 c as a yellow solid. 
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Yield: 35.5 mg, 0.109 mmol, 100%. 
Melting point: 85 °C. 
UV (MeOH): λ = 228, 249, 292, 347 nm. 
Fluorescence (0.6 mg/100 mL MeOH): λex =  346 nm, λem = 400 nm. 
IR (ATR): ν = 3425, 3339, 3057, 2952, 2924, 2850, 1610, 1503, 1465, 1409, 1294, 1203, 
1176, 1108, 1052, 1004, 781, 736, 715, 670, 623 cm–1.  
1H NMR (500 MHz, CDCl3): δ = 0.90 (t, J = 6.7 Hz, 3 H), 1.27 – 1.39 (m, 6 H), 1.41 – 1.47 
(m, 2 H), 1.59 – 1.65 (m, 2 H), 2.41 (s, 3 H), 2.79 (t, J = 7.9 Hz, 2 H), 3.81 (s, 3 H), 4.35 (br s, 
2 H), 7.21 (t, J = 7.5 Hz, 1 H), 7.35 (t, J = 7.6 Hz, 1 H), 7.41 (d, J = 8.0 Hz, 1 H), 7.83 (s, 1 
H), 7.95 (d, J = 7.8 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.23 (CH3), 14.10 (CH3), 22.67 (CH2), 28.28 
(CH2), 29.33 (CH2), 29.84 (CH2), 29.99 (CH2), 31.88 (CH2), 60.01 (CH3), 109.40 (C), 110.13 
(CH), 113.18 (C), 119.07 (CH), 120.61 (CH), 123.73 (C), 124.11 (CH), 127.25 (C), 132.51 
(C), 136.07 (C), 139.16 (C), 139.24 (C) ppm.  
MS (200 °C): m/z (%) = 324 (M+, 65), 309 (100), 239 (46), 224 (17), 195 (11). 
HRMS: m/z [M+] calcd for C21H28N2O: 324.2202; found: 324.2184. 
 
4-(5-iso-Butylbiuret-1-yl)-1-heptyl-3-methoxy-2-methyl-9H-carbazole 85 c 
 
To a refluxing solution of compound 78 c (42.0 mg, 
0.129 mmol) in acetonitrile (20 mL), biuret 108 (79.2 mg, 0.388 
mmol) in acetonitrile (10 mL) was added continuously over 3 h. 
The resulting mixture was then stirred for further 2 h at reflux 
temperature. The mixture was cooled to room temperature and 
quenched with water (20 mL), extracted with DCM (3 x 20 mL) 
and the combined organic layers were dried with magnesium sulphate. Evaporation of the 
solvent and purification of the residue by flash chromatography on silica gel (DCM/MeOH = 
100/1) provided 85 c as a yellow solid. 
Yield: 38.4 mg, 0.118 mmol, 91%. 
Melting point: 87 – 88 °C. 
UV (MeOH): λ = 241, 264 (sh), 298, 331, 344 nm. 
Fluorescence (1.2 mg/100 mL MeOH): λex =  344 nm, λem = 372 nm.  
IR (ATR): ν = 3292, 2951, 2926, 2856, 1697, 1536, 1456, 1222, 1107, 761, 738, 643 cm–1. 
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1H NMR (500 MHz, acetone-d6): δ = 0.90 – 0.95 (m, 9 H), 1.28 – 1.45 (m, 6 H), 1.49 – 1.55 
(m, 2 H), 1.65 – 1.70 (m, 2 H), 1.79 – 1.82 (m, 1 H), 2.43 (s, 3 H), 2.97 (t, J = 8.1 Hz, 2 H), 
3.08 – 3.11 (m, 2 H), 3.80 (s, 3 H), 7.10 – 7.13 (m, 1 H), 7.32 – 7.35 (m, 1 H), 7.45 (d, J = 8.1 
Hz, 1 H), 7.98 (d, J = 7.9 Hz, 1 H), 10.26 (br s, 1 H) ppm.  
13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.46 (CH3), 14.32 (CH3), 20.21 (2 CH3), 
23.28 (CH2), 29.25 (CH2), 29.38 (CH), 30.04 (CH2), 30.28 (CH2), 30.62 (CH2), 32.63 (CH2), 
47.50 (CH2), 61.19 (CH3), 111.35 (CH), 119.20 (CH), 122.05 (C), 123.11 (CH), 123.60 (C), 
125.75 (CH), 127.68 (C), 136.94 (C), 137.06 (C), 141.19 (C), 141.31 (C), 148.57 (C), 154.70 
(C=O), 155.75 (C=O) ppm. 
MS (320 °C): m/z (%) = 466 (M+, 1), 350 (40), 335 (41), 324 (43), 309 (100), 265 (16), 239 
(33), 224 (14), 195 (11), 172 (8), 99 (6).  
HRMS: m/z [M+] calcd for C27H38N4O3: 466.2944; found: 466.2929. 
Anal. calcd for C27H38N4O3: C 69.50, H 8.21, N 12.01; found: C 68.75, H 8.33, N 11.62%. 
 
4-(5-iso-Butylbiuret-1-yl)-1-heptyl-3-hydroxy-2-methyl-9H-carbazole 32 d 
 
Carbazole 85 c (14.0 mg, 0.030 mmol) in DCM (3 mL) was 
cooled to –78 °C and boron tribromide (1 M in DCM, 99 µL, 
0.099 mmol) was added to the solution. After 2 h at –78 °C the 
brown solution was stirred at 0 °C for 90 min. The mixture was 
quenched with water (10 mL), extracted with DCM (3 x 10 mL) 
and the combined organic layers were dried with magnesium 
sulphate. Evaporation of the solvent and purification of the residue by flash chromatography 
on silica gel (PE/Et2O = 1/10) provided 32 d as a yellow solid.  
Yield: 10.0 mg, 0.022 mmol, 74%. 
Melting point: 117 – 120 °C (lit. 118 – 120 °C)[57]. 
UV (MeOH): λ = 239, 225 (sh), 266 (sh), 290 (sh), 301, 343 nm.  
Fluorescence (0.5 mg/100 mL MeOH): λex =  301 nm, λem = 381 nm.  
IR (ATR): ν = 3480, 3312, 3119, 2958, 2923, 2852, 1703, 1662, 1537, 1456, 1417, 1232, 
1162, 1107, 1049, 745, 721, 662 cm–1. 
1H NMR (500 MHz, acetone-d6): δ = 0.88 – 0.92 (m, 3 H), 1.02 (d, J = 6.7 Hz, 6 H), 1.28 – 
1.43 (m, 6 H), 1.48 – 1.54 (m, 2 H), 1.66 – 1.72 (m, 2 H), 1.89 – 1.95 (m, 1 H), 2.43 (s, 3 H), 
3.00 – 3.03 (m, 2 H), 3.22 – 3.25 (m, 2 H), 6.90 (br s, 1 H), 7.12 – 7.15 (m, 1 H), 7.33 – 7.37 
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(m, 1 H), 7.48 (d, J = 8.1 Hz, 1 H), 8.27 (br s, 1 H), 8.44 (d, J = 7.5 Hz, 1 H), 8.91 (br s, 1 H), 
10.23 (br s, 1 H), 10.94 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.78 (CH3), 14.33 (CH3), 20.21 (2 CH3), 
23.29 (CH2), 29.17 (CH2), 29.51 (CH), 30.05 (CH2), 30.47 (CH2), 30.57 (CH2), 32.64 (CH2), 
47.59 (CH2), 111.45 (CH), 114.90 (C), 116.67 (C), 119.11 (CH), 121.99 (CH), 122.81 (C), 
122.92 (C), 125.44 (CH), 125.52 (C), 134.71 (C), 140.84 (C), 143.00 (C), 154.73 (C=O), 
155.99 (C=O) ppm. 
MS (300 °C): m/z (%) = 453 (M+ + 1, 0.2), 452 (M+, 0.2), 338 (13), 337 (39), 336 (51), 312 
(14), 311 (30), 310 (29), 253 (19), 252 (66), 251 (100), 227 (27), 226 (63), 225 (62), 172 (14), 
57 (6), 30 (11). 
HRMS: m/z [M+] calcd for C26H36N4O3: 452.2787; found: 452.2790.  
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5.9 Synthesis of antiostatins B2, B3 and B5 (32 a, 32 b and 32 d) 
 
tert-Butyl 1-hexyl-3-methoxy-2-methyl-9H-carbazole-9-carboxylate 71 e 
 
A solution of di-tert-butyl oxydiformate (409.0 mg, 1.869 mmol) in 
acetonitrile (2 mL) was added to a solution of carbazole 41 e 
(276.0 mg, 0.934 mmol) in acetonitrile (8 mL). 4-
(Dimethylamino)pyridine (114.2 mg, 0.934 mmol) was added to the 
solution and the reaction mixture was stirred at room temperature for 18.5 h. Evaporation of 
the solvent and purification of the residue by flash chromatography on silica gel (PE/Et2O = 
15/1) provided 71 e as a colourless solid. 
Yield: 367.0 mg, 0.928 mmol, 99%. 
Decomposition: 55 – 56 °C. 
UV (MeOH): λ = 232, 265, 296, 325 nm. 
IR (ATR): ν = 2962, 2927, 2849, 1737, 1447, 1348, 1291, 1145, 1117, 771, 748, 666 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.83 – 0.86 (m, 3 H), 1.25 – 1.30 (m, 6 H), 1.47 – 1.53 (m, 
2 H), 1.68 (s, 9 H), 2.34 (s, 3 H), 2.97 – 3.01 (m, 2 H), 3.93 (s, 3 H), 7.24 (s, 1 H), 7.27 – 7.30 
(m, 1 H), 7.35 – 7.39 (m, 1 H), 7.86 (d, J = 7.6 Hz, 1 H), 7.97 (d, J = 8.3 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ =12.67 (CH3), 14.07 (CH3), 22.65 (CH2), 28.22 
(3 CH3), 28.65 (CH2), 29.75 (CH2), 30.37 (CH2), 31.68 (CH2), 55.91 (CH3), 83.41 (C), 98.18 
(CH), 115.25 (CH), 119.06 (CH), 122.63 (CH), 125.53 (C), 125.56 (C), 126.14 (CH), 126.98 
(C), 131.56 (C), 132.97 (C), 140.66 (C), 151.83 (C), 155.37 (C=O) ppm. 
GC-MS (EI): m/z (%) = 395 (M+, 7), 339 (32), 295 (100), 280 (9), 224 (31), 210 (13), 194 
(6), 180 (10), 167 (10), 57 (12). 
Anal. calcd for C25H33NO3: C 75.91, H 8.41, N 3.54; found: C 76.09, H 8.17, N 3.63%.  
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tert-Butyl 1-hexyl-3-methoxy-2-methyl-4-nitro-9H-carbazole-9-carboxylate 82 e  
 
Acetic anhydride (947 mg, 9.28 mmol) was added to a suspension of 
claycop (696 mg) and Et2O (20 mL). Carbazole 71 e (367.0 mg, 0.928 
mmol) dissolved in Et2O (10 mL) was added over 10 min. The 
suspension was allowed to stir for 2.5 h. After filtration over silica gel 
with Et2O (0.5 L) the solvent was evaporated and the residue purified by flash 
chromatography on silica gel (PE/Et2O = 15/1) to afford compound 82 e as a yellow solid. 
Yield: 369.2 mg, 0.838 mmol, 90%. 
Decomposition: 86 – 87 °C. 
UV (MeOH): λ = 229, 263 (sh), 290 nm.  
IR (ATR): ν = 2956, 2928, 2855, 1736, 1525, 1466,1369, 1240, 1147, 1133, 1116, 844, 742 
cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.83 – 0.86 (m, 3 H), 1.23 – 1.28 (m, 6 H), 1.45 – 1.51 (m, 
2 H), 1.69 (s, 9 H), 2.43 (s, 3 H), 2.97 – 3.00 (m, 2 H), 3.88 (s, 3 H), 7.28 – 7.31 (m, 1 H), 
7.45 – 7.48 (m, 1 H), 7.68 (d, J = 7.9 Hz, 1 H), 7.97 (d, J = 8.3 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.15 (CH3), 14.03 (CH3), 22.59 (CH2), 28.13 
(3 CH3), 28.19 (CH2), 29.72 (CH2), 30.78 (CH2), 31.60 (CH2), 62.91 (CH3), 84.71 (C), 114.93 
(CH), 117.31 (C), 121.13 (CH), 121.89 (C), 123.55 (CH), 128.10 (CH), 130.73 (C), 134.66 
(C), 135.34 (C), 136.69 (C), 141.03 (C), 146.76 (C), 151.19 (C=O) ppm. 
GC-MS (EI): m/z (%) = 340 (M+ – 100, 100), 325 (22), 269 (9), 238 (9), 224 (10), 210 (6), 
194 (18), 180 (13), 167 (8), 55 (2). 
Anal. calcd for C25H32N2O5: C 68.16, H 7.32, N 6.36; found: C 67.81, H 7.17, N 6.34%.  
 
1-Hexyl-3-methoxy-2-methyl-4-nitro-9H-carbazole 77 a 
 
Carbazole 82 e (300.0 mg, 0.681 mmol) was heated neat to 180 – 
190 °C under argon atmosphere for 45 min. Cooling to room 
temperature provided compound 77 a as a yellow compound. 
Yield: 231.0 mg, 0.679 mmol, 100%. 
Decomposition: 122 °C. 
UV (MeOH): λ = 230, 249, 297 nm. 
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IR (ATR): ν = 3391, 2955, 2923, 2854, 1508, 1358, 1313, 1272, 1112, 1094, 1009, 736 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.89 – 0.91 (m, 3 H), 1.24 – 1.37 (m, 4 H), 1.44 – 1.50 (m, 
2 H), 1.61 – 1.67 (m, 2 H), 2.43 (s, 3 H), 2.87 – 2.91 (m, 2 H), 3.90 (s, 3 H), 7.18 – 7.21 (m, 1 
H), 7.42 – 7.46 (m, 2 H), 7.86 (d, J = 8.0 Hz, 1 H), 8.04 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.35 (CH3), 14.07 (CH3), 22.62 (CH2), 29.00 
(CH2), 29.03 (CH2), 29.69 (CH2), 31.73 (CH2), 63.02 (CH3), 110.89 (CH), 112.54 (C), 119.76 
(C), 120.24 (CH), 121.88 (CH), 126.98 (CH), 127.68 (C), 128.31 (C), 135.55 (C), 136.87 (C), 
139.90 (C), 144.43 (C) ppm.  
GC-MS (EI): m/z (%) = 340 (M+ – 100, 100), 325 (24), 269 (12), 238 (10), 224 (13), 210 (8), 
194 (20), 180 (13), 167 (9), 55 (2). 
Anal. calcd for C20H24N2O3: C 70.56, H 7.11, N 8.23; found: C 70.50, H 7.28, N 8.41%. 
 
4-Amino-1-hexyl-3-methoxy-2-methyl-9H-carbazole 78 a  
 
Palladium on activated charcoal (30 wt%, 14.0 mg) in EtOAc (8 mL) 
was added to carbazole 77 a (26.9 mg, 0.079 mmol). The reaction 
mixture was stirred under hydrogen atmosphere (1 atm) at room 
temperature for 1 d. Then the reaction mixture was filtered over celite® 
with Et2O (0.5 L). Evaporation of the solvent and purification of the residue by flash 
chromatography on silica gel (PE/Et2O = 2/1) afforded compound 78 a as a yellow oil. 
Yield: 20.0 mg, 0.064 mmol, 82%. 
Melting point: 110 °C. 
UV (MeOH): λ = 228, 249, 292, 346 nm. 
IR (ATR): ν = 3426, 3340, 3058, 2951, 2925, 2852, 1609, 1502, 1453, 1409, 1299, 1203, 
1177, 1109, 1052, 1005, 781, 735, 716, 669, 642, 623 cm–1.  
1H NMR (500 MHz, CDCl3): δ = 0.89 (m, 3 H), 1.28 – 1.35 (m, 4 H), 1.43 – 1.46 (m, 2 H), 
1.57 – 1.62 (m, 2 H), 2.39 (s, 3 H), 2.76 – 2.78 (m, 2 H), 3.79 (s, 3 H), 4.34 (br s, 2 H), 7.18 – 
7.21 (m, 1 H), 7.32 – 7.35 (m, 1 H), 7.41 (d, J = 8.0 Hz, 1 H), 7.78 (s, 1 H), 7.93 (d, J = 7.8 
Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.24 (CH3), 14.12 (CH3), 22.70 (CH2), 28.31 
(CH2), 29.72 (CH2), 29.81 (CH2), 31.87 (CH2), 60.04 (CH3), 109.40 (C), 110.14 (CH), 113.18 
(C), 119.10 (CH), 120.63 (CH), 123.74 (C), 124.14 (CH), 127.28 (C), 132.53 (C), 136.06 (C), 
139.17 (C), 139.24 (C) ppm.  
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GC-MS (EI): m/z (%) = 310 (M+, 38), 295 (100), 239 (34), 224 (19), 195 (14). 
MS (150 °C): m/z (%) = 310 (M+, 45), 295 (100), 239 (35), 224 (15), 195 (12). 
HRMS: m/z [M+] calcd for C20H26N2O: 310.2045; found: 310.2034.  
 
4-(5-iso-Butylbiuret-1-yl)-1-hexyl-3-methoxy-2-methyl-9H-carbazole 85 a 
 
To a solution of compound 78 d (24.5 mg, 0.079 mmol) in 
acetonitrile (10 mL) at reflux, biuret 108 (48.5 mg, 0.237 mmol) 
in acetonitrile (10 mL) was added continuously over 3 h. The 
resulting mixture was stirred at reflux for further 1.5 h. The 
mixture was cooled to room temperature and quenched with 
water (10 mL), extracted with DCM (3 x 15 mL) and the organic 
layer was dried with magnesium sulphate. Evaporation of the solvent and purification of the 
residue by flash chromatography on silica gel (PE/Et2O = 2/1) provided 85 a as a yellow 
solid. 
Yield: 31.1 mg, 0.069 mmol, 87%. 
Melting point: 178 °C. 
UV (MeOH): λ = 242, 264 (sh), 287 (sh), 298, 331, 344 nm. 
IR (ATR): ν = 3336, 2954, 2922, 2853, 1724, 1686, 1500, 1458, 1235, 737 cm–1. 
1H NMR (500 MHz, acetone-d6): δ = 0.90 – 0.97 (m, 3 H), 0.94 (d, J = 6.7 Hz, 6 H), 1.27 – 
1.40 (m, 4 H), 1.50 – 1.55 (m, 2 H), 1.65 – 1.70 (m, 2 H), 1.72 – 1.84 (m, 1 H), 2.43 (s, 3 H), 
2.98 – 3.01 (m, 2 H), 3.09 – 3.12 (m, 2 H), 3.80 (s, 3 H), 7.10 – 7.13 (m, 1 H), 7.32 – 7.36 (m, 
1 H), 7.46 (d, J = 8.1 Hz, 1 H), 7.98 (d, J = 7.9 Hz, 1 H), 8.68 (br s, 1 H), 9.38 (br s, 1 H), 
10.27 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.47 (CH3), 14.34 (CH3), 20.21 (2 CH3), 
23.35 (CH2), 29.27 (CH2), 29.40 (CH), 30.24 (CH2), 30.35 (CH2), 32.57 (CH2), 47.51 (CH2), 
61.20 (CH3), 111.35 (CH), 119.21 (CH), 122.07 (C), 123.13 (CH), 123.61 (C), 125.76 (CH), 
127.07 (C), 136.95 (C), 137.07 (C), 141.19 (C), 141.32 (C), 148.58 (C), 154.65 (C=O), 
155.72 (C=O) ppm. 
MS (250 °C): m/z (%) = 452 (M+, 2), 336 (38), 321 (40), 310 (47), 295 (100), 265 (16), 239 
(35), 224 (16), 195 (12), 172 (15).   
HRMS: m/z [M+] calcd for C26H36N4O3: 452.2787; found: 452.2802. 
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4-(5-iso-Butylbiuret-1-yl)-1-hexyl-3-hydroxy-2-methyl-9H-carbazole 32 a 
 
Carbazole 85 a (32.0 mg, 0.071 mmol) in DCM (5 mL) was 
cooled to –78 °C and BBr3 (1 M in DCM, 233 µl, 0.233 mmol) 
added to the solution. After 1 h at –78 °C, the solution was 
stirred at 0 °C for another 3.5 h. The mixture was quenched with 
water (10 mL), extracted with DCM (3 x 10 mL) and the 
combined organic layers were dried with magnesium sulphate. 
Evaporation of the solvent and purification of the residue by flash chromatography on silica 
gel (PE/Et2O = 1/10) provided 32 a as a yellow solid.  
Yield: 24.5 mg, 0.056 mmol, 79%. 
Melting point: 119 – 120°C (lit. 119 – 120 °C)[57]. 
UV (MeOH): λ = 239, 254 (sh), 265 (sh), 303, 341, 352 nm.  
IR (ATR): ν = 3313, 2956, 2926, 2857, 2467, 1663, 1531, 1459, 1227, 737 cm–1. 
1H NMR (500 MHz, acetone-d6): δ = 0.87 – 0.98 (m, 3 H), 1.02 (d, J = 6.7 Hz, 6 H), 1.29 – 
1.41 (m, 4 H), 1.45 – 1.54 (m, 2 H), 1.66 – 1.72 (m, 2 H), 1.90 – 1.96 (m, 1 H), 2.43 (s, 3 H), 
3.00 – 3.03 (m, 2 H), 3.23 (d, J = 6.6 Hz, 2 H), 7.12 – 7.15 (m, 1 H), 7.34 – 7.37 (m, 1 H), 
7.49 (d, J = 8.1 Hz, 1 H), 8.44 (d, J = 7.5 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.76 (CH3), 14.33 (CH3), 20.20 (2 CH3), 
23.34 (CH2), 29.17 (CH2), 29.49 (CH), 30.26 (CH2), 30.42 (CH2), 32.58 (CH2), 47.58 (CH2), 
111.44 (CH), 114.91 (C), 116.64 (C), 119.10 (CH), 121.98 (CH), 122.80 (C), 122.92 (C), 
125.44 (CH), 125.50 (C), 134.70 (C), 140.83 (C), 143.00 (C), 154.73 (C=O), 155.98 (C=O) 
ppm. 
MS (300 °C): m/z (%) = 438 (M+, 0.3), 322 (43), 296 (27), 251 (100), 195 (10), 172 (24). 
HRMS: m/z [M+  – 116] calcd for C20H22N2O2: 322.1681; found: 322.1679. 
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3-Methoxy-2-methyl-1-(5-methylhex-1-yl)-4-nitro-9H-carbazole 77 b  
 
Carbazole 82 c (400.0 mg, 0.880 mmol) was heated neat to 180  – 
190 °C under argon atmosphere for 45 min. Cooling to room 
temperature provided compound 77 b as a yellow solid without further 
purification. 
Yield: 311.1 mg, 0.879 mmol, 100%. 
Melting point: 120 °C. 
UV (MeOH): λ = 230, 249, 279, 296 nm.  
IR (ATR): ν = 3401, 2951, 2925, 2856, 1509, 1363, 1315, 1275, 1112, 1094, 1010, 737 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 (d, J = 6.6 Hz, 6 H), 1.21 – 1.33 (m, 2 H), 1.43 – 1.49 
(m, 2 H), 1.51 – 1.64 (m, 3 H), 2.41 (s, 3 H), 2.85 – 2.88 (m, 2 H), 3.90 (s, 3 H), 7.19 (dt, J = 
2.1, 6.0 Hz, 1 H), 7.39 – 7.44 (m, 2 H), 7.85 (d, J = 8.0 Hz, 1 H), 8.04 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.31 (CH3), 22.59 (2 CH3), 27.79 (CH2), 
27.97 (CH), 28.99 (CH2), 29.23 (CH2), 38.76 (CH2), 62.98 (CH3), 110.92 (CH), 112.45 (C), 
119.68 (C), 120.13 (CH), 121.76 (CH), 126.91 (CH), 127.76 (C), 128.21 (C), 135.51 (C), 
136.77 (C), 139.90 (C), 144.35 (C) ppm.  
GC-MS (EI): m/z (%) = 354 (M+, 100), 339 (13), 320 (4), 309 (4), 281 (4), 269 (12), 238 (7), 
224 (11), 210 (8), 194 (18), 192 (10), 180 (15), 167 (5), 152 (4). 
MS (200 °C): m/z (%) = 354 (M+, 100), 340 (10), 293 (3), 269 (8), 238 (5), 224 (6), 194 (12), 
180 (7), 167 (5), 149 (10), 43 (6). 
HRMS: m/z [M+] calcd for C21H26N2O3: 354.1943; found: 354.1932. 
 
4-Amino-3-methoxy-2-methyl-1-(5-methylhex-1-yl)-9H-carbazole 78 b  
 
Palladium on activated charcoal (30 wt%, 16.0 mg) in EtOAc (15 mL) 
was added to carbazole 77 b (32.0 mg, 0.090 mmol). The reaction 
mixture was stirred under hydrogen pressure (1 atm) at room 
temperature for 1 d. Then the reacton mixture was filtered over celite® 
with Et2O (0.5 L). Evaporation of the solvent and purification of the 
residue by flash chromatography on silica gel (PE/Et2O = 2/1) afforded compound 78 b as a 
yellow oil. 
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Yield: 28.0 mg, 0.086 mmol, 96%. 
Melting point: 70 °C. 
UV (MeOH): λ = 228, 250, 281, 292, 346 nm.  
IR (ATR): ν = 3369, 3346, 2928, 2865, 1731, 1601, 1505, 1456, 1440, 1411, 1297, 1107, 
1198, 998, 780, 733 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.88 (d, J = 6.6 Hz, 6 H), 1.22 – 1.26 (m, 3 H), 1.41 – 1.47 
(m, 2 H), 1.52 – 1.62 (m, 2 H), 2.40 (s, 3 H), 2.77 – 2.80 (m, 2 H), 3.80 (s, 3 H), 4.34 (br s, 2 
H), 7.18 – 7.22 (m, 1 H), 7.32 – 7.36 (m, 1 H), 7.41 (d, J = 8.0 Hz, 1 H), 7.81 (br s, 1 H), 7.94 
(d, J = 7.8 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.24 (CH3), 22.66 (2 CH3), 27.84 (CH2), 
28.03 (CH), 28.34 (CH2), 30.08 (CH2), 38.93 (CH2), 60.03 (CH3), 109.41 (C), 110.14 (CH), 
113.19 (C), 119.09 (CH), 120.62 (CH), 123.73 (C), 124.13 (CH), 127.25 (C), 132.51 (C), 
136.05 (C), 139.17 (C), 139.24 (C) ppm. 
GC-MS (EI): m/z (%) = 324 (M+, 37), 309 (100), 239 (36), 224 (18), 195 (14). 
Anal. calcd for C21H28N2O: C 77.74, H 8.70, N 8.63; found: C 77.33, H 8.98, N 7.87%. 
 
4-(5-iso-Butylbiuret-1-yl)-3-methoxy-2-methyl-1-(5-methylhex-1-yl)-9H-carbazole 85 b  
 
Biuret 108 (150.0 mg, 0.732 mmol) in actonitrile (20 mL) was 
continuously added over 3 h to a solution of compound 78 b 
(79.2 mg, 0.244 mmol) in acetonitrile (10 mL) at reflux 
temperatures. The resulting mixture was then stirred at reflux for 
further 1.5 h. The mixture was cooled to room temperature and 
quenched with water (20 mL), extracted with DCM (3 x 20 mL) 
and the organic layer was dried with magnesium sulphate. 
Evaporation of the solvent and purification of the residue by flash chromatography on silica 
gel (DCM/MeOH = 100/1) provided 85 b as a yellow solid. 
Yield: 94.3 mg, 0.202 mmol, 83%. 
Melting point: 135 °C. 
UV (MeOH): λ = 218, 241, 264 (sh), 286 (sh), 298, 331, 345 nm. 
IR (ATR): ν = 3407, 3272, 2954, 2926, 2870, 1701, 1522, 1458, 1285, 1225, 1105, 1007, 
760, 737 cm–1. 
N
H
OMe
HN
(CH2)4
NH
NH
O
O
 EXPERIMENTAL PART 
 
 - 146 -  
1H NMR (500 MHz, acetone-d6): δ = 0.92 (d, J = 6.2 Hz, 6 H), 0.93 (d, J = 6.7 Hz, 6 H), 
1.22 – 1.32 (m, 2 H), 1.50 – 1.61 (m, 3 H), 1.62 – 1.70 (m, 2 H), 1.76 – 1.82 (m, 1 H), 2.43 (s, 
3 H), 2.98 – 3.01 (m, 2 H), 3.07 – 3.10 (m, 2 H), 3.80 (s, 3 H), 7.10 – 7.13 (m, 1 H), 7.32 – 
7.36 (m, 1 H), 7.45 (d, J = 8.1 Hz, 1 H), 7.98 (d, J = 7.9 Hz, 1 H), 10.27 (br s, 1 H) ppm.  
13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.48 (CH3), 20.22 (2 CH3), 22.92 (2 
CH3), 28.50 (CH2), 28.74 (CH), 29.31 (CH2), 29.40 (CH), 30.52 (CH2), 39.65 (CH2), 47.51 
(CH2), 61.19 (CH3), 111.34 (CH), 119.22 (CH), 122.11 (C), 123.14 (CH), 123.62 (C), 125.77 
(CH), 127.67 (C), 136.94 (C), 137.06 (C), 141.19 (C), 141.32 (C), 148.57 (C), 154.66 (C=O), 
155.74 (C=O) ppm. 
MS (320 °C): m/z (%) = 466 (M+, 1), 350 (39), 335 (34), 324 (52), 310 (64), 309 (100), 265 
(16), 239 (37), 224 (18), 195 (11), 172 (17), 99 (13), 30 (15). 
HRMS: m/z [M+] calcd for C27H38N4O3: 466.2944; found: 466.2926. 
 
4-(5-iso-Butylbiuret-1-yl)-3-hydroxy-2-methyl-1-(5-methylhex-1-yl)-9H-carbazole 32 b 
 
Carbazole 85 b (13.0 mg, 0.279 mmol) in DCM (5 mL) was 
cooled to –78 °C and BBr3 (1 M in DCM, 92 µL, 0.919 mmol) 
was added to the solution. After 1 h at –78 °C the solution was 
stirred at 0 °C for further 3 h. The mixture was quenched with 
water (10 mL), extracted with DCM (3 x 10 mL) and the 
combined organic layers were dried with magnesium sulphate. 
Evaporation of the solvent and purification of the residue by 
flash chromatography on silica gel (PE/Et2O = 1/10) provided 32 b as a yellow solid.  
Yield: 11.8 mg, 0.026 mmol, 94%. 
Melting point: 119 – 120 °C (lit. 117 – 118 °C)[57]. 
UV (MeOH): λ = 242 (sh), 267 (sh), 302, 340, 352 nm.  
IR (ATR): ν = 3319, 2954, 2926, 2869, 1669, 1527, 1228, 737 cm–1. 
1H NMR (500 MHz, acetone-d6): δ = 0.91 (d, J = 6.6 Hz, 6 H), 1.03 (d, J = 6.6 Hz, 6 H), 
1.24 – 1.41 (m, 2 H), 1.49 – 1.61 (m, 3 H), 1.63 – 1.71 (m, 2 H), 1.90 – 1.98 (m, 1 H), 2.43 (s, 
3 H), 3.01 – 3.04 (m, 2 H), 3.23 – 3.24 (m, 2 H), 6.89 (br s, 1 H), 7.12 – 7.15 (m, 1 H), 7.33 – 
7.37 (m, 1 H), 7.48 (d, J = 8.1 Hz, 1 H), 8.28 (br s, 1 H), 8.44 (d, J = 7.5 Hz, 1 H), 8.89 (br s, 
1 H), 10.24 (br s, 1 H), 10.93 (br s, 1 H) ppm. 
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13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.77 (CH3), 20.20 (2 CH3), 20.91 (2 
CH3), 28.43 (CH2), 28.74 (CH), 29.21 (CH2), 29.49 (CH), 30.70 (CH2), 39.70 (CH2), 47.59 
and 47.71 (∑ 1 CH2), 111.44 and 111.50 (∑ 1 CH), 114.92 (C), 116.70 (C), 119.11 (CH), 
121.98 (CH), 122.81 (C), 122.85 (C), 125.44 (CH), 125.56 (C), 134.69 and 134.81 (∑ 1 C), 
140.83 and 140.96 (∑ 1 C), 143.00 (C), 154.78 (C=O), 155.04 (C=O) ppm. 
MS (300 °C): m/z (%) = 452 (M+, 0.5), 336 (41), 310 (35), 251 (93), 225 (100), 195 (10), 172 
(27), 99 (7), 73 (8). 
HRMS: m/z [M+ – 116] calcd for C21H24N2O2: 452.2787; found: 336.1821. 
 
tert-Butyl 3-methoxy-2-methyl-1-(6-methylheptyl)-9H-carbazole-9-carboxylate 71 f  
 
To a solution of di-tert-butyl oxydiformate (1275.0 mg, 5.820 mmol) 
and 4-(dimethylamino)pyridine (357.0 mg, 2.903 mmol) in acetonitrile 
(1 mL), carbazole 41 f (947.0 mg, 2.930 mmol) in acetonitrile (10 mL) 
was added. The solution was stirred at room temperature for 23 h. 
Evaporation of the solvent and purification of the residue by flash 
chromatography on silica gel (PE/Et2O = 19/1) provided 71 f as a colourless solid. 
Yield: 1.248 g, 2.930 mmol, 100%. 
Decomposition: 59 °C. 
UV (MeOH): λ = 265, 296, 325 nm.  
IR (ATR): ν = 2956, 2926, 2846, 1737, 1447, 1417, 1347, 1290, 1145, 1117, 848, 830, 771, 
748 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.83 (d, J = 6.6 Hz, 6 H), 1.09 – 1.14 (m, 2 H), 1.26 – 1.28 
(m, 4 H), 1.46 –1.53 (m, 3 H), 1.69 (s, 9 H), 2.35 (s, 3 H), 3.00 (t, J = 8.0 Hz, 2 H), 3.94 (s, 3 
H), 7.25 (s, 1 H), 7.28 – 7.31 (m, 1 H), 7.36 – 7.39 (m, 1 H), 7.86 (d, J = 7.5 Hz, 1 H), 7.98 
(d, J = 8.3 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.68 (CH3), 22.61 (2 CH3), 27.19 (CH2), 
27.90 (CH), 28.20 (3 CH3), 28.70 (CH2), 30.31 (CH2), 30.38 (CH2), 38.97 (CH2), 55.90 
(CH3), 83.39 (C), 98.17 (CH), 115.26 (CH), 119.05 (CH), 122.62 (CH), 125.52 (C), 125.55 
(C), 126.13 (CH), 126.98 (CH), 131.54 (C), 132.97 (C), 140.66 (C), 151.81 (C), 155.37 
(C=O) ppm. 
GC-MS (EI): m/z (%) = 323 (M+ – 100, 100), 308 (11), 224 (40), 210 (21), 194 (11), 180 
(18), 167 (6). 
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tert-Butyl 3-methoxy-2-methyl-1-(6-methylheptyl)-4-nitro-9H-carbazole-9-carboxylate 
82 f 
 
Acetic anhydride (751.0 mg, 7.36 mmol) was added to a suspension of 
claycop (552.0 mg) and Et2O (10 mL). Carbazole 71 f (238.0 mg, 
0.561 mmol) dissolved in Et2O (10 mL) was added over 10 min. The 
suspension was allowed to stir 5 h. After filtration over silica gel with 
Et2O (0.5 L) the solvent was evaporated and the residue purified by 
flash chromatography on silica gel (PE/Et2O = 19/1) to afford compound 82 f as a yellow 
solid. 
Yield: 214.0 mg, 0.457 mmol, 81%. 
Decomposition: 121 °C. 
UV (MeOH): λ = 230, 249, 279, 296 nm.  
IR (ATR): ν = 2955, 2924, 2863, 1744, 1528, 1370, 1278, 1236, 1148, 1134, 1118, 988, 846, 
744 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.84 (d, J = 6.6 Hz, 6 H), 1.10 – 1.14 (m, 2 H), 1.24 – 1.29 
(m, 4 H), 1.45 – 1.52 (m, 3 H), 1.69 (s, 9 H), 2.44 (s, 3 H), 2.98 – 3.00 (m, 2 H), 3.88 (s, 3 H), 
7.28 – 7.31 (m, 1 H), 7.45 – 7.48 (m, 1 H), 7.68 (d, J = 7.8 Hz, 1 H), 7.97 (d, J = 8.4 Hz, 1 H) 
ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 13.16 (CH3), 22.60 (2 CH3), 27.14 (CH2), 
27.90 (CH), 28.13 (3 CH3), 28.24 (CH2), 30.29 (CH2), 30.81 (CH2), 38.90 (CH2), 62.91 
(CH3), 84.70 (C), 114.94 (CH), 117.31 (C), 121.13 (CH), 121.90 (C), 123.55 (CH), 128.11 
(CH), 130.73 (C), 134.66 (C), 135.35 (C), 136.69 (C), 141.04 (C), 146.77 (C), 151.18 (C=O) 
ppm. 
GC-MS (EI): m/z (%) = 368 (M+ – 100, 100), 353 (12), 323 (5), 269 (10), 238 (9), 224 (9), 
210 (6), 194 (17), 180 (11), 167 (5), 152 (3). 
Anal. calcd for C27H36NO5: C 69.21, H 7.74, N 5.98; found: C 69.37, H 7.87, N 5.91%.  
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3-Methoxy-2-methyl-1-(6-methylheptyl)-4-nitro-9H-carbazole 77 d  
 
Carbazole 82 f (206.0 mg, 0.440 mmol) was heated neat to 180 – 
190 °C under argon atmosphere for 45 min. Cooling to room 
temperature provided compound 77 d as a yellow solid without any 
purification. 
Yield: 162.0 mg, 0.440 mmol, 100%. 
Melting point: 104 °C. 
UV (MeOH): λ = 230, 249, 279, 296 nm.  
IR (ATR): ν = 3363, 2921, 2852, 1519, 1355, 1311, 1283, 1147, 1115, 1091, 1010, 743, 635 
cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.87 (d, J = 6.6 Hz, 6 H), 1.16 – 1.20 (m, 2 H), 1.32 – 1.38 
(m, 2 H), 1.42 – 1.51 (m, 2 H), 1.52 – 1.55 (m, 1 H), 1.63 – 1.66 (m, 2 H), 2.43 (s, 3 H), 2.88 
– 2.91 (m, 2 H), 3.91 (s, 3 H), 7.18 – 7.22 (m, 1 H), 7.44 – 7.45 (m, 2 H), 7.86 (d, J = 8.0 Hz, 
1 H), 8.04 (br s, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.35 (CH3), 22.64 (2 CH3), 27.31 (CH2), 
27.91 (CH), 28.98 (CH2), 29.00 (CH2),  30.23 (CH2), 38.81 (CH2), 63.11 (CH3), 110.87 (CH), 
112.24 (C), 119.47 (C), 120.06 (CH), 121.78 (CH), 126.91 (CH), 127.78 (C), 128.21 (C), 
135.37 (C), 136.56 (C), 139.67 (C), 144.20 (C) ppm.  
GC-MS (EI): m/z (%) = 368 (M+, 100), 353 (12), 269 (10), 238 (8), 224 (8), 210 (6), 194 
(13), 180 (10), 167 (6), 152 (3). 
Anal. calcd for C22H28N2O3: C 71.71, H 7.66, N 7.60; found: C 71.91, H 7.82, N 7.66%. 
 
4-Amino-3-methoxy-2-methyl-1-(6-methylheptyl)-9H-carbazole 78 d 
 
Palladium on activated charcoal (30 wt%, 12.5 mg) in EtOAc (10 mL) 
was added to carbazole 77 d (25.0 mg, 0.071 mmol). The reaction 
mixture was stirred under hydrogen atmosphere (1 atm) at room 
temperature for 3.5 d. It was then filtered over celite® with Et2O 
(0.5 L). Evaporation of the solvent afforded compound 78 d as a yellow 
solid. 
Yield: 23.8 mg, 0.071 mmol, 100%. 
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Melting point: 106 °C. 
UV (MeOH): λ = 227, 249, 281, 292, 346 nm.  
IR (ATR): ν = 3452, 3370, 3344, 3057, 2926, 2866, 1601, 1456, 1441, 1411, 1297, 1198, 
997, 733 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.86 (d, J = 6.6 Hz, 6 H), 1.15 – 1.19 (m, 2 H), 1.31 – 1.39 
(m, 2 H), 1.40 – 1.45 (m, 2 H), 1.45 – 1.64 (m, 3 H), 2.39 (s, 3 H), 2.76 – 2.79 (m, 2 H), 3.79 
(s, 3 H), 4.34 (br s, 2 H), 7.18 – 7.21 (m, 1 H), 7.32 – 7.35 (m, 1 H), 7.41 (d, J = 8.0 Hz, 1 H), 
7.80 (br s, 1 H), 7.94 (d, J = 7.8 Hz, 1 H) ppm. 
13C NMR and DEPT (125 MHz, CDCl3): δ = 12.24 (CH3), 22.65 (2 CH3), 27.41 (CH2), 
27.99 (CH), 28.31 (CH2), 29.85 (CH2), 30.29 (CH2), 39.01 (CH2), 60.04 (CH3), 109.41 (C), 
110.14 (CH), 113.20 (C), 119.10 (CH), 120.63 (CH), 123.73 (C), 124.14 (CH), 127.27 (C), 
132.49 (C), 136.07 (C), 139.19 (C), 139.24 (C) ppm. 
GC-MS (EI): m/z (%) = 338 (M+, 36), 323 (100), 239 (37), 224 (19), 195 (15). 
Anal. calcd for C22H30N2O: C 78.06, H 8.93, N 8.28; found: C 77.79, N 9.24, H 8.28%. 
 
4-(5-iso-Butylbiuret-1-yl)-1-(6-methylheptyl)-3-methoxy-2-methyl-9H-carbazole 85 d 
 
To a solution of compound 78 d (15.0 mg, 0.044 mmol) in 
acetonitrile (5 mL) at reflux, biuret 108 (27.1 mg, 0.133 mmol) in 
actonitrile (5 mL) was added continuously over 3 h. The resulting 
mixture was stirred for additional 2 h at reflux. The mixture was 
cooled to room temperature and quenched with water (10 mL), 
extracted with DCM (3 x 10 mL) and the combined organic layers 
were dried with magnesium sulphate. Evaporation of the solvent 
and purification of the residue by flash chromatography on silica gel (PE/Et20 = 1/10) 
provided 85 d as a yellow solid. 
Yield: 17.9 mg, 0.037 mmol, 84%. 
Melting point: 154 – 155 °C. 
UV (MeOH): λ = 219, 241, 264 (sh), 286 (sh), 298, 331, 344 nm.  
IR (ATR): ν = 3301, 2955, 2926, 2869, 1672, 1531, 1456, 1400, 1294, 1224, 1145, 1109, 
1008, 762, 737 cm–1. 
1H NMR (500 MHz, acetone-d6): δ = 0.89 (d, J = 6.6 Hz, 6 H), 0.93 (d, J = 6.7 Hz, 6 H), 
1.20 – 1.25 (m, 2 H), 1.36 – 1.40 (m, 2 H), 1.41 – 1.44 (m, 3 H), 1.47 – 1.59 (m, 2 H), 1.65 – 
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1.80 (m, 1 H), 2.42 (s, 3 H), 2.92 – 3.00 (m, 2 H), 3.09 (t, J = 6.3 Hz, 2 H), 3.79 (s, 3 H), 7.09 
– 7.12 (m, 1 H), 7.31 – 7.35 (m, 1 H), 7.45 (d, J = 8.1 Hz, 1 H), 7.97 (d, J = 7.9 Hz, 1 H), 
10.26 (br s, 1 H) ppm.  
13C NMR and DEPT (125 MHz, acetone-d6): δ = 12.47 (CH3), 20.21 (2 CH3), 22.89 (2 
CH3), 28.12 (CH2), 28.64 (CH), 29.26 (CH2), 29.34 (CH), 30.30 (CH2), 30.90 (CH2), 39.76 
(CH2), 47.50 (CH2), 61.19 (CH3), 111.35 (CH), 119.20 (CH), 122.06 (C), 123.12 (CH), 
123.60 (C), 125.75 (CH), 127.68 (C), 137.06 (2 C), 141.31 (2 C), 148.57 (C), 154.68 (C=O), 
155.73 (C=O) ppm. 
MS (250 °C): m/z (%) = 480 (M+, 0.6), 364 (18), 349 (17), 338 (47), 323 (100), 239 (35), 224 
(15), 172 (22), 99 (10).  
HRMS: m/z [M+ – 116] calcd for C23H28N2O2: 364.2151; found: 364.2158.   
 
4-(5-iso-Butylbiuret-1-yl)-1-(6-methylheptyl)-3-hydroxy-2-methyl-9H-carbazole 32 d 
 
Carbazole 85 d (26.0 mg, 0.054 mmol) in DCM (5 mL) was 
cooled to –78 °C and boron tribromide (1 M in DCM, 179 µl, 
0.179 mmol) was added to the solution. After 1 h at –78 °C the 
brown solution was stirred at 0 °C for 2.5 h. The mixture was 
quenched with water (10 mL), extracted with DCM (3 x 10 mL) 
and the combined organic layers were dried with magnesium 
sulphate. Evaporation of the solvent and purification of the 
residue by flash chromatography on silica gel (PE/Et2O = 1/10) provided 32 d as a yellow 
solid.  
Yield: 19.9 mg, 0.043 mmol, 79%. 
Melting point: sub. 92 °C (lit. 92 – 94 °C)[57]. 
UV (MeOH): λ = 220, 239, 266 (sh), 290, 302, 341, 352 nm.  
IR (ATR): ν = 3311, 2954, 2926, 2868, 1668, 1533, 1460, 1227, 737 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 0.89 (d, J = 6.6 Hz, 6 H), 1.02 (d, J = 6.7 Hz, 6 H), 1.20 – 
1.24 (m, 2 H), 1.36 – 1.47 (m, 2 H), 1.50 – 1.59 (m, 3 H), 1.67 – 1.73 (m, 2 H), 1.89 – 1.96 
(m, 1 H),  2.43 (s, 3 H), 3.00 – 3.03 (m, 2 H), 3.21  3.24 (m, 2 H), 6.99 (br s, 1 H), 7.11 – 7.14 
(m, 1 H), 7.33 – 7.36 (m, 1 H), 7.49 (d, J = 8.1 Hz, 1 H), 8.43 (d, J = 7.5 Hz, 1 H), 10.28 (br s, 
1 H), 10.94 (br s, 1 H) ppm. 
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13C NMR and DEPT (125 MHz, CDCl3): δ = 12.78 (CH3), 20.19 (2 CH3), 22.88 (2 CH3), 
28.13 (CH2), 28.62 (CH), 29.15 (CH2), 29.49 (CH), 30.26 (CH2), 30.81 (CH2), 39.76 (CH2), 
47.69 (CH2), 111.51 (CH), 115.00 (C), 116.78 (C), 119.08 (CH), 121.96 (CH), 122.83 (C), 
122.96 (C), 125.40 (CH), 125.49 (C), 134.80 (C), 140.97 (C), 143.12 (C), 154.88 (C=O), 
155.20 (C=O) ppm. 
MS (220 °C): m/z (%) = 466 (M+, 0.003), 350 (41), 324 (48), 251 (74), 225 (100), 172 (25), 
99 (15), 30 (26). 
HRMS: m/z [M+ – 116] calcd for C22H26N2O2: 350.1994; found: 350.1986. 
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5.10 Crystal data 
5.10.1 4-(5-iso-Butylbiuret-1-yl)-1-heptyl-3-methoxy-2-methyl-9H-carbazole 
(85 c) 
Empirical formula  C27H38N4O3 
Formula weight  466.61 g mol–1 
Habit, colour irregular block, yellow 
Temperature  198(2) K 
Wavelength  0.71073 Å 
Crystal system  hexagonal 
Space group  R -3 
Unit cell dimensions a = 27.586(4) Å α= 90° 
 b = 27.586(4) Å β= 90° 
 c = 19.842(4) Å γ = 120° 
Volume 13077(4) Å3 
Z 18 
Density (calculated) 1.067 g/cm3 
Absorption coefficient 0.070 mm–1 
F(000) 4536 
Crystal size 0.48 x 0.19 x 0.08 mm3 
θ range for data collection   3.05 to 25.40° 
Index ranges -33<=h<=31, -33<=k<=33, -23<=l<=23 
Reflections collected 53022 
Independent reflections 5332 [R(int) = 0.0424] 
Completeness to θ = 25.40° 99.7%  
Max. and min. transmission 0.9944 and 0.8093 
Refinement method full-matrix least-squares on F2 
Data to parameter ratio 13.0:1 
Goodness-of-fit on F2 1.067 
Final R indices [I>2sigma(I)] R1 = 0.0704, wR2 = 0.2044 
R indices (all data) R1 = 0.0867, wR2 = 0.2221 
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Largest diff. peak and hole 0.629 and -0.747 e.Å-3 
CCDC number 708521 
5.10.2 5-iso-Butyl-1-nitrobiuret (108) 
Empirical formula  C6H12N4O4 
Formula weight  204.20 g mol–1 
Habit, colour irregular block, colourless 
Temperature  198(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P b c a 
Unit cell dimensions a = 10.571(1) Å α= 90° 
 b = 6.448(1) Å β= 90° 
 c = 28.570(3) Å γ = 90° 
Volume 1947.4(4) Å3 
Z 8 
Density (calculated) 1.393 g/cm3 
Absorption coefficient 0.117 mm–1 
F(000) 864 
Crystal size 0.36 x 0.22 x 0.03 mm3 
θ range for data collection 3.44 to 25.00° 
Index ranges -12<=h<=12, -7<=k<=7, -33<=l<=33 
Reflections collected 13855 
Independent reflections 1543 [R(int) = 0.0342] 
Completeness to θ = 25.00° 90.1%  
Absorption correction semi-empirical from equivalents 
Max. and min. transmission 0.9965 and 0.8422 
Refinement method full-matrix least-squares on F2 
Data to parameter ratio 8.5:1 
Goodness-of-fit on F2 1.091 
Final R indices [I>2sigma(I)] R1 = 0.0386, wR2 = 0.0919 
R indices (all data) R1 = 0.0551, wR2 = 0.1015 
Largest diff. peak and hole 0.163 and -0.168 e.Å-3 
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CCDC number 708520 
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5.10.3 4-Amino-1-heptyl-3-methoxy-2-methyl-9H-carbazole (78 c) 
Empirical formula  C21H28N2O 
Formula weight  324.45 g mol–1 
Habit, colour irregular block, yellow 
Temperature  198(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21/c 
Unit cell dimensions a = 15.921(3) Å α= 90° 
 b = 4.739(1) Å β= 113.91(3)° 
 c = 26.736(5) Å γ = 90° 
Volume 1844.1(6) Å3 
Z 4 
Density (calculated) 1.169 g/cm3 
Absorption coefficient 0.072 mm–1 
F(000) 704 
Crystal size 0.25 x 0.08 x 0.05 mm3 
θ range for data collection 3.05 to 26.00° 
Index ranges -19<=h<=19, -5<=k<=5, -32<=l<=32 
Reflections collected 27882 
Independent reflections 3615 [R(int) = 0.0538] 
Completeness to θ = 26.00° 99.8%  
Absorption correction semi-empirical from equivalents 
Max. and min. transmission 0.9964 and 0.9022 
Refinement method full-matrix least-squares on F2 
Data to parameter ratio 9.8/1 
Goodness-of-fit on F2 1.049 
Final R indices [I>2sigma(I)] R1 = 0.0528, wR2 = 0.1061 
R indices (all data) R1 = 0.1027, wR2 = 0.1269 
Largest diff. peak and hole 0.173 and -0.174 e.Å-3 
CCDC number    708519 
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5.10.4 tert-Butyl 3-methoxy-2-methyl-4,6-dinitro-1-pentyl-9H-carbazole-9-
carboxylate (82 g) 
Empirical formula  C24H29N3O7 
Formula weight  471.50 g mol–1 
Habit, colour irregular block, yellow 
Temperature  273(2) K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group  P -1 
Unit cell dimensions a = 7.986(1) Å α= 72.10(3)° 
 b = 12.397(4) Å β= 83.27(2)° 
 c = 12.591(4) Å γ = 81.33(1)° 
Volume 1169.3(5) Å3 
Z 2 
Density (calculated) 1.339 g/cm3 
Absorption coefficient 0.099 mm–1 
F(000) 500 
Crystal size 0.23 x 0.19 x 0.16 mm3 
θ range for data collection 3.02 to 25.40° 
Index ranges -9<=h<=9, -14<=k<=14, -15<=l<=15 
Reflections collected 31505 
Independent reflections 4283 [R(int) = 0.0873] 
Completeness to θ = 25.40° 99.6%  
Absorption correction semi-empirical from equivalents 
Max. and min. transmission 0.9843 and 0.8393 
Refinement method full-matrix least-squares on F2 
Data to parameter ratio 8.6:1 
Goodness-of-fit on F2 1.031 
Final R indices [I>2sigma(I)] R1 = 0.0533, wR2 = 0.1274 
R indices (all data) R1 = 0.0962, wR2 = 0.1470 
Largest diff. peak and hole 0.434 and -0.343 e.Å-3 
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5.11 Abbreviations 
 
Ac   acetyl 
ATR   attenuated total reflexion 
BINAP  2,2’-bis(diphenylphosphino)-1,1’binaphthyl 
Boc   tert-butyloxycarbonyl 
bp.   boiling point 
calcd    calculated 
cat.   catalytic 
Cbz   benzyloxycarbonyl 
conc.   concentrated 
COSY   correlation spectroscopy 
d   day(s) 
dba   dibenzylideneacetone 
DCM   dichloromethane 
decomp.  decomposition 
DEPT   distortionless enhancement by polarisation transfer 
DMAA  N,N-dimethylacetamide 
DME   1,2-dimethoxyethane 
DMF   N,N-dimethylformamide 
dppf   1,1’-bis(diphenylphosphino)ferrocene 
eq.   equivalent(s) 
Et   ethyl  
EXSY   exchange spectroscopy 
FT   fourier transformation 
GC   gas chromatography 
h hour(s) 
HMBC heteronuclear multiple bond correlation 
HRMS high resolution mass spectroscopy 
HSQC   heteronuclear single quantum correlation 
IC50    half maximal (50%) inhibitory concentration 
IR   infrared spectroscopy 
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LHMDS  lithium hexamethyldisilazide 
lit.   literature 
MS   mass spectroscopy 
MIC90   minimal concentration for 90% inhibition 
min   minute(s) 
MSNT   2,4,6-mesitylene-sulphonyl-3-nitro-1,2,4-triazolide 
MW   microwave irradiation 
NBS   N-bromosuccinimide 
n. c.    no conversion 
NCS   N-chlorosuccinimide 
NMO   N-methylmorpholine-N-oxide 
NMR   nuclear resonance spectroscopy 
NOESY  nuclear overhauser effect spectroscopy 
o   ortho 
PE   petrolium aether 
ppm   parts per million 
quant.   quantitative 
rac.   racemic 
RF   reflux 
ROESY  rotational nuclear overhauser effect spectroscopy 
r.t.   room temperature 
s   second(s) 
SET   single electron transfer 
SI   selectivity index 
sub.   sublimation 
subst.    substituted 
t   tertiary 
TEMPO  2,2,6,6-tetramethylpiperidine-1-oxyl 
TCl-d2   1,1,2,2-tetrachloroethane-d2 
TLC   thin layer chromatography 
TPAP   tetrapropylammonium perruthenate 
UV   ultra-violet 
VIS   visible 
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wt%   percent by weight  
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